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Abstract 
Faecal incontinence (FI) is a debilitating disorder that affects a significant portion of 
the population. The research included in this thesis aimed to test the hypothesis that  
magnetic actuating of smooth muscle cells loaded with superparamagnetic iron oxide 
nanoparticles (SPION) can modify the cell phenotype, which could be used with as a 
future  therapy.  The  research  focused  on  exploring  a  novel  method  of  magnetic 
actuation and assessing its effects on the phenotype and biocompatibility of human 
rectal smooth muscle cells (HRSMC). A 2D model was used to demonstrate the effects 
of  SPION  on  HRSMC.    Initially,  the  effect  of  incubating  HRSMC  with  different 
concentrations  of  SPION  (0,  31.25,  250  and  1000  µg/ml)  for  24  hours  was 
investigated.  Transmission  electron  microscopy  revealed  that  SPION  were 
endocytosed  by  cells  and  became  concentrated  inside  endosomes.  Superconducting 
quantum interference device (SQUID) measurements showed that SPION loading was 
concentration dependent and also that saturation occurred for concentrations above 250 
µg/ml. SPION loading of HRSMC led to inhibition of the gene expression of actin and 
calponin  when  incubated  in  differentiation  medium,  with  or  without  magnetic 
actuation, suggesting SPION caused the cells to shift towards a more proliferative 
phenotype.  Live  cell  imaging  revealed  actuation  of  SPION-loaded  HRSMC  with 
stronger  magnets  led  to  an  observable  movement  of  internalized  SPION  and  the 
plasma membrane.   
The findings from this research indicate SPION is biocompatible and may alter the 
phenotype of HRSMC. Therefore, SPION may offer novel benefits for regenerating 
damaged muscle in the treatment of FI. Further investigation is needed to assess the 
effects of magnetic actuation on SPION loaded cells. 	 ﾠ iii 
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1. Introduction 
1.1  Faecal Incontinence 
Faecal incontinence has been defined as an alteration of the faecal passage where the 
patient experiences involuntary loss of flatus, liquid or solid faecal contents (1, 2).  
Consequently, the patient is unable to control the passage of faecal mass through the 
anus experiencing in some cases an urge of faecal incontinence (with a feeling before 
leaking) or a passive incontinence (without experiencing the urge before leaking) (3). 
This  affliction  is  a  consequence,  sign  or  symptom  of  other  alterations  including 
mechanical, neurological and sensorial causes (1, 4). The multi-aetiology of faecal 
incontinence makes it difficult to effectively treat. Patients who suffer from faecal 
incontinence  experience  social  isolation  and  stigma  which  can  bring  significant 
negative  consequences  to  their  quality  of  life  (5).  Patients  who  suffer  from 
incontinence have to plan their lives around a quick access to the toilet. Therefore this 
have a consequence on their quality of life by avoiding activities such as shopping, go 
to the cinema, dinning with friends or family are some examples. In addition there are 
not very reluctant to share their problem with a healthcare professional due to the 
embarrassment that augments the difficulty of their situation. Epidemiological studies 
showed that men and women are equally affected (6-9). Therefore, there is a need to 
provide  an  effective  and  long-term  solution  to  this  problem.  Before  exploring  the 
available treatments, it is important to understand the epidemiology, assessment and 
aetiology of faecal incontinence.   
1.2 Epidemiology  
The statistics of faecal incontinence are very inconsistent therefore is difficult to be 
very accurate with the severity of the condition. It has been estimated that the number Chapter 1: Introduction and Thesis Overview  
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of patients suffering from faecal incontinence varies between 2.2 to 20.7%(6, 10).  
Previous epidemiological studies were conducted in order to determine the number of 
people  affected  by  faecal  incontinence.  In  an  American  telephone  survey  of  the 
population  of  Wisconsin  (USA),  2570  households  were  randomly  selected  and 
telephoned  (200  households  per  month)  resulting  in  6959  individuals.  The  survey 
showed only 153 individuals were affected by faecal incontinence, which accounts 
approximately 3% out of the total population. Specifically 36% were incontinent to 
solid feaces, 54% to liquid feaces and 60% to gas. In this study the number of women 
affected was more than men (63%) with 30% to be more than 65 years old (11). 
Additionally, the results from a different study showed that 18.4% suffered from faecal 
incontinence out of 81 randomly selected individuals. The severity had increased with 
age and men were affected more than women. Finally that 1/3 of the individuals ever 
discussed their condition with a physician due to embarrassment and the fear of social 
exclusion (12).   
There are several studies that have explored the prevalence of faecal incontinence in 
women. However women at all ages could be affected by faecal incontinence but the 
severity increases with age. In a community-dwelling woman in a health maintenance 
organization  (HMO)  in  Washington  State  (USA)  a  total  of  6000  women  were 
examined (aged between 30-90 years old) for prevalence of faecal incontinence. The 
results showed only 7.2% of the total population was affected and the prevalence was 
more notable with age(13). Similar results were observed in a community study in 
Olmsted County, Minnesota (USA) where the results showed that severity of faecal 
incontinence increases with age out of a population of 2,800 women (14). 
The prevalence of faecal incontinence has investigated not only by age or sex but also 
by race, geographical location or even if it is a hospital or a community home.  Chapter 1: Introduction and Thesis Overview  
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In a study, 6,099 individuals were interviewed door to door. The results showed that 
585 individuals out of 6,099 resulting 9.6% suffered from faecal incontinence. Faecal 
incontinence is associated with age but is more prominent in the black population 
rather than the white. (15).  
The  geographical  location  or  the  place  is  also  a  contributing  factor  of  faecal 
incontinence. In a study in a care facility in France, 234 patients out of 1,186 patient 
(aged 60 years old and older) suffered from faecal incontinence resulting in 20% (16). 
In a similar study with French population in a household community, a questionnaire 
was given to 7,196 patients  (aged 15 years and older). The evaluation showed that 
16.8% of the patients had experienced problems with faecal incontinence. (17). 
However in a community study of western Syndney (Australia) different results were 
observed. A questionnaire was sent to 220 individuals with average age 53 years old 
(55% women). The results showed that 2-9% of the total population suffered from 
faecal incontinence (18). However, in a hospital outpatient clinic north Queensland 
(Australia),  a  notable  increase  in  the  number  of  people  affected  from  faecal 
incontinence was observed. Out of 435 patients (n=261 with gynecological problems 
and  n=174  with  colorectal  problems)  with  average  age  53  years  old  90  showed 
symptoms of faecal inconitence which account in 20.7% out of the total population. 
According to the authors that were the highest percentage reported in the literature of 
people affected from feacal incontinence on a hospital setting in north Queensland 
apart from nursing home studies. It was suggested that people who suffer from chronic 
constipation  or  urinary  incontinence  should  be  reported  to  their  physicians  to  be 
checked for faecal incontinence as well. In this study the number of people affected by 
faecal incontinence was significantly increased compared to the previous study(19).  
From the previous studies, the number of people affected from faecal incontinence Chapter 1: Introduction and Thesis Overview  
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varies due to geographical location, race, sex and hospital setting or community home.  
Faecal inconitinece except from a debilitating condition that decreases the quality of 
life of individuals as described above but also is an economical burden as well. The 
average costs of 63 women who suffered from feacal incontinence due to obstretic 
damage injury were investigated. The results showed that the average cost per patient 
was  $17,166  and  evaluation  and  follow  up  charges  reached  to  a  total  $65,412. 
Therefore the total charges for all the patients were totaled $559,341, and physician 
charges accounted for 18% of these charges (20). Similarly, the cost of 457 patients 
with mean age 73.6 years for men and 73.8 years for women were evaluated. The 
results showed that the total annual cost of frequency of urinary and faecal incontinent 
was $9771 (21). 
According to a NHS report; 31% of primary care patients receive basline examination 
(relevant  medical  history,  general  examination,  general  examination  and  anorectal 
examination)  as  part  of  the  assessment.  The  salary  of  a  health  care  professional 
providing this care is approximately £38,923 and the cost per patient £43. Additionally 
the patients who receive the baseline examination will need a follow up assessment in 
1 year costing about £22 (22). 
As described faecal incontinence is a socio-economical problem for the community. 
New treatment modalities, should be assessed to determine their cost-effectiveness 
1.3 Etiology 
The anal sphincter is partly responsible for faecal continence. This sphincter consists 
of  two  layers  (Figure  1.1).  The  internal  anal  sphincter  (IAS)  is  a  ring  of  circular 
smooth muscle (23, 24). The IAS surrounds the entire anal canal and it has a thickness 
of 2 to 3 mm (24).  The Internal anal sphincter is innervated by the sympathetic (which Chapter 1: Introduction and Thesis Overview  
	 ﾠ
	 ﾠ 6 
causes  contraction)  and  parasympathetic  nervous  systems  (responsible  for  its 
relaxation).    The  IAS  is  under  autonomic  control  and  produces  80%  of  the  anal 
sphincter resting tone. The external sphincter contracts voluntarily and generates a 
constant baseline pressure(25).   The IAS is supplied by rectal blood vessels (23). The 
external anal sphincter has an oval tube shape and consists of skeletal muscle fibres.  
 
 
Figure 1.1 Anatomy of the Anal Sphincter. 
The  etiology  of  faecal  incontinence  could  be  multifactorial.  The  causes  could  be 
congenital neurological such as spina bifida, myelomeningocele, and meningocele or 
acquired  such  as  stroke,  multiple  sclerosis  and  spinal  cord  injury.  Also  abnormal 
gastrointestinal function such as intestinal malabsorption, inflammatory bowel disease  
are amongst others. Finally the cause of faecal incontinence could be a combination of 
different factors. The possible causes of incontinence are summarized in table 1.1  
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Congenital 
 
Anatomical 
Obstetric injury 
 
Neurological 
 
Functional 
 
Imperforate anus 
 
Vaginal delivery 
 
Diabetes mellitus 
 
Psychiatric disorder 
 
Rectal agenesis 
 
Anorectal surgery 
 
Multiple sclerosis 
 
Malabsorption 
 
Cloacal defects 
 
Sphincter-sparing 
bowel resection 
 
Stroke 
 
Inflammatory 
bowel disease 
 
Myelomeningocele 
 
Pelvic fracture 
 
Dementia 
 
Radiation proctitis 
 
Meningocele  Anal impalement   Central nervous 
system tumour, 
infection, trauma 
 
 
Hypersecretory 
tumours 
 
    Spina bifida 
 
Rectal 
intussusception, 
prolapse 
 
       
     Pudendal neuropathy  Faecal impaction 
 
      Physical disabilities 
Table 1.1 Causes of Faecal incontinence (adapted from Madoff, R.D.) 
People  who  suffer  from  3
rd  degree  haemorrhoids  and  decide  to  have  a  
haemorrhoidectomy are prone of developing faecal incontinence (26).  
Aging is an important factor of developing faecal incontinence. In a study, the resting 
anal  canal  pressure  (RAP)  and  the  squeeze  pressure  (MSP)  was  measured  by 
comparing 143 patients suffering from faecal incontinence to a control population of 
157 healthy individuals. The results showed that the RAP was significant lower in 
females 40 years of age and over as compared to males in the control population. MSP 
values were significantly lower in females at virtually all ages. The authors concluded 
that aging affects the RAP in both sexes but to a greater degree in women. (27). 
Patients who suffer from rectal cancer and recently had a low anterior resection (LAR) 
are really prone to develop faecal incontinence at some stage. In a study, 17 patients Chapter 1: Introduction and Thesis Overview  
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were investigated with anorectal manometry after LAR surgery the results showed that 
14  patients  out  of  17  were  incontinent  with  damage  to  sphincter  muscle  fibers  or 
innervation (28). Similar results were observed in 99 patients with anorectal cancer 
after been subjected to surgery and radiochemotherapy. The results showed 36 (36.4%) 
patients experienced urgency to defecate with inability to delay defecation for more 
than 15 min, also Incontinence to flatus, liquid and solid stools was reported at least 
once a week in 24 (24.2%), 11 (11.1%) and 5 (5.1%) patients, respectively (29) 
People who underwent lateral internal sphincteroplasty due to chronic anal fissures 
also are really prone of developing faecal incontinence in the future. In a study 585 
patients were treated with lateral internal sphincteroplasty. The results showed that 
fissures were healed up to 96% but 45% of the patients developed faecal incontinence 
occurred in 53.4 percent of women and 33.3 percent of men (30). In another study, 
where a total of 298 patients (158 males; 53 % mean age, 46.9 years;) were subjected 
to sphincteroctomy due to chronic anal fissures. Reappearance of the fissure occurred 
in  17  patients  (5.6  percent)  of  whom  9  (52  percent)  were  females.  Temporary 
incontinence was reported in 31 percent of patients and persistent incontinence to gas 
occurred in 30 %(31). 
Finally another factor of faecal incontinence is vaginal childbirth. There are lots of 
studies that have investigated the effects of vaginal delivery. In a study 184 women 
were  investigated  for  faecal  incontinence  with  anorectal  manometry  6  weeks  after 
delivery. The results showed that 42 of 168 (25%) after vaginal delivery had developed 
faecal incontinence and 76 out of 168 (45%) had abnormal anal physiology however 
16 women (9%) who delivered by cesarean remain continent(32). Similarly in another 
study, the sphincter squeeze pressure was examined in 159 females after delivery with 
endoanal ultrasound and anal manometry. The manometric data provided confirmatory Chapter 1: Introduction and Thesis Overview  
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evidence, with significantly reduced maximum squeeze pressures in patients with a 
disrupted anal sphincter (33). 
Primiparous  women  are  more  prone  to  develop  faecal  incontince  compare  to 
multiparous women. In a study 38 primiparous women with average age 31 years old 
were evaluated with anal manometry, endoanalultrasonography and pudendal nerve 
terminal motor latency during pregnancy and after delivery. The results showed that 6 
patients  developed  external  anal  sphincter  disruptions  as  revealed  with  endoanal 
ultrasonography (1 patient had light scarring in the external anal sphincter). As control 
samples 3 patients were used who underwent cesarean section. (34).  In another study, 
at the antenatal clinic at the University Hospitals of Geneva, Switzerland, 100 women 
with  vaginal  delivery  of  their  first  child  were  assessed  for  anal  incontinence.  The 
results  showed  16  out  of  92  women  (17%)  after  3  months  of  delivery  had  anal 
incontince and 11 out of 77 (14%) at 30 months(35). 
1.4 Assessment 
The way clinicians use to asses if the patient suffer from faecal incontinence is: 1) 
clinical history, 2) scoring system (36), 3) physical examination, 4) manometry (37).  
5) MRI and 6) ultrasound. Clinicians need to record the type of incontinence (flatus, 
liquid, or solid stool), the frequency and changes in the stool consistency. Findings 
from  the  physical  examination  such  as  a  breakdown  perianeal  skin,  scars  from 
previous operations also contribute towards the correct assessment. Except from the 
physical  examination  the  grade  scoring  and  the  clinical  history,  the  anorectal 
physiology is a useful diagnostic tool and a way to confirm the degree of the problem 
(6, 9). 
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1.5 Management  
Depending on the severity of incontinence, several treatment options can be considered 
to enhance the quality of life of patients (4, 38). In general terms, treatments for faecal 
incontinence can be classified as non invasive, minimally invasive and invasive. Non 
invasive include 1) Pharmacological treatments (39), 2) Biofeedback (40-44) and 3) 
Diet (45), minimally invasive include 1) Bulking agents (minimally invasive) (46-48) 
and finally invasive techniques such as 1)  sacral nerve stimulation (4, 49, 50), 2) 
Graciloplasty (4, 51, 52),  Artificial anal sphincter (AAS) (50, 53) and Colostomy (54). 
 The  clinician  always  should  start  from  a  conservative  treatment  such  as  diet  and 
biofeedback towards a more destructive treatment. Changes in the diet include the 
addition  of  supplementary  fibre  and  avoid  foods  that  cause  diarrhea.  Anti-diarrhea 
medications also are prescribed such as loperamide, diphenoxylate. Occasionally the 
anti-diarrhea  medication  could  resolve  the  problem  with  no  further  action.  If  the 
patient remain incontinent after the conservative treatment further action need to be 
taken. Semi-invasive techniques such as bulking agents could be the solution for some 
individuals, if that treatment is not sufficient invasive surgery is the last option for 
someone  who  suffers  from  faecal  incontinence.  An  algorithm  for  the  treatment  of 
faecal incontinence is summarized in Figure 1.2 (6, 8)  
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Figure 1.2 Algorithm for incontinence (adapted from Madoff, R.D.) 
1.5.1 Conservative Treatment 
1.5.1.1 Biofeedback 
Biofeedback is used as a conservative treatment for patients who suffer from faecal 
incontinence. In a study the effects of augmented biofeedback with those of sensory 
biofeedback  was  investigated  in  a  population  of  40  women  with  dysfunctional 
sphincter after childbirth. All patients were assessed before and after twelve weeks of 
biofeedback  training,  using  a  fecal  incontinence  questionnaire  and  anorectal 
manometry.  The  results  showed  that  patients  were  improved  in  both  type  of 
biofeedback  but  the  patients  who  received  augmented  biofeedback  had  a  better 
manometry  results.  Augmented  biofeedback  training  is  superior  to  sensory 
biofeedback alone in the treatment of impaired fecal continence after obstetric trauma 
(55). Biofeedback had also beneficiary results to an elderly population. In a different Chapter 1: Introduction and Thesis Overview  
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study, 13 geriatric patients were allocated to sphincter exercises. Basically, they had to 
perform 50 sphincter exercises per day for a four weeks period. The results showed 
that biofeedback training had significantly augmented the sphincter strength and was 
associated  with  greater  than  75%  decreases  in  incontinence  for  10  of  the  patients 
(77%). Improvements were maintained up to 60% six months later but then dropped to 
42% after 1 year. (56). On the contrary in a different study, 171 patients who suffered 
from faecal incontinence divided in 4 groups: (1) standard care (advice); (2) advice 
plus instruction on sphincter exercises; (3) hospital-based computer-assisted sphincter 
pressure  biofeedback;  and  (4)  hospital  biofeedback  plus  the  use  of  a  home 
electromyelogram biofeedback device. The results showed that biofeedback did not 
show any functional improvement than standard care with advice (53% improved in 
group 3 vs. 54% in group 1). These improvements were maintained for 1 year after 
finishing the treatment. (44). 
Conservative treatment improves the quality of life of patients who suffer from faecal 
incontinence but only for a short period of time. More invasive procedures required 
tackling the problem. 
1.5.2 Semi-Invasive Treatment 
1.5.2.1 Bulking Agents 
In patients with faecal incontinence in whom conservative treatment fails different 
options  are  incorporated  such  as  bulking  agent.  Bulking  agents  have  been  used  to 
narrow the anal canal and consequently to help retain stool (4, 48). The use of these 
agents is considered a minimally invasive treatment for incontinence (46). Bulking 
agents are placed in the submucosa above the dentate line to create a bulge.  Chapter 1: Introduction and Thesis Overview  
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Several  injectable  agents  have  been  identified  and  are  still  under  study  including 
carbon-based, silicone particles, collagen agents, autologous fat and calcium particles 
(48). In a study the long-term effects of carbon beads (Durasphere) in 18 patients and 
found  significant  increase  in  continence  12  months  after  the  delivery  (46).      In  a 
different  study  a  silicone-based  agent  (Bioplastique
TM)  was  used  in  10  incontinent 
patients (6 females; median age, 64, range, 41-80 years). The patients were examined 
before and 6 weeks after their treatment with clinical assessment, anorectal manometry 
and ultrasound. Ultrasound confirmed the correct position of the silicon in all patients 
and the maximum resting and squeezing pressured did not change significantly before 
and after treatment. The results showed that after 6 weeks, 6 out of 10 patients showed 
an improvement, however, 3 patients did not improve and remain incontinent. Finally 
5 out of 10 experiencing pain and ulceration at the injection site (47).  Bioplastique
TM 
was also used in a different study. 6 patients (4 males, average age 53 years) were 
received  the  treatment.  The  injection  was  introduced  circumferentially,  trans-
sphincterically.  The  findings  were  confirmed  with  anorectal  manometry  and 
ultrasound. Ultrasound confirmed the silicon agent was placed in the correct position 
and there was an increase in maximum anal resting and squeeze pressures. The results 
showed after 18 months, 5 out of 6 patients had a marked improvement(57).  
Expandable  microballoons  have  been  used  previously  for  the  treatment  of  urinary 
incontinence however in a study was used to treat patients with faecal incontinence 
problems. 6 patients (4 male) with average age of 43 with severe faecal incontinence 
received expandable microballons in the submucosa of the anal canal. Anal manometry 
was used to assess the outcomes. The results showed that the anal pressure at rest was 
not  improved  in  any  patient  when  compared  before  and  after  treatment.  Anal Chapter 1: Introduction and Thesis Overview  
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implantation of expandable microballoons is a safe and effective method however it 
seems to be more efficient with urinary rather than faecal incontinence patients(58).  
Additionally autologous fat has been injected as a treatment for faecal incontinence. In 
a study 14 patients aged between 38-62 years old received 60 ml of fat harvested from 
the abdominal wall and injected submucosally in the rectal neck. The patient were 
remained continent during the first 2-3 months post-surgery but at the 6
th month only 3 
out  of  the  14  patients  remained  continent.  Perianal  injection  of  fat  from  the  same 
patient  is  a  simple  and  cost  effective  technique  in  comparison  with  other  bulking 
agents however the results were not so convincing. Further investigation is required 
(59). Finally, glutaraldehyde cross-linked (GAX) collagen was also used as injectable 
bulking agent. 17 patients who suffered from faecal incontinence were injected with 
GAX. The evaluation was assessed with anorectal physiology and endoanal ultrasound 
before  and  after  the  injections.  All  patients  tolerated  the  treatments  without  side 
effects.  The  results  showed  that  11  out  of  the  17  patients  marked  a  significant 
improvement and 4 out of 17 no significant improvement. (60). 
Although several potential treatment options have been developed, none have been 
shown to provide long-term efficacy. If the condition of the patient has been improved 
at this stage, further invasive procedures will be incorporated.  
1.5.3 Invasive Procedures 
Restoration  of  continence  to  patients  when  traditional  treatment  fails,  or  when 
traumatic or neurogenic injuries are extensive, remains a challenge. Options available 
to such patients include dynamic graciloplasty, an artificial anal sphincter, and sacral 
nerve stimulation. 
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1.5.3.1 Sacral Spinal Nerve Stimulation 
Patients with chronic fecal incontinence in whom conservative treatments had failed 
are  consulted  to  have  sacral  nerve  stimulation.  It  includes  the  implantation  of  a 
stimulator subcutaneously, which delivers an electrical stimulation to the sacral nerve.  
Sacral nerve modulation appears to offer a valid treatment option for some patients 
with fecal incontinence and functional defects of the internal anal sphincter or of the 
striated muscle(6) 
Previous studies that have used sacral nerve stimulation in a group of 6 patients. The 
results  showed  that  incontinence  was  improved  in  all  patients.  The  Wexner  score 
decreased from a mean of 17 to 2 and the maximum squeeze pressure increased from a 
mean of 48.5 mmHg to 92.7 mmHg and median squeeze pressure increased from a 
mean of 37.3 mmHg to 72.5 mmHg. One patient has complaint of discomfort and the 
electrical  stimulator  was  removed  after  5  months.  Long-term  sacral  spinal  nerve 
stimulation  improves  continence  and  increases  striated  anal  sphincter  function  in 
patients with fecal incontinence (61). In another sacral nerve stimulation study, 10 
patients have received an electrode into the S3 or S4 foramen. The electrode was left in 
situ for a minimum of one week with chronic stimulation. The results showed that 7 
patients were became continent, 1 patient was significantly improved and 1 patient 
observed no difference. The maximum squeeze pressure was increased but not the 
resting pressure as showed by anorectal manometry (62). Similarly in 16 patients (4 
males; average age; 51.4 years old) received an electrode in the S2 (1 patient), S3 (14 
patients), or S4 (1 patient) sacral foramen. The results showed an increase in mean 
maximal pressure at rest of 37.7 mmHg and with the electrode 49.1 mmHg and in 
mean  maximal  pressure  during  squeeze  prestimulation  67.3  mmHg  and  with  the 
electrode 82.6 mmHg (63). Similarly, 5 patients (age 41-68 years) who underwent Chapter 1: Introduction and Thesis Overview  
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sacral nerve stimulation, the results showed significant improvement for all patients. 
Continence  scores  were  improved  (scale  0-20)  from  16  before  surgery  to  2  after 
surgery. No early complication or side effects were observed. Only 1 patient required 
lead  replacement  after  12  months.  The  quality  of  life  assessment  improved  in  all 
patients. The resting pressure increased in four patients, but there was no consistent 
measured physiologic change that could account for the symptomatic improvement 
(62). 
In a qualitative approach, the effect of sacral nerve stimulation was investigated in 37 
patients. The assessment was performed with daily bowel diaries over a period of 3 
weeks  with  a  disease-specific  American  Society  of  Colon  and  Rectal  Surgeons 
(ASCRS) questionnaire. The results showed that incontinence was improved in all 4 
ASCRS scales (64). 
Finally a long-term study of sacral nerve stimulation was performed in 120 patients 
(110 women; mean age, 60.5 years). The patients were followed up 3,6 and 12 months 
after the devise implantation. Patients were assessed with a 14-day bowel diary and 
Fecal  Incontinence  Quality  of  Life  and  Fecal  Incontinence  Severity  Index 
questionnaires. Seventy-six of these patients (63%) were followed a minimum of 5 
years. Fecal Incontinence Quality of Life scores also significantly improved for all 4 
scales between baseline and 5 years and 27 of the 76 patients (35.5%) required a 
device revision, replacement, or explant (65). 
Sacral nerve stimulation greatly improves continence and quality of life in selected 
patients  with  morphologically  intact  or  repaired  sphincter  offering  a  treatment  for 
patients in whom treatment options are limited. The results have shown that short-term 
sacral  nerve  stimulation  notably  decreases  episodes  of  faecal  incontinence  but  this 
treatment does not have long-term functional improvement.  Chapter 1: Introduction and Thesis Overview  
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1.5.3.2 Artificial Anal Sphincter 
Anal sphincter replacement (AAS) is a treatment option if the problem is severe and 
not easy to repair it. Patients receive an artificial anal sphincter when previous methods 
have failed. The causes include obstetric damage, surgical damage, imperforate anus 
and spina bifida. It is the only surgical option for treatment of anal incontinence in 
patients with neurologic disease that affects the pelvic floor and the muscles of the 
lower limb. The AAS is an innovative approach where the artificial anal sphincter 
maintains continence via a fluid-filled cuff that surrounds and compresses the anal 
canal.  The  patient  controls  the  device  via  a  pump  placed  in  the  scrotum  or  labia 
majora. Squeezing the pump 9-12 times it forces the fluid from the cuff into a reservoir 
balloon, which is implanted behind the pubic bone in preperitoneal tissues. Once the 
cuff is deflated, the anal canal is open, allowing the passage of stool. The cuff then 
gradually re-inflates to close the anal canal until defecation is again desired (6-8).  
The  ASS  has  been  used  previously.  In  an  Italian  study  the  Action  artificial  anal 
sphincter  (Acticon  Neosphincter,  American  Medical  Systems,  Minneapolis,  MN, 
USA) was introduced in 28 patients who suffered from faecal incontinence. The results 
showed that early infection were occurred in 4 patients requiring the removal of the 
device and the cuff was accidently broken in another patient and had to be installed a 
new one. The rest of the patients showed a significant improvement. The anorectal 
manometry results showed that the median resting anal pressure increased from 27 
mmHg before surgery to 32 mmHg after operation. Preoperative squeeze pressure was 
42 mmHg while maximum postoperative anal pressure with the activated device was 
67 mmHg. (66). Similarly, in another study the Action artificial anal sphincter was 
introduced in 13 patients. The results have shown that 1 patient had infection of the 
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because  of  late  infection  (7  months)  and  erosion  through  the  skin  respectively  (3 
months).  The  rest  of  the  patients  who  had  the  devise  incorporated  successfully 
resulting in a full continence to solids and lquids. In a different study, the Action 
artificial anal sphincter was introduced in 13 patients. The results showed that 1 patient 
had infection of the perineal wound and the devise was removed. In 2 patients the 
device was removed because of late infection (7 months) and erosion through the skin 
respectively  (3  months).  The  rest  of  the  patients  the  devise  was  incorporated 
successfully resulting in a full continence to solids and lquids. (67). In another study 
24 patients (7 men; average age 44 years old) receive the ASS for a minimum of 6 
months. The assessment was performed with continence scores (as 0 been normal and 
120 been incontinent) and anal manometry preoperatively and postoperatively at a 6 
month interval. The results showed that 7 patients had their devices explanted and the 
rest of the patients continued with the treatment up to the 20
th month. The rest of the 
patients showed a significant decrease in the faecal insentience scores at the 6
th, 12
th 
and  20
th  month.  However,  difficulties  on  empting  the  bowel  was  observed  in  9 
patients.  Additionally,  median  anal  pressures  at  rest  on  manometry  increased 
significantly from 28 mm Hg preoperatively to 60 mm Hg (68). In a different clinical 
trial, an ASS was implanted in 115 patients (86 females- average age 49). Patients 
were  evaluated  with  anal  physiology,  endoanal  ultrasound  and  faecal  incontinence 
scoring. The patients underwent follow up 6 and 12 months post surgery.  The results 
showed 99 patients were reported a potentially adverse effect of the devise. 51 patients 
underwent  revisional  operations.  37  patients  have  had  their  devises  completely 
explanted  of  which  7  have  had  successful  re-implantations.    In  patients  with  a 
functioning  sphincter,  improvement  in  quality  of  life  and  anal  continence  was 
documented. A successful outcome was achieved in 85% of patients with a functioning Chapter 1: Introduction and Thesis Overview  
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device however; morbidity and the need for revisional surgery are high (69). Finally 
the long-term effects of ASS implantation were investigated. 17 patients were received 
an ASS and their evaluation was followed 5 years post surgery. The results showed 
that 2 patients died within the first year post surgery from unrelated causes, 3 patients 
had the devise removed due to infection. Also the devise was removed from 4 patients 
because of malfunction and only in 5 patients had the devise successfully positioned. 
These 5 patients had regular follow up for the following 5 years post surgery. Out of 
these 5 patients, continence was restored in 4 patients completely and only one had 
occasionally leakage of solid stool. (70). 
Implantation of ASS provides a solution for patient who suffered from severe faecal 
incontinence. The results have shown that approximately half of the patients have an 
adequate long-term result. Early infection and rectal erosion, together with difficulty in 
evacuating, are still major concerns with this technique. Longer follow-up is needed to 
determine the extent of problems with infection, erosion, and mechanical failure 
1.5.3.3 Dynamic Gracioplasty 
Dynamic  gracioplasty has been advocated as therapy for refractory fecal incontinence 
and for anorectal reconstruction to avoid colostomy.  
In a dynamic gracioplasty study 139 patients were recruited. Intramuscular leads and 
neurostimulators were implanted to stimulate transposed gracilis or gluteus muscle. 
The  results  have  shown  that  70%  of  the  patients  had  a  reduction  in  solid  stool 
incontinence  however  1/3  of  graciloplasty  patients  experienced  a  major  wound 
complication, with therapy failing in 41% (71). Similarly, in a different study 123 
patients  were  treated  with  dynamic  gracioplasty.  Continence  was  assessed 
preoperatively and postoperatively with the use of 14-day diaries. The results showed 
that  1  patient  had  died  unexpectedly  for  unrelated  reasons,  91  patients  (74%)  had Chapter 1: Introduction and Thesis Overview  
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adverse  effects  and  49  patients  (40%)  required  one  or  more  operations  to  treat 
complications (72).  
Dynamic gracioplasty might be a solution for people who suffer from severe faecal 
incontinence.    However,  the  procedure  has  significant  morbidity  that  can  lead  to 
functional failure.  
1.5.3.4 Colostomy 
If  none  of  the  previous  treatments  have  been  successful,  more  aggressive  surgical 
treatments were incorporated such as colostomy. Colostomy certainly does not restore 
continence, but it does restore control of bowel evacuation and allows the patient to 
return to a normal life (6). 
In a study colostomy was performed in 27 patients. Patients that didn't undergo stoma 
were used as control. The Cleveland Clinic Incontinence Score and anal physiology 
was assessed. The results showed that incontinence scores were improved significantly 
in both groups, no differences were found between the two groups (stoma/no stoma). 
The  anorectal  physiology  results  showed  that  the  maximum  resting  pressure  and 
maximum  squeeze  pressure  increased  significantly  only  in  the  no-stoma  group.  
Stoma-related  complications  occurred  in  7  of  13  patients  having  a  stoma  such  as 
hernia, and wound infection at the closure site (73). In a different study at the Royal 
Prince  Alfred  Hospital  (Australia),  57  female  patients  underwent  sphincter  repair 
primarily  and  then  a  colostomy  was  performed.  All  patients  were  assessed 
preoperatively  and  postoperatively  with  endoanal  ultrasound,  with  a  questionnaire, 
including a four-point Likert scale of continence level, the St. Mark's incontinence 
scoring system (range, 0-13), the Pescatori incontinence scoring system. 21 patients 
were received a colostomy in conjunction with an overlapping anal sphincter repair. 
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Mark's incontinence scoring (from 13 to 3) and the Pescatori incontinence scoring 
(from 6 to 2). Also, 49 of 57 (86%) repairs have been successful, and 8 are considered 
to be failures. Improved or normal continence was achieved in 17 of 21 (81%) patients 
with a stoma and overlapping anal sphincter repair and in 32 of 36 (89%) patients with 
an overlapping anal sphincter repair alone (74).  
Colostomy is an extremely invasive procedure. Infections and morbidly are the main 
negative causes.  
1.6 Regenerative Medicine Applications  
Sphincter  muscles  are  prone  to  degenerative  process  in  the  same  way  with  other 
muscles. The pathophysiology of the incontinence is usually a damage occurring at the 
sphincter muscle at the cellular level. Manometric measures often fail to distinguish 
the  cellular  processes  responsible  for  the  damage.  Regenerative  medicine  aims  to 
restore function of the damaged sphincter with either restore sphincter innervations, or 
restore the sphincter itself (25, 75).  
The delivery of stem cells in the sphincter area in order to restore function has been 
investigated previously. In a study muscle-derived stem cells were delivered into the 
sphincter  muscle  of  a  3-week  female  Sprague-Dawley  rats  where  previously  was 
cryoinjured and served as a model faecal incontinent in order to investigate if the 
functional properties could be improved. The experiments were divided in 3 groups: 1) 
control  (no  injection,  no  injection),  2)  cryoinjured  (no  injection)  and  3) 
cryoinjury+muscle  derived  stem  cells  (aprox  3,000,000  cells).  All  groups  were 
subsequently subjected to contractility. The results showed that the contractility in the 
cryoinjured group was significantly lower compared to the control group and in the 
muscle-derived stem cell group contraction had significantly increased compared to 
the cryoinjured group. The stem cells were detected in all sphincters. Stem cells were Chapter 1: Introduction and Thesis Overview  
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differentiated  and  α-actin  and  myosin  heavy  chain  was  stained  as  indication  of 
differentiation (76). Similarly, the ability of human umbilical cord matrix (hUCM) and 
rabbit marrow (rBM) stem cells to improve anal sphincter incontinence due to injure 
defects without surgical repair. hUCM were harvested from human Wharton’s jelly 
and rBM stem cells from rabbit femurs and tibias. The rabit sphincter was cryoinjured 
and used a model for faecal incontinence. The experiment is divided in 5 groups: 1) 
control, 2) injection of hUCM cells+RPMI medium, 3) injection of rBM cells+RPMI 
medium, 4) RPMI medium only, 5) saline only. Transplanted cells were tracked in the 
injured  sphincters  by  pre-labeling  with  bromodeoxyuridine.  Electromyography  was 
performed before and 2 weeks after the external anal sphincterotomy, and 2 weeks 
after cell transplantation. We also evaluated the proliferation and differentiation of 
injected  cells  with  histopathologic  techniques.  The  results  showed  a  significant 
improvement  in  sphincter  function  2  weeks  after  the  injection  of  rBM  stem  cells 
compared to control values. Moderate improvement was observed with hUCM stem 
cells. Cells with incorporated bromodeoxyuridine were detected at the site of injury 
after transplantation for both population of cells. Histopathologic evaluation showed 
normal  or  muscle-dominant  sphincter  structure  in  all  animals  receiving  rBM  and 
fibrous-dominant  sphincter  structure  in  most  animals  receiving  hUCM.    Stem  cell 
injection at the site of injury can enhance contractile function of the anal sphincter 
without surgical repair (77). 
Finally the construction of a bioengineered 3D sphincter for potential replacement of 
the entire sphincter was investigated. The 3D bioengineered sphincter was constructed 
with smooth muscle cells isolated from the sphincter tissue of rabbits and the cells 
were seeded in a culture on top of a loose fibrin gel where they migrated and self-
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contracted around a 5-mm-diameter SYLGARD mold, resulting in a 3-D cylindrical 
ring  of  sphincteric  tissue.  The  3D  bioengineered  tissue  was  subjected  to 
electrophysiology testing. The results showed that that 1) the bioengineered IAS rings 
generated a spontaneous basal tone, 2) stimulation with 8-bromo-cAMP (8-Br-cAMP) 
caused  a  sustained  decrease  in  the  basal  tone  (relaxation)  that  was  calcium-
independent, 3) upon stimulation with acetylcholine, bioengineered IAS rings showed 
a  calcium-  and  concentration-dependent  peak  contraction  at  30  seconds  that  was 
sustained for 4 min and 4) addition of 8-Br-cAMP induced rapid relaxation of ACh-
induced contraction and force generation of IAS rings. This is the first report of a 3-D 
in  vitro  model  of  a  gastrointestinal  smooth  muscle  IAS.  Bioengineered  IAS  rings 
demonstrate  physiological  functionality  and  may  be  used  in  the  elucidation  of  the 
mechanisms causing sphincter malfunction (78). 
Regenerative  medicine  approaches  hold  a  great  promise,  however,  the  studies 
conducted require further investigation. More research is necessary to be conducted in 
order to be safe for clinical applications.  
1.7 Current Magnetic Stimulation Approach  
The magnetic stimulation approaches include a magnetic devise called the Magnetic 
Anal Sphincter (MAS) a recent innovation for severe faecal incontince. The MAS was 
previously used for the treatment of gastroesophageal reflux disease. At the moment 
has not define its place in the treatment algorithm of faecal incontinence as seen in 
Figure 1.2 but is considered between minimally invasive and invasive technique.  
The MAS was placed around the anal canal in 14 patients (female, average age 62.8 
years old).  The results showed that 7 patients had adverse effects and 3 patients are no 
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following a separation at the suture connection. Five patients with 6-month follow-up 
demonstrated  a  mean  reduction  in  the  number  of  average  weekly  incontinence 
episodes from 7.2 to 0.7 (90.9%) and a mean reduction in Wexner Continence Score 
from 17.2 to 7.8 (54.7%). Compared with baseline, quality of life improved in all 4 
domains of the fecal incontinence quality of life (FIQoL) scoring system. No patients 
have reported that their condition has worsened. Two patients at 1-year follow-up both 
reported perfect continence. (79). Also, the same group has compared MAS with sacral 
nerve  stimulation  in  12  female  patients  (average  age  65  years  old).  As  control  16 
females were implanted with a permanent SNS pulse generator during the same period, 
of similar age, preoperative function scores, aetiology and duration of incontinence, 
served as a reference group. The duration of hospital stay, complications, change in 
incontinence and quality of life scores and anal physiology were compared in the two 
groups. Four patients with MAS experienced a 30-day complication and there was 1 
device removal in each group. A significant improvement in incontinence and quality-
of-life  scores  occurred  in  both  groups.  Mean  anal  resting  pressure  increased 
significantly in patients implanted with MAS (80). 
 
MAS  is  a  promising  new  technique.  Implantation  is  simple  and  it  requires  no 
adjustments from the physician or patient once the device is implanted. The results are 
not very conclusive and the number of patients is very low. Also, there is no study 
investigating the long-term effects and the only comparable study with sacral nerve 
stimulation demonstrated that MAS is effective as sacral nerve stimulation based in in 
improving continence and quality-of-life, with similar morbidity.  
Therefore, there is still a need for developing new technologies or interventions to 
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of faecal continence. Ideally new interventions should use minimal or non-invasive 
and cost effective methods that people can easily access.  
1.8 Magnetic Regulation of Sphincter Smooth Muscle Cells as a New Potential 
Therapy for Faecal Incontinence 
Smooth muscle cells have the ability to shift between a contractile or proliferative 
phenotype. This phenotypic continuum has been controlled previously; 1) chemically 
and 2) mechanically.  
In this study, the phenotypic continuum of smooth muscle cells will be controlled 
magnetically. This approach would be in the semi-invasive spectrum and would offer 
an alternative treatment for faecal incontinence. 
1.9 Physiology of Smooth Muscle Cells and Phenotypic Continuum  
Smooth muscle cells (SMC) constitute the muscular part of the gastrointestinal tract 
from the distal oesophagus to the internal anal sphincter (81). Their length is between 
200  to  300  µm  and  the  width  between  5-15  µm  (82)  which  makes  them  smaller 
compared to a skeletal fibre which has width 10-100 µm. One of the main differences 
of smooth muscle cells compared with cardiac and skeletal muscle is the lack of cross 
striation  (hence  the  name  smooth)  and  also  that  contraction  is  under  involuntary 
control because they receive neural innervations from the autonomic nervous system, 
whereas  skeletal  muscle  is  innervated  by  from  the  somatic  nervous  system  (83).  
Contractile filaments and the dense bodies occupy ~80% of the cell interior. The dense 
bodies are electron dense portions of smooth muscle in which thin filaments (actin and 
tropomyosin namely) bind. It is presumed that the dense bodies operate similarly to the 
Z-lines in skeletal muscle. Smooth muscle and skeletal cells have the same amounts of 
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different proteins such as caldesmon and caponin. Caldesmon is an 87 kDa protein and 
has binding sites for myosin, actin, tropomyosin and Ca
2+-calmodulin. Calponin is a 34 
kDa protein and has binding sites for actin, tropomyosin and Ca
2+calmodulin. Both 
proteins are inhibiting the actin-activated ATPase activity of phosphorylated smooth 
muscle myosin (84). 
Smooth muscle contains three types of filaments: 1) the thin actin filaments, 2) the 
thick myosin filaments, and 3) and the intermediate filaments. 
Actin filaments contain actin a 42 kDa globular protein (G-actin) which polymerises 
and forms a two stranded helical filament (F-actin) (82). The thick filaments contain 
myosin molecules, which are further divided in two pairs of myosin light chain (MLC) 
and one pair of heavy chain (MHC).  The heavy chains are coiled together making a 
helix and at the end of the strand a globular head is formed by the two pairs of myosin 
light  chain.  Its  head  has  a  binding  site  for  actin  (82).  Smooth  muscle  is  rich  in 
intermediate filaments that contain two specific proteins, desmin and vimentin. 
Smooth muscle cells can change their phenotype from a quiescent contractile to a 
synthetic  phenotype.  During  the  proliferation/synthetic  phase,  smooth  muscle  cells 
proliferate and produce more extracellular matrix. This can be a limitation for tissue 
engineering  applications  for  example  a  bioengineered  vascular  graft  seeded  with 
smooth  muscle  cells  due  to  Intimal  Hyperplasia  (IH),  a  vascular  condition  where 
smooth muscle cells lose their contractile proteins and an increase their proliferation, 
migration and production of extracellular matrix has been observed. For vascular tissue 
engineering promotion of a well-differentiated smooth muscle cells is the main goal in 
order  to  minimize  IH  and  also  to  understand  the  molecular  mechanisms,  which 
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When culturing in vitro, proliferative smooth muscle cells acquire a spread shape that 
grows on top of each other in a “hill and valley” morphology. They have a wide rough 
endoplasmic  reticulum,  Golgi  and  ribosomes  and  also  lack  contractile  bundles. 
Contractile smooth muscle cells have minimal rough endoplamic reticulum, Golgi and 
ribosomes. In culture, these cells possess a dense fusiform morphology (85).  Several 
genes play a role in the proliferation and differentiation of smooth muscle cells such as 
caldesmon,  smooth  muscle  actin,  calponin,  SM22,  α-  and  β-  tropomyosin  and  α1 
integrin. These genes are transcriptionally regulated and controlled by the binding of a 
serum response factor (SRF). This factor binds to a cis-regulatory element known as 
CArG box (CCAAAAAAGG) which is responsible for the transcriptional activation of 
contractile genes mentioned before (81).    
1.10 Mechanisms of Regulating the Phenotypic Continuum of Smooth Muscle 
Cells  
1.10.1 Chemical Stimulation  
Extracellular  signals  play  a  role  in  the  shift  between  the  synthetic  to  contractile 
phenotype.  A wide variety of signalling factors have been implicated in the transition 
of SMC into the proliferative synthetic phenotype.  
Table 1.2 summarizes all the soluble factors that are involved in this process. 
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Stimulation towards a 
synthetic/proliferative phenotype  
Stimulation towards a contractile 
phenotype  
Platelet-derived growth factor (PDGF  Heparin 
Basic fibroblast growth factor (bFGF  Transforming growth factor beta 1 (TGF-
b1) 
Insulin-like growth factors 
(IGFs), 
Ang-II, 
Epidermal growth factor  IGF-1 
a-Thrombin 
Factor Xa 
Ang- II 
Endothelin-1 
Unsaturated lysophosphatidic acids 
Fetal bovine serum (in vitro) 
Table 1.2 Soluble Factors Responsible for Smooth Muscle Cell Plasticity 
1.10.2 The Application of Mechanical Stimulation to Cells 
1.10.2.1 Mechanisms of Mechanotransduction  
Smooth muscle cells are able to sense external mechanical loads and translate it into a 
biochemical intracellular cascade of events- a process called as mechanotransduction.  
Understanding the biophysical factors that make the cell change phenotype and also 
their  intracellular  signals  that  control  this  change  is  very  important  for  tissue 
engineering  applications.  Mechanotransduction  is  the  conversion  of  a  mechanical 
signal  or  stimuli  into  an  intracellular  biochemical  signal.  An  example  type  of 
mechanical  signal  is  stretching,  which  results  in  changes  to  the  cell  morphology, 
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Cells use mechanoreceptors to detect a mechanical signal/stimulus and then transmit 
the message inside the cells. Once the mechanical signal has been detected the cell 
uses the cytoskeleton and a biochemical pathway to transmit the signal until it reaches 
its target, which will eventually cause a change in the cell phenotype.  
Examples of different mechanoreceptors that will respond to extracellular signals are:  
•  Integrins- transmembrane proteins that link the ECM with the cytoskeleton. 
•  Stretch-activated ion channels-ion channel proteins across the cell membrane 
connecting the ICM with the ECM. 
•  Cell  surface  receptor  proteins-  they  are  classified  into  G  protein-linked  or 
enzyme-linked cell surface receptors. These receptors respond to extracellular 
signal molecules such as proteins, hormones, and peptides.  
Mechanical stimulation can be delivered to cells in vitro using a variety of physical 
processes conditions including:  
•  Compression loading: this is a method of compressing the existing air in a 
culture system that results in hydrostatic pressure applied to the cells.   
•  Stretching:  it  is  a  common  approach  that  involves  the  use  of  a  flexible 
membrane where the cells are attached and deform this membrane by applying 
uniaxial or biaxial strain. Also cyclic and static strain can be applied.  
•  Fluid flow: it is a method in which shear stress is applied to cells as a way of 
mechanical  stimulation.  This  can  be  achieved  using  viscometers  and  flow 
chambers (87).  
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1.10.3 Effects of Mechanical Strain on Smooth Muscle Cell Phenotype 
Vascular  smooth  muscle  cells  (VSMC)  in  the  arterial  wall  experience  mechanical 
strain during the cardiac cycle. There are two main forces that act on the vascular wall: 
a) fluid shear stress, which affects mostly the endothelium because it acts parallel to 
the direction of the blood flow, and b) cyclic mechanical stretch, which acts on the 
vascular smooth muscle cells. Mechanical strain can influence the behaviour of the 
VSMC  phenotype,  shifting  it  from  a  differentiated/contractile  phenotype  to  a 
synthetic/proliferative  phenotype.  The  proliferative  phenotype  is  seen  in 
atherosclerotic lesions and is characterized by increased proliferation, matrix secretion, 
and decrease in the contractile proteins such as smooth muscle myosin heavy chain 
(88). 
Williams et al suggested that no stretch or static culture can lead to a loss of the 
contractile  phenotype  and  the  initiation  of  a  proliferative  phenotype,  however, 
excessive  stretch  can  also  lead  to  a  proliferative  phenotype  and  increased  matrix 
formation (88). 
In a study by Bonacci et al, the effects of collagen type I and laminin on bovine airway 
smooth muscle cells (ASM) was investigated in response to mechanical strain. The 
study  demonstrated  that  the  combination  of  a  collagen  coated  surface  with  strain 
enhanced the proliferation of ASM (89).   
In a similar study human cardiac stem cells were seeded into a fibronectin coated 
silicon chamber and mechanical strain was applied with 60 cycles per minute and 
120%  elongation  by  using  a  mechanical  stretch  system  (STB-140-10,  STREX) 
(stretching conditions that mimic the heart rate and 20% fractional shortening). Non-
stretched cells were used as controls. Cell growth, proliferation, and apoptosis, release 
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again after 3 days of culture. The release of different growth factors after 12 hours of 
stretching was investigated to determine how mechanical strain affected the release of 
different growth factors. Results showed there was a 1.9-fold and 29.5-fold increase in 
the concentration of VEGF and bFGF in the stretched group compared with the non-
stretched group (90). 
1.11 Application of Magnetic Field to Cells  
The application of magnetic fields to cells is not a new concept. In 1949 Crick et al, 
used magnetic fields to investigate the properties of the cytoplasm under an applied 
stress (91). Currently magnetic actuation research has involved the tagging of cells 
with magnetic particles allowing the manipulation of cell function or movement by an 
external magnetic field regardless of its location in the tissue. This advantage makes 
the technique useful for in vivo applications. Studies using magnetic actuation include 
the delivery of magnetically tagged cells to an area of interest (92-94) and magnetic 
seeding of cells to optimize attachment to a substrate (95-97).  
Recent work has shown that it is possible to target specific ion channels or surface 
receptors of different types of cells and change their behavior. This technique offers a 
great potential in the field of tissue engineering and regenerative medicine (98). 
1.11.1 Techniques of Magnetic Nanoparticle Actuation  
There  are  different  techniques  of  manipulating  a  cell’s  phenotype  using  magnetic 
actuation  (Figure  1.2).  These  techniques  include  magnetic  twisting  cytometry  and 
magnetic  tweezers.  Magnetic  twisting  cytometry  produces  a  mechanical  torque 
between  the  magnetic  particle  and  the  cell  surface  at  a  vertical  position.  This 
mechanical torque drives the particle to twist on the cell surface. The magnetic particle 
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this particular receptor/ligand. The second technique is magnetic tweezers where a 
magnetic field pulls the magnetic particles attached to the cells. In both techniques the 
force generated by the cells can be measured (99).  
 
Figure 1.3 Schematic Representation of the Different Techniques of Magnetic Actuation: 
a)  Magnetic  tweezers:  micromagnetic  particles  coated  with  RGD  peptides  attached  on  the 
plasma  membrane  (i)  or  with  an  antibody  against  an  ion  gated  channel  (ii)  an  external 
magnetic field (B = magnetic field vector) is applied to the particles vertically by pulling the 
particles.  The  mechanoreceptors  are  pulled  towards  the  field  source  that  initiates  an 
intracellular signalling.  b) Magnetic twisting cytometry: micromagnetic particles coated with 
RGD peptides attached on the plasma membrane (iii) or with an antibody against an ion gated 
channel (iv) an external magnetic field is applied to the particles making them “twist’’.  
 
One of the early studies using magnetic twisting cytometry by Wang et al investigated 
if  extracellular  matrix  receptors  such  as  integrins  provide  a  molecular  path  for 
mechanical signal transfer to the cytoskeleton.  In that study, endothelial cells were 
incubated with spherical micromagnetic beads that have been previously coated with 
an RGD sequence (Arg-Gly-Asp) known for binding to integrin receptors. A twisting 
magnetic field was applied providing a mechanical stress to the cells of 68 dyne/cm
2. 
The mechanical properties of cells were measured based on their angular strain (the 
average bead rotation) before and after disrupting the cytoskeleton with cytochalasin D 
(a metabolite that disrupts actin polymerisation). The angular strain of cells tagged 
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with RGD magnetic beads were increased after exposure to cytochalasin D for 15 
minutes. Following these findings and also the fact that the cell’s framework consists 
of  microfilaments,  microtubules  and  intermediate  filaments  which  respond 
dynamically  as  a  single  unit  when  stress  is  applied,  it  was  suggested  that  the 
mechanical  behaviour  of  the  cytoskeleton  in  response  to  mechanical  force  can  be 
explained with tensengrity (firstly introduced as a concept in architecture) rather than 
compressional continuity and hypothesised that cells might use tensegrity to mediate 
mechanotransduction within cytoskeleton (100).  
Several studies have used lab based magnetic bioreactors that mimic the action of 
magnetic twisting cytometry or magnetic tweezers to manipulate the cells for specific 
applications. The development of bioreactors is crucial for ex vivo tissue engineering. 
One  of  the  paradigms  of  tissue  engineering  suggests  that  autologous  cells  from  a 
patient growing on a scaffold within a bioreactor need to experience mechanical forces 
similar to those experienced in the body. These mechanical forces are considered to be 
crucial to initiate a cascade of signalling events inside the cell. Currently there are 
some constraints on the use of compressive loading or tensile loading bioreactors to 
mechanically  stimulate  3D  bioengineered  scaffolds  containing  cells.  However, 
magnetic actuation directed at specific mechanoreceptors has the potential for tissue 
engineering, particularly for the manipulation of scaffold/cells that are implanted into 
the patient (101, 102).  
In  a  study  by  Glogauer  et al,  magnetic  force  was  applied  to  study  force-induced 
changes in the cytoskeleton. Fibroblasts were incubated with ferric oxide bead-like 
microparticles (Fe3O4) coated with collagen and attached to the surface of cells via 
receptors of the integrin family. A static magnetic force was applied to fibroblasts 
using  a  permanent  magnet.  The  results  showed  that  when  force  was  applied Chapter 1: Introduction and Thesis Overview  
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continuously for 30 minutes there was an increase in F-actin (103).  
Hughes et al presented one of the first studies that demonstrated direct ion channel 
activation  with  the  use  of  magnetic  actuation.  Magnetic  particles  with  diameters 
between  250  nm  to  2.7  µm  were  targeted  with  either  monoclonal  antibodies  or 
complexes of nickel and nitrolotriacetic acid. An 80 mT magnetic field was applied to 
the  cells  with  a  frequency  of  1  Hz  in  cyclical  fashion.  The  results  showed  that 
manipulation of magnetic particles attached to the extracellular loop region of TREK-1 
resulted in an increase in the expression of TREK-1. The technique of tagging ion 
channels with magnetic particles allows applying highly localized forces to specific 
region of the cells (104).  
Similarly in another study, TREK-1 was used to differentiate stem cells in vitro and in 
vivo. Silica magnetic particles 250 nm in diameter with COOH coating (Micromod) 
were  tagged  with  an  anti-TREK  (transmembrane  ion  channel  stretch  activated 
potassium channel) antibody and an RGD peptide. These particles were then applied to 
human bone marrow stromal cells (HBMSCs) and an oscillating magnetic field (1 Hz) 
was used to deliver force of 1-100 pN per particle. Cells were stimulated for 1 hour 
every  day  for  a  period  of  7  days.  The  cells  expressed  an  up-regulation  of  mRNA 
expression for Sox9, core binding factor alpha 1(Cbfa1) and osteopontin, indicating 
manipulation by magnetic actuation can induce the differentiation of osteoprogenitor 
cell populations toward an osteogenic lineage (102). 
Additionally, carboxyl ferromagnetic microparticles with a size range of 4-4.5 µm, 
coated with L-arginyl-glycyl L-aspartic acid (also known as RGD) were tagged to 
mesenchymal stem cells (MSCs) via integrin receptors. An external magnetic field 
oscillating at a frequency of 1 Hz was used to deliver 6 pN of force per cell via the 
microparticles  attached  to  the  cell  surface  integrins.  The  results  showed  that  the Chapter 1: Introduction and Thesis Overview  
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membranes of MSCs were depolarized in response to force delivered by the magnetic 
field and that this response was mediated by big potassium (BK) channels and release 
of intra-calcium (105). 
Magnetic actuation has also been used to control the differentiation of cells. A study 
by Hu et al examined the possibility of controlling differentiation by mechanically 
activating the PDFG receptor α and β of HBMSCs with a bioreactor. The objective of 
the study was to identify whether magnetic fields applied to nanoparticle-bound PDGF 
receptors could regulate the phenotype of human bone marrow stromal cells. Magnetic 
particles with a diameter of 250 nm (Micromod) were conjugated with anti-human 
PDGF-α and β antibodies (R&D Systems). The conjugated particles were incubated 
with cells and magnetic force was applied. The protein levels of smooth muscle α-actin 
expression (SMA) were estimated using immunocytochemistry. There was an increase 
in  protein  levels  after  3  hours  of  continuous  magnetic  actuation.  Additionally  by 
performing real time PCR there was an up regulation of SMA mRNA levels after 3 
hours of continuous magnetic actuation (106). 
Similarly  Glossop  et al  investigated  the  differentiation  of  mesenchymal  stem  cells 
(MSCs) by actuation using magnetic particles. MSCs were incubated with 250 nm 
superparamagnetic iron oxide particles (Nanomag-silica;Micromod) and an oscillating 
magnetic field of 90 mT applied for 1 hour at 1 Hz. The results showed no change in 
the mRNA expression of MAP3K8 and IL-1B both following magnetic actuation. One 
of the limitations of the study stated by the authors was the short period of the duration 
of the experiment (24 hours) (107). 
1.12 Magnetic Fields and Superparamagnetism  
Magnetism  is  a  physical  phenomenon  that  is  mediated  by  magnetic  fields.  All 
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spin around the nucleus. Electrons carry a negative electrical charge and produce a 
magnetic field as they move through space. A magnetic field is produced whenever an 
electrical charge is in motion. The strength of this field is called the magnetic moment. 
Since all the materials have atoms are affected at some extent by a magnetic field, 
However, not all materials react the same way(108). 
When a material is placed under a magnetic field of strength H, the magnetic forces of 
the materials electrons will be affected. This is the Faraday’s law of induction.  
B = µ0(H +M) 
 
Where µ0 is the permeability of free space, and the magnetization M = m/V is the 
magnetic moment per unit volume, where m is the magnetic moment on a volume V of 
the material.    
Not all materials behave the same in the presence of a magnetic field. Materials that 
their electrons paired together in opposite direction cancel each other therefore the 
magnetic field is zero. However other materials with unpaired electrons will expose a 
net magnetic field and make them more attractable to an external magnetic field. All 
materials are magnetic to some extent, with their response depending on their atomic 
structure and temperature. They are categorized in terms of their volumetric magnetic 
susceptibility, χ, where M = χH, describes the magnetization induced in a material by 
H (109). 
The  materials  could  be  classified  as  paramagnetic,  ferromagnetic  or  diamagnetic. 
Paramagnetic materials have a small susceptibility to magnetic fields in comparison to 
diamagnetic which have a weak magnetic susceptibility. These materials are slightly 
attracted to an external magnetic field but when the field is removed the materials do 
not retain the magnetic properties and the χ ranges between 10
−6 to 10
−1. 
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repelled  by  a  magnetic  filed  therefore  the  material  does  not  retain  the  magnetic 
properties when the external magnetic field is removed therefore the χ ranges between 
10−6  to  10
−3.  Finally  the  ferromagnetic  materials  have  a  large  susceptibility  to  an 
external  magnetic  field.  Materials  exhibit  strong  attraction  towards  an  external 
magnetic field and are able to retain the magnetic properties even after the removal of 
the external magnetic field. Ferromagnetic materials have some unpaired electrons so 
their atoms have a net magnetic moment. They get their strong magnetic properties due 
to  the  presence  of  magnetic  domains.  In  these  domains,  large  numbers  of  atom's 
moments  (10
12  to  10
15)  are  aligned  parallel  so  that  the  magnetic  force  within  the 
domain is strong. When a ferromagnetic material is in the un-magnetized state, the 
domains are nearly randomly organized and the net magnetic field is zero. When a 
magnetizing  force  is  applied,  the  domains  become  aligned  to  produce  a  strong 
magnetic field within the part. The susceptibility in ordered materials depends not just 
on temperature, but also on H, which gives rise to the characteristic sigmoidal shape of 
the M–H curve, with M approaching a saturation value at large values of H as showed 
in Figure 1.4 (108) (109). 
   
(a)  (b) 
Figure 1.4  The magnetic response of SPION loaded HRSMC. (a) HRSMC alone (no SPION), 
the M-H curve are shown for diamagnetic and (b) SPION-loaded cells (1000 µg/ml), the M-H 
curve has the characteristic sigmoidal shape indicating the presence of a superparamagnetic 
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The magnetic force that experience a magnetic material (magnetic dipole-m) when 
exposed to a magnetic field could be described by the following equation:  
Fm = (m . ł)B 
Where is Fm is the force, ł is a symbol used in mathematics to denote the geometrical 
differentiation with respect to the direction of m with hypothetical coordinates m=(0,0) 
on the z-axis (110) (109). 
1.13 Superparamagnetic Iron Oxide Nanoparticles (SPION) 
Superparamagnetic  particles  consist  of  either  magnetite  (Fe3O4)  or  maghemite  (γ-
Fe2O3). Both magnetite and maghemite are members of the iron oxide family. The 
internal structure of ferromagnetic materials is composed of magnetic domains, which 
are regions grouping magnetic moments with the same orientation. Under the action of 
an external magnetic field, the domains with an orientation closer to that of the field 
tend to grow at the expense of those with a dissimilar orientation. This is regarded as 
the  magnetization  process.  When  the  dimensions  of  the  material  are  progressively 
reduced down to a certain size, which ranges from tens to hundreds of nanometers and 
is characteristic of each substance, the formation of magnetic domains is no longer 
favourable and the material becomes a single domain. In this state all the magnetic 
moments  have  the  same  orientation,  and  the  magnetization  of  the  particle  can  be 
represented by a single “giant” magnetic moment. If the size is further reduced, there 
will be a value from which the thermal energy overcomes the magnetic one, and the 
magnetisation of each particle will be continuously fluctuating between two limiting 
orientations separated by an energy barrier. It is then said the system has entered into a 
superparamagnetic regime (111). Chapter 1: Introduction and Thesis Overview  
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1.14 Synthesis of Iron Oxide Nanoparticles  
Superparamagnetic iron oxide nanoparticles can be prepared by various methods that 
affect the size distribution, shape and surface chemistry of the particles, which in turn 
affect the magnetic behaviour of the nanoparticles (112). Figure 1.3 summarizes the 
different processes available.  
 
Figure 1.5 A diagram that summarized the different methods of SPION Synthesis 
1.14.1 Co-Precipitation 
Co-precipitation is a common method for manufacturing magnetic nanoparticles. In an 
aqueous  solution  Fe
3+  and  Fe
2+  salts  are  mixed  with  alkaline  because  of  the  low 
reaction temperature and the hydrophilic surface properties of the resulting particles.  
Magnetite is synthesised by addition of ammonia to the aqueous mixture of Fe
3+ and 
Fe
2+ chloride (ratio 2:1) with the pH between 8 and 14. It is possible to control the size Chapter 1: Introduction and Thesis Overview  
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2Fe3O4 + O2 → 2γFe2O3 
	 ﾠ
and the shape, composition of the nanoparticles by changing the pH, ionic strength, 
temperature and nature of the salts, or the Fe(II)/Fe(III) concentration ratio (112).  
Maghemite  (γFe2O3) is formed from magnetite (Fe3O4) in the presence of oxygen, as 
described in the following reaction (112). 
 
1.15 Research Hypothesis 
Previous  research  have  described  that  cyclic  mechanical  strain  could  regulate  the 
phenotypic  continuum  of  smooth  muscle  cells.  It  could  shift  the  cells  towards  a 
contractile or proliferative phenotype (89). For example a study by Bonacci et al where 
airway smooth muscle cells (ASM) were subjected to cyclic strain with a Flexcell 
system resulted in an increase in the proliferation of ASM.  
Additionally, the possibility of regulating the phenotype of different type of cells from 
distance with the use of an external magnetic field was also investigated previously 
(106).  Specifically,  a  study  by  Hu  et  al  where  the  possibility  of  controlling  the 
differentiation  of  human  bone  marrow  stromal  cells  (HBMSC)  by  mechanically 
activating the PDFG receptor α and β with the use of an external magnetic field. The 
results showed an increase in the gene and protein expression of smooth muscle actin.  
Therefore, the combination of delivering a cyclic mechanical strain (mimicking the 
flex cell system) by an external oscillating magnetic field and SPION could have an 
effect on the phenotypic continuum of the cells. The SPION will be endocytosed by 
the cells rather than tagged to different proliferative or contractile receptors as have 
seen previously. This approach could potentially have a therapeutic application.  Chapter 1: Introduction and Thesis Overview  
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In this study, it was hypothesized that mechanical stretching of an external oscillating 
magnetic  field  could  change  the  phenotypic  continuum  (proliferation  or 
differentiation) of SPION-loaded HRMSC. 
1.16 Thesis Aims and Objectives  
The research described in this thesis aimed to investigate the feasibility of applying an 
external oscillating magnetic field to SPION-loaded HRSMC to regulate the 
phenotypic continuum of the cells.  
The objectives of the research were: 
1.  To load HRSMC with SPION and localise them inside the cells; this objective will 
be explored with superconducting quantum interference device (SQUID) which 
quantifies the amount of magnetic material inside the cells and the localization of 
SPION with Tramission electron microscopy (TEM).  
2.  To investigate the biocompatibility of SPION-loaded HRSMC in response to an 
external  magnetic  field.  This  objective  will  be  investigated  with  lactate 
dehydrogenase (LDH) toxicity assay, caspase 3-7 apoptosis assay and reactive 
oxygen species(ROS) assay.  
3.  To explore the effects on cell phenotype when an external magnetic field was 
applied to SPION loaded HRSMC; this objective will be investigated with cell 
proliferation  bromodeoxyuridine  (BrdU)  assay,  CyQUANT®  Cell  Proliferation 
Assay,  immunocytochemistry  and  real-time  PCR  of  different  contractile  or 
proliferative markers such as smooth muscle actin, myosin heavy chain, calponin 
and caldesmon.  Chapter 1: Introduction and Thesis Overview  
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4.  To investigate whether an oscillating external magnetic field could change the 
shape  of  the  cells  by  stretching  the  plasma  membrane;  this  objective  will  be 
explored with time-lapse microscopy and scanning electron microscopy.  
1.17 Thesis overview 
Chapter 2: Materials and Methods 
This chapter provides an overview of the materials and methods used throughout the 
research project.  
Chapter 3: Preliminary Investigation of SPION Effects on HRSMC 
The aim of this chapter was to explore the interaction of SPION with cell culture 
medium; the loading efficiency of SPION by HRSMC; the localization inside the cells 
after endocytosis had occurred; and finally the effects of different concentrations of 
SPION on the phenotype and biocompatibility of HRSMC.  
Chapter 4:  Chapter 4: Effect of Magnetic Actuation on the Phenotype of SPION- 
Loaded HRSMC 
The aim of this chapter was to investigate the effects of applying external magnetic 
fields to HRSMC loaded with SPION. This included exploring the effect of a magnetic 
field on the cell phenotype. Additionally, the effect of applying a magnetic field on cell 
toxicity, release of reactive oxygen species, and apoptosis were investigated.  
Chapter 5:  Membrane Deformation of SPION-Loaded HRSMC in Response to 
an Externally Applied Magnetic Field	 ﾠChapter 1: Introduction and Thesis Overview  
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The aim of this chapter was to investigate whether application of an external magnetic 
field to SPION-loaded HRSMC results in an observable change to the cell shape by 
stretching the plasma membrane.  	 ﾠ
Chapter 6:  Thesis Summary, Conclusion and Future work	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2.1 Materials  
2.1.1 Mammalian Cells 
Primary human rectal smooth muscle cells (HRSMC) isolated from foetal rectal tissue 
of a healthy donor were obtained from the TCS CellWorks, UK (Catalog Number: 
2980). 
2.1.2 Cell Culture Medium  
•  Proliferation Medium. Minimum Essential Medium Eagle (MEME; Sigma 
Aldrich, UK). The medium was supplemented with 10% foetal bovine serum 
(FBS) (Sigma Aldrich, UK). In addition the medium was also supplemented 
with  1x  non-essential  amino  acids  (NEAA),  2  mM  glutamine,  50  U/ml 
penicillin and 50 µg/ml streptomycin (all purchased from Sigma Aldrich, UK).  
•  Differentiation Medium. Dulbecco’s Modified Eagle Medium DMEM (Sigma 
Aldrich,  UK).  The  medium  was  supplemented  with  1x  NEAA,  2  mM 
glutamine, 50 U/ml penicillin and 50 µg/ml streptomycin (all purchased Sigma 
Aldrich, UK) and 2 ng/ml transforming growth factor (TGF)-β (PerproTech EC 
Ltd, UK) (113-115). 
2.1.3 Cell Culture Solutions 
Trypsin-ethylenediaminetetraacetic acid (EDTA) 1x solution 0.25% trypsin and 0.1% 
EDTA (Sigma). Dulbecco’s phosphate buffered saline (PBS) (Sigma). 
2.1.4  Superparamagnetic Iron Oxide Nanoparticles (SPION) 
•  SPION  (fluidMAG-UC/A  anionic  charged  SPION;  50  nm  particles  with  a 
magnetite core suspended in water with a stock concentration of 25 mg/ml and 
particle density of ~1.3x1016 particles/g; Chemicell GmbH, Berlin, Germany). Chapter 2: General Materials and Methods 
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•  SPION  (fluidMAG-UC/A  anionic  charged  SPION;  200  nm  particles  with  a 
magnetite core suspended in water with a stock concentration of 25 mg/ml and 
particle  density  of  ~  2.2  x  10
14  particles/g;  Chemicell  GmbH,  Berlin, 
Germany). 
2.2 Methods  
2.2.1 Cell Culture  
2.2.1.1 Cell Culturing Conditions  
HRSMC were maintained in proliferation medium. The cells were cultured in vented 
75cm
2
 tissue culture flasks (Nunclon
TM, Delta treated flask, Denmark). Cell cultures 
were incubated at 37ºC with 5% CO2 in a humidified atmosphere (MCO-18AIC; UV; 
Sanyo CO2; incubator, Japan).   
2.2.1.2 Cell Subculture 
HRSMC  cultured  in  tissue  culture  flasks  were  not  allowed  to  exceed  70-80% 
confluence so as to avoid contact inhibition and loss of their ability to proliferate. Sub-
culturing was performed aseptically inside a class II microbiological safety cabinet 
(Walker Safety Cabinets Ltd, UK). The monolayers attached to the base of the flasks 
were  washed  with  10  ml  of  1  x  sterile  PBS  followed  by  the  addition  of  2  ml 
trypsin/EDTA.  The  flask  was  incubated  for  2  minutes  to  facilitate  enzymatic 
detachment of the cells. When the cells were fully detached (confirmed by viewing the 
contents of the flask with an inverted microscope) 10 ml of fresh proliferation medium 
was added to the flask and the contents transferred to a sterile 30 ml container (Sterilin 
Limited, UK). The container was centrifuged at 1000 rpm for 5 minutes to pellet the Chapter 2: General Materials and Methods 
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cells in the bottom of the container. The supernatant was removed and the pellet was 
re-suspended in fresh culture medium.   
2.2.1.3 Cell Counting  
To quantify the number of cells in a suspension 10 µl of the cell suspension was placed 
into a haemocytometer (Neubauer Clear Sight, Hawksley, UK) and a coverslip placed 
on top. 
The mean number of cells was calculated from the central squares located on both 
sides of the haemocytometer and the following equation was used to calculate the 
number of cells per ml. 
Number of cells/ml = mean number of cells per central square x 10
4. 
2.2.1.4 Cell Cryopreservation 
Cells were cryopreserved to retain a sufficient stock of cells from similar passage 
numbers for future experiments. After trypsinization and centrifugation, the cell pellet 
was  re-suspended  in  1ml  of  Bambanker  (Anachem,  UK)  freezing  solution.    The 
solution  was  transferred  in  to  2  ml  cryogenic  vials  (Nalgene,  Nalgene  Company, 
USA). The samples were then stored in a -80
0C freezer (New Brunswick scientific 
ultra-low temperature freezer; Wolf laboratories Limited, UK).  
2.2.1.5 Cell Resuscitation 
The cryovials were thawed at 37
0C for 5 minutes. To avoid contamination of the cells, 
the vial was transferred into the class II microbiological safety cabinet and sprayed 
with  70%  industrial  methylated  spirit  (industrial  methylated  spirit;  Scientific  & 
Chemicals Supplies Ltd, UK) in water. The cell suspension was transferred into a 30 Chapter 2: General Materials and Methods 
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ml container containing 10 ml of cell culture medium. The cells were centrifuged for 5 
minutes  at  1000  rpm  in  order  to  remove  the  Bambanker  (Anachem,  UK).  The 
supernatant was discarded and the pellet was re-suspended in 10 ml of fresh culture 
medium. The solution was transferred to a 75 cm
2 cell culture flask (Nunclon
TM delta 
treated, Denmark) and incubated at 37
0C in 5% CO2. 
2.2.2  Measurement  of  Cellular  Loading  with  Superparamagnetic  Iron  Oxide 
Nanoparticles 
2.2.2.1 Superconducting Quantum Interference Device (SQUID) 
The  magnetometers  are  measuring  the  magnetic  properties  of  materials.  The 
magnetometers  could  be  classified  according  to  the  method  used  to  measure  the 
magnetic properties of the materials. This could be magnetometers: 1) that require 
motion  of  the  sample  within  a  coil  (vibrating  magnetometers-superconducting 
quantum  interference  device-SQUID)  and  2)  those  that  require  force  or  torque  in 
which the sample is kept static while the field is rotated for example (Faraday balance, 
Gouy method).  
A SQUID magnetometer was used in this study to measure the amount of iron loaded 
per cell. The SQUID is a magnetometer that measures very small magnetic fields, 
down to 5 x 10
-18 T.  SQUID uses a Josephson junction, which is made out of two 
superconductors separated by an insulating layer, thin enough so that electrons can 
pass through. SQUID is usually made of lead alloy or niobium. The coils are kept 
within the vacuum space of a liquid helium-filled chamber that allows cooling of the 
coils to 9 K. The coils have a 2.02 cm diameter, and the total length of the coil system 
is 3.04 cm. The SQUID is moving the sample through a superconducting coil. As the 
sample moves the magnetic dipole moment of the sample induce an electric current in Chapter 2: General Materials and Methods 
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the detection coils (the magnetic moment of the sample in recorded in electromagnetic 
units-emu).    The  SQUID  converts  the  current  to  voltage,  therefore  determines  the 
magnetic moment of the sample by measuring the voltage of the detection system. The 
changes in the voltage are directly proportional to the changes of the magnetic flux as 
the sample moves through the coil. 
The  sample  is  exposed  to  different  temperatures  and  magnetic  fields.  Initially  the 
sample is exposed to zero magnetic fields and the temperature is dropped up to 9K. 
Then  temperature  stabilizes,  a  magnetic  field  is  applied  to  the  sample  and  the 
temperature rises.  The behaviour of the sample is recorded constantly at all different  
magnetic fields and temperatures (116-119).  
(i)  5x10
5  HRSMC  were  seeded  in  a  75  cm
2  culture  flask.  The  flasks  were 
incubated at 37
0C, in a humidified atmosphere and 5% CO2 for 24 hours.   
(ii)  Medium was removed and experimental media containing SPION particles was 
added, as specified for each experiment.  
(iii)  Following incubation, the cells were washed 5x with 10 ml of PBS.    
(iv)  2 ml of trypsin was added to each flask and incubated at 37
0C, 5% CO2 for 1 
minute.   
(v)  10 ml of fresh media was added to each flask and the detached cells were 
collected in a 30 ml container.   
(vi)  Samples  were  centrifuged  at  1000  rpm  for  5  minutes,  the  supernatant  was 
removed, and the pellet was re-suspended in 10 ml of PBS. This procedure was 
repeated once.  
(vii)  Supernatant was removed and the pellet was re-suspended in 1 ml of PBS. A 
cell count was performed as described in section 2.2.1.3. The samples were 
transferred in a 1.5 ml micro-centrifuge tube (Kartell SPA, Italy). The lid of the Chapter 2: General Materials and Methods 
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tube was pierced using a needle (BD microlane TM 3; 18G 2’’, 1.2 X50 mm) to 
allow air to escape from the tube during the freeze dry process.  
(viii)  The samples frozen at -80°C (New Brunswick Scientific ultra low temperature 
freezer Wolf laboratories Ltd, UK).  
(ix)  The  samples  were  placed  into  a  freeze  drier  (Edwards  Modulyo,  UK)  and 
lyophilized for 24 hours.   
(x)  The  freeze-dried  pellets  of  cells  were  transferred  to  SQUID  capsules  (QD-
P125E; Quantum Design, USA).  
(xi)  Samples were analysed with a Quantum Design SQUID-VSM magnetometer 
(Quantum Design Inc, San Diego, CA). An MH curve was generated at 300 K 
using a field between +/- 7T.  
2.2.3 Ultrastructural Localisation of SPION 
2.2.3.1 Preparation of Samples for Electron Microscopy 
Transmission  electron  microscopy  (TEM)  was  used  to  determine  the  cellular 
localisation of SPION.  
(i)  HRSMC  were  seeded  in  25  cm
2  tissue  culture  flasks  and  incubated  as 
specified for each experiment.   
(ii)  Media  were  removed  and  experimental  media  containing  SPION  particles 
were added, as specified for each experiment.  
(iii)  Following incubation, the cells were washed 5x with 10 ml of PBS.  
(iv)  To detach cells from the flask, 2 ml of trypsin was added and the flasks were 
incubated at 37
0C, 5% CO2 for 1 minute.  
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collected in a 30 ml container.  
(vi)  Cells  were  centrifuged  at  1000  rpm  for  5  minutes,  the  supernatant  was 
removed,  and  the  pellet  was  re-suspended  in  10  ml.  The  procedure  was 
repeated once.  
(vii)  The sample was centrifuged at 1000 rpm, the supernatant was removed and 1 
ml of 2.5% v/v glutaraldehyde (Sigma, UK) was added to the pellet to fix the 
cells inside a fume cupboard.  
(viii)  The solution was transferred in a 1.5 ml micro-centrifuge tube and incubated 
overnight.  
(ix)  After removing the fixative the samples were washed in 0.5 ml of PBS and 
centrifuged at 1000 rpm 3x for 1 minute.  
(x)  The  samples  were  post  fixed  with  2%  osmium  tetroxide  (OsO4) 
(Ceimiglinited, UK) for 1 hour inside a fume cupboard.  
(xi)  The  cell  pellet  was  washed  3x  with  0.5  ml  of  PBS  for  10  minutes  and 
centrifuged at 1000 rpm for 1 minute.  
(xii)  The  cell  pellet  was  dehydrated  in  a  progressive  series  in  water/ethanol 
mixtures:   
a.  25% v/v ethanol        4 minutes 
b.  50% v/v ethanol        4 minutes  
c.  75% v/v ethanol        4 minutes 
d.  95% v/v ethanol        4 minutes 
e.  100% v/v ethanol      4 minutes  
f.  100%  ethanol  over  sieves      20  minutes  (the  last  step  was 
repeated 5 times).  
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minutes to act as a transition solvent before the embedding stage. 
(xiv)  Propylene oxide was removed and a mixture containing 1:1 v/v propylene 
oxide:  embedding  resin  (Araldite  CY212  resin;Agar  Scientific,  UK)  was 
added for 20 minutes.  
(xv)  1:1 propylene oxide was removed and 1:3 propylene oxide:embedding resin 
was added for 1.5 hours. 
(xvi)  The final propylene oxide:resin was removed and 100%resin was added. 
(xvii)  The samples were transferred to capsules (Beem Inc, USA) and placed on a 
hot plate at 60ºC for 24 hours.   
(xviii)  The resin blocks containing the samples were thin sectioned (70 nm) with an 
ultramicrotome (Reichertjung ultracut E, Germany) and directly collected onto 
copper grids for its examination under a JEOL JEM 1200EX TEM operating 
at 80 Kv. 
2.2.4 Cellular Techniques to Investigate Changes in the Phenotype 
2.2.4.1 Protein Expression of Smooth Muscle Contractile Markers 
2.2.4.1.1 Immunocytochemistry  
Immunocytochemistry  was  used  to  detect  the  expression  of  different  contractile 
smooth muscle markers such as actin, myosin heavy chain, caldesmon and calponin.  
(i)  HRSMC  were  seeded  in  a  Fluorodish  Cell  Culture  Dish  –  35  mm  (World 
Precision Instruments, USA) and incubated as specified for each experiment.  
(ii)  The medium was removed gently and cells were fixed in 4% formaldehyde in 
PBS for 10 minutes at room temperature.  
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(iv)  Then cells were blocked with 3% BSA + 0.1% triton X-100 in PBS for 1 hour 
at room temperature.  
(v)  The solution was removed and the primary antibody was added to each well. 
Cells were incubated for 1 hour.  
Primary antibody  Description  
Actin (1:1000) 
 
Monoclonal Anti-a Smooth Muscle 
Actin, Clone 1A4, 15mM 
Product No. A2547 (Sigma) 
Myosin Heavy Chain (1:500) 
 
Monoclonal Anti-Myosin (Smooth), 
Clone hSM-V produced in mouse, 15 
mM, Product No. M7786 (Sigma) 
Caldesmon (1:500) 
 
Monoclonal Anti-Caldesmon (Smooth) 
Mouse Ascites Fluid 
Clone hHCD, 15 mM, Product No. 
C4562 (Sigma)  
Calponin (1:1000) 
 
Monoclonal Anti-Calponin Clone hCP 
produced in mouse, 15 mM, Product 
No. C2687 (Sigma)  
Primary  antibody  (Isotype 
control) 
 
Actin (1:500) 
Caldesmon (1:500) 
Calponin (1:500) 
Mouse IgG1,κ (MOPC-21), Purified 
Immunoglobulin, Mouse Isotype 
Control, 15 mM, Product No. M5284 
(Sigma) 
 
Myosin heavy chain (1:500) 
1:500) 
Mouse IgG2a Isotype Control; Clone 
UPC-10 purified immunoglobulin, 15 
mM, Product No. M5409 (Sigma) 
 
(vi)  After the incubation period, cells were washed 3x with PBS.  
(vii)  Cells were incubated with the secondary antibody for 1 hour.   
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Secondary antibody   Description 
Actin (1:500) 
Myosin Heavy chain (1:500) 
Caldesmon (1:500) 
Calponin (1:500) 
Anti-mouse IgG (whole molecule) 
FITC conjugate, Antibody developed 
in Goat IgG, 15 mM, Product No. F 
9006 (Sigma) 
 
(viii)  Cells were washed 3x with PBS.   
(ix)  Cells  were  mounted  onto  glass  slides  (Thermoscientific,  Menzel-Glaser 
Superfrost
® plus, UK) with DAPI (Vectashield
® Mounting Medium with DAPI, 
Vector Laboratories Ltd, UK). 
(x)  An upright fluorescence microscope (BX51 Olympus, GX Optical, UK) was 
used to acquire images. 
2.2.4.2  Quantification  of  Gene  Expression  of  Smooth  Muscle  Contractile  and 
Proliferative Markers 
2.2.4.2.1 RNA Extraction from Cells 
For the RNA extraction step, an RNeasy mini kit was used (Qiagen, UK). The RNeasy 
mini kit purifies RNA from animal cells, animal tissues and yeasts and cleans up RNA 
from  crude  RNA  steps  and  enzymatic  reactions  (e.g  DNase  digestion,  proteinase 
digestion, RNA ligation and labelling reaction). 
(i)  3x10
5 cells were seeded in a 75 cm
2 culture flask. The flasks were incubated at 
37°C in a humidified atmosphere and 5% CO2 for 24 hours.  
(ii)  Medium was removed and experimental media containing SPION particles was 
added, as specified for each experiment. 
(iii)  Following incubation, the cells were washed 5x with 10 ml of PBS. 
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days. 
(v)  On day 7, 2 ml of trypsin was added to each flask and incubated at 37
0C for 1 
minute.  
(vi)  10 ml of fresh media was added to each flask and the detached cells were 
collected in a 30 ml container.  
(vii)  Samples  were  centrifuged  at  1000  rpm  for  5  minutes,  the  supernatant  was 
removed, and the pellet was re-suspended in 10 ml of PBS. This procedure was 
repeated once.  
(viii)  Supernatant was removed and the pellet was re-suspended in 350 ml of lysis 
solution/β-mercaptoethanol (10 µl of β-mercaptoethanol  per 1 ml of buffer)  in 
1 ml of PBS. The samples were transferred in a 1.5 ml micro-centrifuge tube 
(Kartell SPA, Italy). 
(ix)  350 µl of 70% ethanol was added to the homogenised lysate and mixed by 
pipetting. The sample was transferred to an RNeasy column.  
(x)  Samples  were  centrifuged  at  10,000  rpm  for  15  seconds  with  a  centrifuge 
(Eppendorf  Micro  Centrifuge  5410)  and  the  ‘flow  throw’  remaining  at  the 
bottom of the tube was discarded. 700 µl of RW1 buffer (containing ethanol) 
provided with the kit was added to the tube and the sample was centrifuged for 
15 seconds at 10,000 rpm. 
(xi)  The ‘flow throw’ remaining at the bottom of the tube was discarded and 500 µl 
of RPE Buffer (washing buffer) provided with the kit was added. The samples 
were centrifuged for 15 seconds at 10,000 rpm, the ‘flow throw’ was discarded, 
and a further 500 µl of RPE buffer was added and the sample was centrifuged 
for 2 minutes. The second centrifugation stage was longer than the first in order 
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ethanol was carried over during the RNA elution step that may interfere with 
downstream reactions.  
(xii)  To avoid carryover of the RPE buffer the RNeasy spin column was replaced 
with a 2 ml collection tube. The sample was centrifuged for 1 minute at 10,000 
rpm.   
(xiii)  30 µl of RNase free water was added to elute the RNA from the spin column 
membrane. 
(xiv)  The samples were stored in a -80°C freezer until further analysis. 
2.2.4.2.2 RNA quantification  
A  NanoDrop  ND-1000  spectrophotometer  (Thermoscientific,  UK)  was  used  to 
quantify the amount of RNA present in the samples. The spectrophotometer measures 
the RNA samples up to 3200 ng/ml with a spectrum range from 220 to 750 nm.  
(i)  1 µl of RNA was pipetted onto the receiving fibre and a second fibre (‘source 
fiber’) was placed on top. A pulsed xenon flash lamp provided the light source, 
which passed through the sample. The data were analysed using the ND-1000 
spectrophotometer software.  
2.2.4.2.3 cDNA Libraries  
Complementary DNA (cDNA) libraries are a combination of cloned cDNA fragments 
inserted into a host cell, which together constitute some portion of the transcriptome of 
the organism. cDNA is produced from fully transcribed mRNA found in the nucleus 
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(i)  The following reagents from a cDNA synthesis kit (Applied Biosystems, UK) 
were  added  to  a  1.5  ml  micro  centrifuge  tube  and  mixed:  10  µl  of  reverse 
transcription  buffer,  4  µl  of  deoxynuclotide  triphosphates  (dNTPs),  10  µl  of 
random primers, 5 µl of reverse transciptase and 61µl of RNA free water.  
(ii)  90 µl of the above solution and 10 µl of extracted RNA sample were added to a 
fresh 1.5 ml micro centrifuge tube and mixed.  
(iii)  The samples were heated at 25
0C for 10 minutes, 37
0C for 120 minutes, and 
85
0C  for  5  minutes  and  finally  cooled  at  4
0C  using  a  DNA  Thermal  Cycler 
Model 480 Perkin Elmer Cetus, UK). After the last step the samples were stored 
at -20°C.  
2.2.4.2.4 Real-Time Polymerase Chain Reaction 
Real time polymer chain reaction (PCR) was used to quantify the amount of cDNA 
present  in  the  sample.  The  advantage  of  using  real  time  PCR  is  that  it  enabled 
monitoring of the progress of the PCR reaction as it occurred by precisely measuring 
the  amount  of  each  amplicon  at  each  cycle  during  the  PCR  process.  The  signal 
produced was directly proportional to the amount of PCR product in the reaction.  
The expression of six genes was investigated along with GAPDH as the house keeping 
gene.  These  were  actin  (ACTA2),  myosin  heavy  chain  (MYH11),  caldesmon 
(CALD1), calponin (CNN1), vimentin (VIM) and tropomyosin 4 (TMP4) (Applied 
Biosystems, UK).  The characteristics of all the different markers are summarized in 
the following table: 
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Marker  Description  
Actin (ACTA2) 
 
Is  a  43  kDa  cytoskeletal  protein  associated  with  cell  motility  (myosin 
heavy  chain  as  well).  Additionally,  is  also  involved  in  other  cellular 
processed  such  as  locomotion,  secretion,  cytoplasmic  streaming, 
phagocytosis  and  cytokinesis.  Six  distinct  actin  isotypes  have  been 
identified in mammalian cells(120).  
Myosin  Heavy 
Chain  
(MYH11) 
 
Skeletal muscle Myosin is 200–204 kDa protein that generates force to 
drive muscle contraction. It is comprised of two heavy chains and four 
light chains. Most organisms produce many muscle MHC isoforms with 
temporally and spatially regulated expression patterns. The globular head 
of each MHC molecule protrudes from the thick filament and binds actin 
of thin filaments in an ATP-dependent fashion(120-122).   
Caldesmon 
(CALD1) 
 
It is a 120-150 kDa protein and regulates smooth muscle contraction. Two 
types of isoforms exist h-caldesmon expressed in smooth muscle cells and 
i-caldesmon expressed in non-muscular tissue. Caldesmon could be found 
in either proliferative or synthetic smooth muscle cells. H-Caldesmon is an 
actin and calmodulin-binding protein that regulates cellular contraction, 
exocytosis, endocytosis, cell movement and cell shape change(123-127).  
Calponin 
(CNN1) 
 
Is a 34 kDa protein which modulates the myosin ATP-ase activity. The 
modulation  of  the  ATP-ase  is  occurred  with  phosphorylation  of  either 
caldesmon or calponin. It is located in the same region with actin filaments 
and is involved in smooth muscle cell contraction.  (128, 129) 
vimentin (VIM)   Is a 52-58 kDa protein expressed in smooth muscle cells but also other 
type  of  cells  such  as  fibroblasts,  lymphocytes,  and  endothelial  cells.  It 
maintains cell shape and integrity of cytoplasm one of the most common 
markers for proliferative cells(130-135) 
Tropomyosin  4 
(TMP4) 
Is a 30 kDa protein and is expressed in smooth muscle cells. It regulates 
actin binding and is involved in smooth muscle contraction. It is expressed 
in  low  levels  in  contractile  smooth  muscle  cells  but  high  levels  of 
tropomyosin 4 could be found in proliferative smooth muscle cells(136-
138).  
Table 2.1 A table that summarizes all the genes used in this study 
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(i)  The following reagents were added to a 1.5 ml micro centrifuge tube and mixed:  
12.5 µl of Taqman universal master mix (Applied Biosystems, UK), 1.25 µl of 
primer and 6.25 µl of RNA free water and 5 µl of cDNA sample.  
(ii)  The  mixtures  were  transferred  to  a  384  well  plate  (MicroAmp
TM,  Applied 
Biosystems) and sealed with a film lid. The plate was centrifuged for 1 minute at 
10,000 rpm and then was placed in a LightCycler 480, (Roche, UK) for the real 
time PCR reaction to occur. At the end of the real time PCR reaction the sample 
was normalised according to the housekeeping gene GAPDH. 
2.2.4.3 Aspect Ratio  
The aspect ratio is the ratio of the width of a cell to its length. The aspect ratio of 
muscle cells differentiated towards a contractile phenotype is typically greater than the 
aspect ratio of cells in a proliferative state and can be used as an indicator of the 
phenotypic status of cells in culture. The aspect ratio was therefore used to investigate 
whether proliferation or differentiation medium affected the morphology of SPION-
loaded HRSMC.    
(i)  HRSMC were seeded in tissue culture plates and incubated as specified for each 
experiment.  
(ii)  The  medium  was  removed  and  the  cells  were  fixed  with  1  ml  of  2.5% 
gluteraldehyde for 10 minutes at room temperature. 
(iii)  The solution was removed and the cells were washed 3x with 1 ml of PBS. 
(iv)  The cells were imaged using a phase contrast inverted microscope (AmScope 
40x-900X Phase Contrast Inverted Microscope with 3M Camera, USA).  
(v)  The aspect ratio was calculated using image analysis software (Image J, national Chapter 2: General Materials and Methods 
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Institute of Health, USA). 
2.2.4.4 Determination of Cell Proliferation 
Four methods were used to investigate cell proliferation. 
2.2.4.4.1 Cell Proliferation BrdU Assay 
The  proliferation  of  cells  was  measured  with  a  colorimetric  BrdU  ELISA  Assay 
(Roche,  UK).  5-bromo-2'-deoxyuridine  (BrdU)  is  a  nucleoside  and  thymidine 
analogue.  BrdU  incorporates  into  the  newly  synthesized  DNA  of  replicating  cells 
substituting for thymidine. The assay involves labelling cells with concentration of 100 
µM followed by detection using a mouse monoclonal antibody directed against BrdU.  
(i)  Human  rectal  smooth  muscle  cells  were  seeded  in  tissue  culture  plates  and 
incubated as specified for each experiment. 
(ii)  After  the  incubation  period  the  medium  was  removed  from  each  well  and 
replaced with fresh medium containing BrdU label (100 µM) and incubated for 
2 hours at 37
0C, 5% CO2. 
(iii)  Labelling medium was removed by inverting the plate and tapping off.  
(iv)  A sufficient volume of fixative and denaturing solution provided with the assay 
was added to the wells to cover the cells, as specified for each experiment. The 
plate was incubated for 30 minutes at room temperature.  
(v)  Fixative denaturing was removed from all the wells by inverting and tapping 
off and anti-BrdU-peroxidase monoclonal antibody was added to each well and 
incubated for 90 minutes at room temperature.  
(vi)  Antibody  conjugated  solution  was  then  removed  by  inverting  the  plate  and 
tapping off the solution. The wells were rinsed 3x with PBS/washing solution.  Chapter 2: General Materials and Methods 
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(vii)  A sufficient volume of substrate solution provided with the assay was added to 
each well and incubated for 30 minutes at room temperature.  
(viii)  Transfer 100 µl to a 96 well plate (Nunclon TM, Delta surface, Denmark). 
(ix)  25 µl/well of 1 M H2SO4 stop solution was added to each of the wells.  
(x)  The  optical  density  of  the  reaction  product  in  the  wells  was  read  with  a 
colorimetric plate reader (Multiskan FC; Thermoscientific, UK) at 450 nm with 
a reference wavelength at 690 mm. 
2.2.4.4.2 Measurement of Cellular DNA Content Using the CyQUANT® Assay  
The proliferation of cells was also measured with the CyQUANT® Cell Proliferation 
Assay Kit. It is a rapid proliferation assay compared to the BrdU assay described in 
section 2.2.4.4.1. It is based in a fluorescent dye (CyQUANT® GR), which exhibits 
strong fluorescence when bound to cellular nucleic acids. After the addition of the dye, 
the  fluorescence  could  be  measured  directly.  The  amount  of  fluorescent  product 
generated  is  proportional  to  the  amount  of  the  fluorescent  dye  (CyQUANT®  GR) 
present in the sample.  
(i)  HRSMC were seeded in tissue culture plates and incubated as specified for each 
experiment. 
(ii)  The medium was removed and 200 µl was added of Cyquant NF dye reagent (in 
1x HBSS buffer). 
(iii)  It was incubated at 37
0C, 5% CO2   using a plate shaker (Stuart mini orbital 
shaker SSM1, Bibby Sterilin Ltd, UK) at speed 70 for 1 hour.  
(iv)  After the incubation period, 100 µl of the solution were transferred in a black 
plate (Costar
®, black with clear flat bottom, Corning B.V, Amsterdam). 
(v)  The  fluorescence  was  measured  using  a  fluorescence  plate  reader  (TECAN Chapter 2: General Materials and Methods 
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SpectraFluor,  USA)  at  an  excitation  wavelength  of  485  nm  and  an  emission 
wavelength at 530 nm. 
2.2.4.4.3 Direct Cell counts 
Direct  cell  counts  were  performed  in  order  to  investigate  the  cell  proliferation  of 
HRSMC. 
(i)  HRSMC were seeded in tissue culture plates and incubated as specified for each 
experiment. 
(ii)  After the incubation period the medium was removed and the cells were washed 
1x with 1 ml PBS. 
(iii)  1 ml of trypsin was added to each well and incubated at 37
0C, 5% CO2 for 1 
minute. 
(iv)  5  ml  of  fresh  medium  was  added  in  each  well  and  the  detached  cells  were 
collected in a 15 ml container. 
(v)  Samples  were  centrifuged  at  1000  rpm  for  5  minutes,  the  supernatant  was 
removed and the pellets were re-suspended in 1ml of fresh media. 
(vi)  A cell count was performed as described in section 2.2.1.3. 
2.2.4.4.4 Cell Metabolic Activity Assay 
The metabolic activity of HRSMC cells was determined by using the CellTiter 96 
Aqueous Non-Radioactive Cell Proliferation Assay (Promega, UK). This colorimetric 
assay is composed of solutions of a tetrazolium compound [3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium,  inner  salt;  MTS] 
and an electron coupling reagent (phenazine methosulfate; PMS). MTS is bioreduced 
by  cells  into  a  formazan  product  that  is  soluble  in  tissue  culture  medium.  The 
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enzymes found in metabolically active cells. The quantity of formazan product was 
measured by the amount of 490 nm absorbance which was directly proportional to the 
number of living cells in culture. 
(i)  HRSMC were seeded in tissue culture plates and incubated as specified for each 
experiment.   
(ii)  After the incubation period the medium was removed and replaced with fresh 
medium containing 20 µl MTS/PMS combined solution which was added to the 
wells and incubated for 2 hours at 37
0C, 5% CO2. 
(iii)  Absorbance of the formazan was measured at 490 nm with colorimetric reader 
Multiskan FC (Thermoscientific, UK).  
(iv)  All  optical  densities  of  test  samples  were  normalised  with  the  control  and 
expressed as a percentage change with the value measured for control cells. 
2.2.5  Cellular Techniques to Investigate Changes in the Biocompatibility of Cells   
Three techniques were used to investigate cellular biocompatibility:  
2.2.5.1 Reactive Oxygen Species  
The  generation  of  reactive  oxygen  species  (ROS)  occurs  in  all  aerobic  organisms. 
However, in stressed cells it happens at a non-controlled rate. The over-production of 
ROS creates changes in the protein and nucleic acid formation. Diseases associated 
with ROS include atherosclerosis, carcinogenesis, ischemic reperfusion, and aging.  
The  ROS  generation  in  cells  was  investigated  with  the  Image-iT™  LIVE  Green 
Reactive Oxygen Species Detection Kit. The assay is based in the expression of a 
fluorescent  marker  on  5-(and-6)-carboxy-2′,7′-dichlorodihydrofluorescen  diacetate 
(carboxy-H2  DCFDA).  To  induce  apoptosis,  tert-butyl  hydroperoxide  (TBHP)  was 
used.  To  stain  the  nucleus  of  the  cells  Hoechst  33342  was  used.  Using  this Chapter 2: General Materials and Methods 
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combination of fluorescent dyes the detection of ROS in stressed or non-stressed cells 
is distinguished with fluorescence microscopy. The fluorescent marker (carboxy-H2 
DCFDA) DCFDA has excitation/emission maxima of approximately 495/529 nm and 
the Hoechst 33342 has excitation/emission maxima of approximately 350/461 nm.  
(i)  HRSMC  were  seeded  in  a  Fluorodish  Cell  Culture  Dish  -  35mm  (World 
Precision Instruments, USA) and incubated as specified for each experiment.  
(ii)  Before the test was started the medium was removed and cells were washed 1x 
with HBSS (Gibco, USA).  
(iii)  25 µM carboxy-H2 DCFDA working solution (in Dimethyl sulfoxide-DMSO) 
was added for 30 minutes at 37
0C, 5% CO2. 
(iv)  The last 5 minutes of the incubation period 1mM Hoechst 33342 stain (provided 
in the kit) was added. 
(v)  After the incubation period the cells were washed 3x with HBSS (Gibco, USA). 
(vi)  The cells were mounted with a drop of HBSS (Gibco, USA). 
(vii)  Images were taken using a fluorescent microscope (Leica DM2000, Germany). 
2.2.5.1.1 Reactive oxygen species (Positive control) 
(i)  HRSMC  were  seeded  in  a  Fluorodish  Cell  Culture  Dish  –  35  mm  (World 
Precision Instruments, USA) and incubated as specified for each experiment.  
(ii)  To induce reactive oxygen species, 100 mM tert-butyl hydroperoxide (TBHP) 
solution (in water) were mixed with culture medium and added. The cell were 
incubated for 90 minutes at 37
0C, 5% CO2.  
(iii)  Before the test was started the medium was removed and cells were washed 1x 
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(iv)  25 µM carboxy-H2 DCFDA working solution (in Dimethyl sulfoxide-DMSO) 
was added for the 30 minutes at 37
0C, 5% CO2. 
(v)  The  last  5  minutes  of  the  incubation  period  1  mM  Hoechst  33342  stain 
(provided in the kit) was added. 
(vi)  After the incubation period the cells were washed 3x with HBSS (Gibco, USA). 
(vii)  The cells were mounted with a drop of HBSS (Gibco, USA). 
(viii)  Images were taken using a fluorescent microscope (Leica DM2000, Germany). 
2.2.5.2 Cytotoxicity Assay - LDH Assay 
The  toxic  effect  of  loading  cells  with  SPION  was  determined  by  the  CytoTox  96 
Assay  (Promega,  UK).  The  assay  quantitatively  measures  lactate  dehydrogenase 
(LDH), a stable cytosolic enzyme that is released upon cell lysis. The quantity of LDH 
product  was  measured  by  the  amount  of  490  nm  absorbance,  which  was  directly 
proportional to the number of lysed cells.  
(i)  HRSMC were seeded in tissue culture plates and incubated as specified for each 
experiment. 
(ii)  After  the  incubation  period  the  medium  was  removed  from  each  well  and 
transferred into a fresh 96 well plate (Nunclon
TM, Delta surface, Denmark). 
(iii)  50 µl of medium was transferred into a fresh well and 50 µl of the LDH solution 
was added to each well. 
(iv)  Samples were incubated in the dark for 30 minutes. 
(v)  50 µl of stop solution was added to each well and the optical density of the 
reaction  produced  in  the  well  was  read  with  a  plate  reader  Multiskan  FC 
(Thermoscientific, UK) at 490 nm.   
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2.2.5.2.1 Cytotoxicity Assay-LDH Assay (Positive Control)  
(i)  HRSMC were seeded in tissue culture plates and incubated as specified for 
each experiment. 
(ii)  10 µl of lysis solution (10x) was added in each well per 100 µl of medium in 
order to lyse the cells. 
(iii)  The cells were incubated at 37
0C, 5% CO2 for 45 minutes. 
(iv)  The plate was centrifuged at 250 x g  (Stuart mini orbital shaker SSM1, Bibby 
Sterilin Ltd, UK) for 4 minutes. 
(v)  After  the  incubation  period  the  medium  was  removed  from  each  well  and 
transferred into a fresh 96 well plate (Nunclon
TM, Delta surface, Denmark). 
(vi)  50  µl  of  medium  was  transferred  into  a  fresh  well  and  50  µl  of  the  LDH 
solution was added to each well.  
(vii)  Cells were incubated in the dark for 30 minutes. 
(viii)  50 µl of stop solution was added to each well and the optical density of the 
reaction  produced  in  the  well  was  read  with  a  plate  reader  Multiskan  FC 
(Thermoscientific, UK) at 490 nm.   
2.2.5.3 Cell Apoptosis - Caspase-3/7 
Cell apoptosis was measured with the Apo-ONE® Homogeneous Caspase-3/7 Assay. 
The Caspase-3/7 buffer lyses the cells and provides optimal caspase-3/7 enzymatic 
activity. The caspase-3/7 substrate rhodamine 110, bis-(N-CBZL-aspartyl-L-glutamyl-
L-valyl-L-aspartic acid amide; Z-DEVD-R110), exists as a pro-fluorescent substrate 
prior to the assay. Both the buffer and the substrate were mixed together and added to 
the sample.  Caspase-3/7 activity cleaves and removes the DEVD peptides with the 
excitation at 499 nm, which results in the rhodamine 110 leaving group becoming Chapter 2: General Materials and Methods 
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intensely fluorescent. The emission maximum is 521 nm. The amount of fluorescent 
product  generated  is  proportional  to  the  amount  of  caspase-3/7  cleavage  activity 
present in the sample. 
(i)  HRSMC were seeded in tissue culture plates and incubated as specified for each 
experiment.  
(ii)  The Substrate Z-DEVD-R110 was diluted (1:100 dilution) with the buffer to 
obtain the desired volume of Apo-ONE® Caspase-3/7 reagent. 
(iii)  The combined solution was added in each well and the plate was shaken at 300 
rpm (Stuart mini orbital shaker SSM1, Bibby Sterilin Ltd, UK) at speed 70 for 
30 seconds.  
(iv)  Then the cells were incubated at 37
0C, 5% CO2 for 30 minutes. 
(v)  After the incubation period, 100µl of the solution were transferred in a black 
plate (Costar
®, black with clear flat bottom, Corning B.V, Amsterdam). 
(vi)  The  fluorescence  of  each  well  was  measured  with  the  optimal  excitation 
wavelength for detection at 499 nm and the emission maximum at a wavelength 
of 521 nm. 
2.2.6 Data Analysis 
Data  analysis  was  performed  using  GraphPad  Prism  version  5.00  for  Windows 
(GraphPad  Software,  San  Diego  California  USA).  In  order  to  compare  if  the 
differences  between  groups  were  statistically  significant  a  one-way  ANOVA  and 
Tukey test was carried out. Any value was considered significant if p< 0.05. 
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3.1 Introduction  
Loading cells with SPION is a requirement for achieving their magnetic actuation in 
the hypothesized manner using an externally applied magnetic field. To achieve this, 
SPION has to be delivered to cells efficiently whilst maintaining biocompatibility. 
Depending on the cell type and intended application there are different ways to achieve 
this.   
 Kyrtatos et al labelled the CD133
+ progenitor cells derived from human mononuclear 
cells (MNCs) with the FDA approved SPION Endorem® using 0.5 mg/ml SPION in 
growth medium. This was a direct loading regime where the SPION was mixed with 
the  culture  medium  and  directly  applied  to  the  cells  relying  on  endocytosis 
mechanisms (92). Similarly in another study, human MNCs were labelled with three 
different types of particles: 45µl Endorem® with diameter 80-150 nm (concentration 
of 11.2 mg iron/ml), or 50 µl BioMag with a diameter 1.5 µm. (concentration 0.8 mg 
iron/ml)  or  5  µl  FluidMAG  with  a  diameter  of  200  nm  (concentration  of  48  mg 
iron/ml) added per ml of culture medium, and cells were incubated for 24 hours (93).  
Another example of a loading regime was described in the study conducted by Vigor et 
al where three different types of SPION were investigated: i) 50 nm Nanomag coated 
with dextran, ii) 50 nm nanomag coated with dextran and PEG polyethylene glycol, 
and  iii)  20  nm  nanomag  coated  with  dextran  and  PEG  polyethylene  glycol 
functionalized  with  recombinant  single  chain  Fv  (scFv)  antibodies  (specific  for 
carcinoembryonic antigen-CEA) for the magnetic resonance imaging (MRI) of cancer 
cells. The results showed that the functionalised antibody-SPION bound specifically to 
CEA-expressing  human  tumour  cells,  generating  selective  image  contrast  for  MRI 
(139).  
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SPION have many advantages in medicine. The particles exert magnetism only when 
an external magnetic field is applied (140).  Due to their small size, cells are able to 
internalise  these  particles  through  endocytic  pathways.  Also  the  particles  can  be 
controlled by an external magnetic field; this ‘‘action at a distance’’ opens up many 
applications where magnetically tagged nanoparticles are functionalised to deliver an 
active  load,  such  as  an  anticancer  drug  (141).  Additionally,  some  SPION  such  as	 ﾠ
ferucarbotran and ferumoxide are approved by the FDA and have been used in clinical 
practice already as a magnetic resonance contrast agent as they offer higher contrast 
enhancement from the conventional gadolinium based contrast agents (142).  
The aim of this chapter was to explore the effects of adding SPION to the cell culture 
medium,  the  loading  efficiency  of  SPION  by  HRSMC,  the  localization  of  SPION 
inside  the  cells  after  endocytosis  had  occurred,  and  finally  the  effects  of  different 
concentrations of SPION on the phenotype and biocompatibility of HRSMC.  
3.2 Materials and Methods  
3.2.1 Preliminary Investigation of SPION  
3.2.1.1 Transmission Electron Microscopy Analysis of SPION 
Transmission electron microscopy (TEM) was used to determine the core diameter of 
the particle. 
(i)  1 µl of SPION (31.25 µg/ml) was added to1000 µl of distilled water. 
The  sample  was  placed  onto  a  carbon-coated  copper  grid  and  incubated  at  room 
temperature until it had dried. The sample was examined under a JEOL JEM 1200EX 
TEM operating at 80 kV.  The average diameter of the clusters of iron oxide crystals 
was determined using image analysis.  
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3.2.1.2 Interaction between SPION and the Cell Culture Medium 
3.2.1.2.1 Dynamic Light Scattering  
Dynamic light scattering (DLS) measures Brownian motion and relates this to the size 
of  the  particles.  The  hydrodynamic  particle  size  of  SPION  samples  in  water  and 
culture medium (10% FBS) was measured by DLS.  
(i)  SPION at a concentration of 31.25 µg/ml was mixed with culture medium and 
water incubated at 37
0C and at 25
0C.  
(ii)  Samples were added in cuvettes and the measurements were performed using a 
Malvern  4700  spectrometer.  The  hydrodynamic  diameter  was  measured  for  a 
period of 30 minutes. 
3.2.2 Preliminary Investigation of SPION Effects on HRSMC 
3.2.2.1 Incubation of HRSMC with SPION 
Human  rectal  smooth  muscle  cells  were  seeded  in  75  cm
2  tissue  culture  flasks 
(Nunclon
TM Delta treated, Denmark) at a cell density of 500,000 cells per culture flask.  
Cell cultures were incubated at 37
0C, 5% CO2 for 24 hours. The medium was removed 
and experimental medium containing different concentrations (31.25, 250 and 1000 
µg/ml) of SPION was added. After 24 hours the medium was removed and the cells 
were washed 5 times with 10 ml of PBS to remove unbound SPION following the 
addition of 2 ml trypsin/EDTA. The flasks were incubated for 2 minutes to facilitate 
enzymatic detachment of the cells. When the cells were fully detached 10 ml of fresh 
proliferation medium was added to the flask and the contents transferred to a sterile 30 
ml container. The container was centrifuged at 1000 rpm for 5 minutes to pellet the 
cells in the bottom of the container. The supernatant was removed and the pellet was  
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re-suspended in fresh culture medium. A cell count was performed as described in 
section 2.2.1.3. Finally, the cells were re-seeded in proliferation medium and incubated 
for 24 hours at 37
0C, 5% CO2 (as shown in Figure 3.1). 
 
Figure 3.1 Incubation of HRSMC with SPION.  
3.2.2.2 Light Microscopy of SPION-Loaded HRSMC 
Light microscopy was used to determine the cellular localisation of SPION. 
(i)  2x10
4 HRSMC were seeded in a 25 cm
2 cell culture flask (Nunclon
TM Delta 
surface, Denmark) and incubated for 24 hours at 37
0C, 5% CO2. 
(ii)  HRSMC were incubated with different concentration of SPION particles (31.25 
µg/ml, 250 µg/ml and 1000 µg/ml) and incubated for 24 hours at 37
0C, 5% 
CO2. 
(iii)  After the incubation period the culture medium was removed and the cells were 
washed 5x with 5 ml of PBS. 
(iv)  1 ml of trypsin was added to each flask and incubated at 37
0C, 5% CO2 for 1 
minute. 
(v)  5  ml  of  fresh  media  was  added  in  each  flask  and  the  detached  cells  were 
collected in a 30 ml container.  
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(vi)  Samples  were  centrifuged  at  1000  rpm  for  5  minutes,  the  supernatant  was 
removed and the pellets were re-suspended in 1 ml of fresh media. 
(vii)  A cell count was performed and 25,000 HRSMC were placed into a 48 well 
plate (Nunclon
TM, Delta surface, Denmark) and incubated for 24 hours at 37
0C 
5% CO2. 
(viii)  The  medium  was  removed  and  the  cells  were  fixed  with  200  µl  2.5%  w/v 
glutaraldehyde in 0.01M PBS (Sigma-Aldrich Company Ltd, UK). 
(ix)  Images were taken with a 20x objective lens using a Leica DM IL Inverted 
Microscope (Leica, UK). 
3.2.2.3 Transmission Electron Microscopy Analysis of SPION-Loaded HRSMC 
Transmission electron microscopy was used to determine the ultrastructural cellular 
localisation of SPION.  
(i)  Steps i-vi from section 3.2.2.2 were followed for this experiment. 
(ii)  2x10
4 HRSMC were seeded in a 25 cm
2 cell culture flask (Nunclon
TM Delta 
treated, Denmark) and incubated for 24 hours at 37
0C, 5% CO2. 
(iii)  After incubation, the medium was removed and the cells were washed 5x with 
10 ml of PBS. 
(iv)  1 ml of trypsin was added to each flask and incubated at 37
0C, 5% CO2 for 
1minute. 
(v)  5  ml  of  fresh  medium  was  added  to  each  flask  and  the  detached  cells  were 
collected in a 30 ml container.  
(vi)  Steps  vi-xviii  from  section  2.2.3  were  repeated  for  the  remainder  of  this 
experiment.  
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3.2.2.4 Quantification of Cellular Loading with SPION   
Two techniques were used to quantify the amount of SPION in cells; SQUID and flow 
cytometry.  
3.2.2.4.1 Determine the Cellular Loading with Different Concentrations of SPION 
Using SQUID 
A Superconducting Quantum Interference Device (SQUID) was used to measure the 
amount of iron in cells following incubation with SPION as described in section 2.4.1. 
(i)  Steps i-vi from section 3.2.2.2 were followed for this experiment. 
(ii)  5x10
4 HRSMC were seeded in a 75 cm
2 culture flask and incubated for 24 hours 
at 37
0C, 5% CO2.    
(iii)  Steps  ii–xi  from  section  2.2.2  were  then  followed  for  the  remainder  of  this 
experiment. 
3.2.2.4.2 Granularity of SPION-Loaded HRSMC  
Cells that have engulfed SPION are more granular. Therefore forward scatter (FS; a 
measurement of size) and side scatter (SS; a measurement of granularity) of SPION 
loaded cells were measured on a FACS Caliber flow cytometer (BD Biosciences). 
Forward scatter FS and SS intensities were digitalized on both linear and logarithmic 
scale. Cellular debris and SPION aggregates were eliminated by using a selection gate.  
(i)  Steps i-vi from section 3.2.2.2 were initially followed for this experiment. 
(ii)  A cell count was performed and 100,000 cells were extracted and placed into a 
25 cm
2 cell culture flask (Nunclon
TM Delta surface, Denmark) and incubated at 
37
0C, 5% CO2 for 24 hours.  
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(iii)  After the incubation period the medium was removed and the cells were washed 
1x with 5 ml of PBS. 
(iv)  1 ml of trypsin was added to each flask and incubated at 37
0C, 5% CO2 for 1 
minute. 
(v)  5  ml  of  fresh  media  was  added  in  each  flask  and  the  detached  cells  were 
collected in a 30 ml container.  
(vi)  The  samples  were  centrifuged  at  1000  rpm  for  5  minutes,  the  supernatant 
removed  and  the  pellet  was  re-suspended  in  5  ml  of  FACS  buffer  (BD 
Bioscences, UK).  
(vii)  The sample was transferred to FACS collection tubes (BD Falcon, USA) and 
analysed using a FACS Calibur flow cytometer (BD Biosciences, UK). 
3.2.2.5 The In Vitro Response of HRSMC to Different Concentrations of SPION 
3.2.2.5.1 Cell Metabolic Activity Assay  
(i)  Steps i-vi from section 3.2.2.2 were initially followed for this experiment.  
(ii)  A cell count was performed and 10,000 cells were extracted and placed into a 96 
well plate (Nunclon
TM Delta surface, Denmark) with a final volume of 100 µl per 
well and incubated at 37
0C, 5% CO2 for 24 hours. 
(iii)  20  µl/well  MTS/PMS  combined  solution  was  added  to  all  the  wells  and 
incubated for 2 hours at 37
0C, 5% CO2. 
(iv)  Absorbance  of  the  formazan  product  was  measured  at  490  nm  with  a 
colorimetric plate reader Multiskan FC (Thermoscientific, UK). 
3.2.2.5.2 Cell Proliferation Assay  
(i)  Steps i - vii from section 3.2.2.2 were initially followed for this experiment.  
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(ii)  10 µl per well BrdU label (final volume of 100 µl) was added to all the wells 
and the plate was incubated for 2 hours at 37
0C, 5% CO2. 
(iii)  Labelling medium was removed by inverting the plate and tapping off. 
(iv)  200 µl of fixative and denaturing solution provided with the assay was added to 
the wells. The plate was incubated for 30 minutes at room temperature. 
(v)  Fixative denaturing was removed from all the wells by inverting the plate and 
tapping off the solution and 100 µl per well anti-BrdU-peroxidase monoclonal 
antibody  was  added  to  each  well  and  incubated  for  90  minutes  at  room 
temperature. 
(vi)  Antibody  conjugated  solution  was  then  removed  by  inverting  the  plate  and 
tapping off the solution. The wells were rinsed 3x with PBS/washing solution. 
(vii)  100 µl of substrate solution provided with the assay was added to each well and 
incubated for 30 minutes at room temperature. 
(viii)  25 µl of 1M H2SO4 stop solution provided with the assay was added to all the 
wells. 
(ix)  Optical  density  of  the  reaction  produced  in  the  well  was  read  with  a 
colorimetric plate reader Mutliskan FC (Thermoscientific, UK) at 450 nm with 
a reference wavelength at 690 nm. 
3.2.2.5.3 Cytotoxicity Assay  
(i)  Steps i-vii from section 3.2.2.2 were initially followed for this experiment. 
(ii)  Supernatants of cells incubated with different concentrations of SPION (0 µg/ml, 
31.25  µg/ml,  250  µg/ml  and  1000  µg/ml)  for  24  hours  were  collected  and 
transferred to a fresh 96 well plate (Thermo Scientific, Nunc, Fisher Scientific, 
UK) accordingly.   
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(iii)  50 µl of medium was removed and placed in a new well and 50 µl of the LDH 
assay reagents was added to each well and the plate was incubated in the dark at 
room temperature for 30 minutes. 
(iv)  50 µl of stop solution was added to each well and the optical density of the 
reaction  produced  in  the  well  was  read  with  a  plate  reader  Multiskan  FC 
(Thermoscientific, UK) at 490 nm.   
3.2.2.5.3.1 Cytotoxicity Assay (Positive Control) 
(i)  Steps i - vii from section 3.2.2.2 were initially followed for this experiment.  
(ii)  10 µl of cell lysis solution (provided with the assay) per 100 µl was added to all 
the wells. 
(iii)  The cells were incubated for 45 minutes at 37
0C, 5% CO2. 
(iv)  The plate was centrifuged at 250 x g for 4 minutes. 
(v)  Supernatants  of  cells  incubated  with  different  concentrations  of  SPION  (0 
µg/ml, 31.25 µg/ml, 250 µg/ml and 1000 µg/ml) were collected and transferred 
to  a  fresh  96  well  plate  (Thermo  Scientific,  Nunc,  Fisher  Scientific,  UK) 
accordingly.  
(vi)  50 µl of medium was removed and placed in a new well and 50µl of the LDH 
solution was added to each well and the plate was incubated in the dark for 30 
minutes. 
(vii)  50 µl of stop solution was added to each well and the optical density of the 
reaction  product  in  the  well  was  read  with  a  plate  reader  Multiskan  FC 
(Thermoscientific, UK) at 490 nm.   
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3.2.2.5.4 Flow Cytometry 
3.2.2.5.4.1 Propidium Iodide Staining of Dead Cells  
Propidium iodide (PI) is commonly used to identify dead cells. PI binds to DNA by 
intercalating  between  the  bases  with  little  or  no  sequence  preference  and  with  a 
stoichiometry of one dye molecule per 4 - 5 base pairs of DNA. PI is membrane 
impermeant and generally excluded from viable cells. 
(i)  Steps i - vi from section 3.2.2.2 were initially followed for this experiment. 
(ii)  A cell count was performed and 100,000 cells were extracted and placed into a 
25 cm
2 cell culture flask (Nunclon
TM Delta surface, Denmark) and incubated at 
37
0C, 5% CO2 for 24 hours. 
(iii)  After the incubation period the medium was removed and the cells were washed 
1x with 5 ml of PBS. 
(iv)  1 ml of trypsin was added to each flask and incubated at 37
0C, 5% CO2 for 1 
minute. 
(v)  5  ml  of  fresh  media  was  added  in  each  flask  and  the  detached  cells  were 
collected in a 30 ml container. 
(vi)  The  samples  were  centrifuged  at  1000  rpm  for  5  minutes,  the  supernatant 
removed,  and  the  pellet  was  re-suspended  in  5  ml  of  PI/FACS  buffer  (BD 
Bioscences, UK) (PI 1:500 dilution in FACS buffer) was added 15 minutes prior 
the measurement. 
(vii)  Solution  was  transferred  to  FACS  collection  tubes  (BD  Falcon,  USA).  The 
samples were analysed using a FACS Calibur flow cytometer (BD Biosciences). 
Red "fluorescence intensities emitted by dead cells (measured at 610 nm) was 
digitalized on a logarithmic scale.   
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3.3 Results 
3.3.1 Preliminary Investigations of SPION  
3.3.1.1 Ultrastructural Analysis of SPION  
Transmission electron microscopy (TEM) was used to determine the core diameter of 
the SPION used for loading cells. The images revealed that the SPION consisted of 
clusters of iron oxide crystals that were each approximately 20 - 30 nm in diameter 
(Figure 3.2).  
 
Figure 3.2 TEM images of SPION showing Clusters of iron oxide crystals 
3.3.1.2 Analysis of the Interaction Between SPION and Cell Culture Medium 
Dynamic light scattering (DLS) was used to investigate the interaction between SPION 
and the cell culture medium. The hydrodynamic particle sizes of SPION samples in 
distilled water or culture medium (proliferation medium described in section 2.1.2) 
were obtained by DLS. Culture medium or water was mixed with 31.25 µg/ml of 
SPION both at 37
0C and at 25
0C. The hydrodynamic diameter was measured for a 
!
!
Iron oxide crystals 
(Fe3O4 )  
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period  of  30  minutes.  It  was  not  possible  to  perform  DLS  with  concentrations  of 
SPION  above  31.25  µg/ml  due  to  the  particle  density  exceeding  the  detection 
limitations  of  the  equipment.  When  SPION  was  mixed  with  culture  medium 
containing  10  %  FBS  and  incubated  at  37
0C  for  30  minutes  there  was  an  initial 
agglomeration of particles with a hydrodynamic diameter of 578.4 nm at 1 minute 
(Figure 3.3 a). As the incubation period increased, the hydrodynamic diameter fell to 
475.7 nm. When SPION was mixed with water and incubated for 30 minutes at 37
0C, 
there was an increase in the hydrodynamic diameter (60.56 nm) the first minute of 
incubation.  However,  as  the  incubation  period  was  increased  the  hydrodynamic 
diameter fell to 59.73 nm, which was close to the starting hydrodynamic diameter of 
the particles (50 nm).  In order to determine if temperature was a critical factor for 
agglomeration of particles, SPION was mixed with culture medium and water for 30 
minutes at 25
0C. Mixing SPION with culture medium at 25
0C (Figure 3.3 b) resulted 
in an increase in the average hydrodynamic diameter (546.9 nm), which then dropped 
to its lowest value after 30 minutes (512.1 nm). When SPION was mixed with water 
there was an increase in the hydrodynamic diameter (61.59 nm) but after 30 minutes it 
fell to an average hydrodynamic diameter of 56.51 nm.  
   
(a)  (b) 
Figure 3.3. DLS Measurements for Culture Medium and SPION (CM+SPION) and 
Distilled Water and SPION (DW+SPION) at 37
0C and 25
0C. (Nanoparticle diameter = 
average cluster diameter in nanometers)  
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3.3.2 Preliminary Investigation of SPION Effects on HRSMC 
3.3.2.1 Light Microscopy of SPION-Loaded HRSMC 
Images of HRSMC after loading with 31.25, 250 and 1000 µg/ml of SPION were taken 
using an inverted light microscope to investigate the localization of SPION. Images 
revealed that cells internalized SPION for all of the concentrations investigated and also 
retained  their  cell  viability  and  characteristic  spindle  shape.  The  amount  of  SPION 
internalized appeared to correlate directly with the concentration of SPION. The uptake 
of  SPION  appeared  to  increase  when  HRSMC  were  incubated  with  1000  µg/ml  of 
SPION for 24 hours (Figure 3.4 c). Although the cells were washed extensively in PBS 
to remove unbound SPION, images showed SPION remaining attached to the plasma 
membrane  (Figure  3.4  c).  Additionally,  the  images  revealed  an  apparent  uneven 
distribution of SPION between the cells.  
     
(a)  (b)  (c) 
Figure 3.4. Light Microscopy Images of SPION-Loaded HRSMC Contained Incubated 
with  Different  Concentrations  of  SPION  (31.25,  250  and  1000  µg/ml)  at  20x 
Magnification. The cells maintained their cell viability and their spindle shape characteristic. 
Images showed the uneven distribution of SPION between the cultured HRSMC.  
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3.3.2.2 Ultrastructural Localization of SPION in HRSMC 
The localization of SPION in HRSMC was determined using TEM. HRSMC were 
incubated with different concentrations of SPION (31.25, 250 and 1000 µg/ml) for a 
period of 24 hours. The images revealed that the cells internalized SPION, with the 
amount  corresponding  directly  with  the  concentration  of  SPION  used.  Uptake  of 
SPION increased when HRSMC were incubated with 1000 µg/ml of SPION for 24 
hours  (Figure  3.5  c).  Although  the  HRSMC  were  washed  extensively  in  PBS  to 
remove  unbound  SPION,  images  showed  SPION  remained  attached  to  the  plasma 
membrane (Figure 3.5 a). 
     
(a)  (b)  (c) 
Figure  3.5.  Transmission  Electron  Microscopy  of  SPION-Loaded  HRSMC,  (a)  31.25 
µg/ml, (b) 250 µg/ml and (c) 1000 µg/ml), Incubated for a Period of 24 Hours. SPION 
became localized in discrete vesicles within the cytoplasm. 
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3.3.2.3  Determine the Cellular Loading of SPION 
3.3.2.3.1 SQUID Magnetometry  
SQUID magnetometry was used to quantify the amount of SPION in HRSMC. Cells 
were incubated with different concentrations of SPION (31.25, 250 and 1000 µg/ml) 
for a period of 24 hours. A doubling dilution was chosen for this experiment.  
The  SQUID  measures  the  magnetic  moment  of  a  sample,  in  Am  per  meter.  The 
average magnetization of the magnetic material (M) was plotted against the strength of 
the magnetic field (H) for all the different concentrations of SPION. The magnetic 
filed ranges between -7 T to 7 T. The graph of the control sample (no SPION-0 µg/ml) 
was diamagnetic confirming no presence of SPION (Figure 3.6-a), however, in the 
SPION-loaded samples (31.25-1000) the graphs had the characteristic sigmoidal shape 
indicating the presence of a magnetic material (Figure 3.6-b,c,d).  
To convert the magnetization of the magnetic material (magnetic material inside the 
cells) to mass of particles per cell, the average magnetization per cell of the magnetic 
material was divided with the average magnetization (92 emu/g) of SPION alone (in 
water) and then was divided by the total number of cells (Figure 3.6).  
This could be described as follows:  
 
Total mass per sample = Average Magnetization of Sample (31.25, 250 and 1000 µg/ml) 
                                             Average Magnetization of SPION Alone (92 emu/g) 
   
SPION per cell = Total Mass per Sample     
                                Number of Cells               
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For example for cells incubated with 31.25 µg/ml (Figure 3.6-b): 
 
Total mass per sample =1.06 x 10
-4 emu  = 1.15 x 10
-6 g 
                                           92 emu/g 
 
SPION per cell = 1.15 x 10
-6 g  = 7.66 x 10
-12   or
    7.66 pg of SPION	 ﾠ	 ﾠ
                            150000 cells  
 
The average SPION per cell in picograms (pg) of 3 different replicates (n=3) from 
each group was plotted against the concentration. The results showed that when cells 
were incubated with increasing concentrations of SPION there was a direct increase in 
the amount of SPION measured in the cells (Figure 3.7).  
 
0 µg/ml  31.25 µg/ml 
   
(a)  (b) 
250 µg/ml  1000 µg/ml 
   
(c)  (d) 
Figure 3.6. The average magnetization of the magnetic material was plotted against the  
magnetic field for all the different concentrations of SPION (31.25, 250 and 1000  µg/ml)  
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Figure 3.7. SPION Concentration per Cell After Incubation with SPION at Different 
Concentrations (31.25, 250 and 1000 µg/ml) as Calculated from SQUID Magnetometry (n 
= 3).  
 
3.3.2.3.2 Cell Granularity After SPION-Loading  
3.3.2.3.2.1 Flow Cytometry	 ﾠ
To further investigate the cellular loading of SPION in HRSMC the forward light 
scatter (FS) and side light scatter (SS) of cells were measured using flow cytometry. 
The  forward  scatter  indicates  the  size  of  the  cells  and  the  side  scatter  shows  the 
granularity  of  the  cells.  This  phenomenon  was  investigated  as  a  technique  for 
determining cell loading with SPION. Side scatter (Figure 3.8 a) showed a significant 
increase for all the concentrations of SPION loaded cells compared with unloaded 
control cells (31.25µg/ml p<0.0001; 250 µg/ml p<0.0001; and 1000 µg/ml p<0.0001). 
Forward scatter (Figure 3.8 b) showed a significant decrease for all concentrations of 
SPION  loaded  cells  (31.25µg/ml  p<0.0001;  250  µg/ml  p<0.0001;  and  1000  µg/ml 
p<0.0001). 	 ﾠ 
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(a)  (b) 
Figure 3.8. The Side Scatter (a) and the Forward Scatter (b) of SPION-Loaded HRSMC 
(31.25 µg/ml, 250 µg/ml, and 1000 µg/ml) Plotted as their Geometrical Mean. For the 
forward scatter there was a continuous decrease and for the side scatter there was continuous 
increase. (*** p<0.0001 compared with unloaded control cells). 
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3.3.2.4 Effect of SPION-Loading on the Phenotype of HRSMC  
3.3.2.4.1 The Effect of SPION-Loading on HRSMC Proliferation   
A  BrdU  ELISA  assay  was  performed  to  investigate  the  effect  of  SPION  on  cell 
proliferation. There was no significant change to the proliferation of cells incubated 
with 31.25 µg/ml and 1000 µg/ml of SPION (Figure 3.9) compared with the control 
cells (p>0.05). However, a significant increase was observed for cells incubated with 
250 µg/ml (p<0.01).  
 
Figure 3.9.  Cell Proliferation  of  HRSMC  Incubated  with  Different  Concentrations  of 
SPION for 24 Hours. A significant increase in cell proliferation was observed at 250 µg/ml 
(p<0.01). (**p<0.01 compared with unloaded control cells). 
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3.3.2.4.2 Cell Metabolic Activity Following Incubation with SPION  
In order to investigate the metabolic activity of HRSMC after culture with SPION an 
MTS/PMS assay was performed. A decrease was observed when cells were incubated 
with 1000 µg/ml of SPION (Figure 3.10) compared with unloaded control cells.  
 
Figure 3.10. Metabolic Activity of Human Rectal Smooth Muscle Cells after 24 Hours 
Incubation with Different Concentrations of SPION. A decrease was observed when cells 
were  incubated  with  1000  µg/ml  of  SPION  compared  with  unloaded  control  cells. 
(***p<0.001 compared with unloaded control cells). 
 
   
C	 ﾠ C	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3.3.2.5 Effect of SPION-Loading and Biocompatibility with HRSMC 
3.3.2.5.1 Cell Toxicity Following Incubation with SPION Measurement of Lactate 
Dehydrogenase Release (LDH)   
The  cytotoxic  effect  of  incubating  HRSMC  with  SPION  was  investigated  by 
measuring cellular release of LDH. Two types of controls were used: i) HRSMC with 
no  SPION  (0  µg/ml)  and  ii)  a  positive  control  (PC)  was  obtained  by  incubating 
HRSMC in a lysis solution (provided with the kit). The lysis solution lyses the cell 
membrane resulting in the maximum production of LDH in the supernatant (100% 
toxic). The detailed process was described in sections 2.2.5.2.1 and 3.2.2.5.3.1. No 
significant change was observed between HRSMC incubated with SPION (31.25-1000 
µg/ml) and control cells (no SPION) as showed in Figure 3.11.  The optical density of 
the positive control (PC) had approximately 20% increased.  
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Figure 3.11. LDH Release in the Supernatant Collected from HRSMC Incubated with 
SPION for a Period of 24 Hours. No significant change was observed following incubation 
between 31.25, 250 and 1000 µg/ml SPION compared to control cells (no SPION). The was an 
apparent increase in the release of LDH in the supernatant in the positive control (PC) 
3.3.2.5.2 Measurement of Cell Viability by Flow Cytometry 
Flow cytometry of cells incubated with propidium iodide (PI) was used to investigate 
the proportion of dead cells after incubation with different concentrations of SPION 
(32.15 µg/ml, 250 µg/ml, 1000 µg/ml) for 24 hours. Unlabelled control cells (Figure 
3.12 a) were acquired to set a gate based on the side scatter, which was subsequently 
used for acquiring PI labelled cells. The percentage of gated cells was used to quantify 
the number of cells stained with PI from 10,000 events. The quantities of cells stained 
with PI increased from 8 % in control cells to 11.23 % in cells incubated with 31.25 
µg/ml SPION (p<0.0001). Similarly, an increase was observed from 8% in control 
cells  to  12.71  %  and  13.97%  for  cells  incubated  with  250  µg/ml  and  1000  µg/ml 
compared with control cells (p<0.0001) (Figure 3.12).  
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(a) 
 
(b) 
 
(c) 
 
(d) 
  
(e) 
Figure 3.12 Side Scatter vs. FL2-H of HRSMC after 
Staining with PI. Cells were incubated with different 
concentrations of SPION (31.25 µg/ml (b), 250 µg/ml 
(c)  and  1000  µg/ml  (d)  for  24  hours.  Cells  with  no 
SPION  (a)  were  used  as  control.  R3  indicated  the 
unstained population of cells. Dead cells were located 
outside the gated region. A significant increase in the 
number of dead cells was observed at 31.25 µg/ml, 250 
µg/ml  and  1000µg/ml  after  HRSMC  stained  with  PI 
after 24 hours (e). (***p<0.001 compared with unloaded 
control cells. 
3.4 Discussion 
This  chapter  describes  the  preliminary  investigations  of  the  effects  of  SPION  on 
HRSMC.  It  explores  the  effects  of  SPION  in  the  culture  medium  used  for  this 
experiment,  the  localization  of  SPION  inside  HRSMC  and  the  loading  efficiency. 
Additionally, the biocompatibility of SPION with HRSMC was investigated. 
Main findings 
•  SPION particles used in the experiments consisted of clusters of iron oxide 
crystals, each measuring approximately 20-30 nm in diameter. The iron oxide 
crystals formed clusters in aqueous solutions, with a hydrodynamic diameter of  
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approximately 50 nm in water and 500 - 600 nm in culture medium due to a 
corona effect. 
•  SPION were endocytosed by HRSMC and located inside endosomes in the 
cytoplasm. 
•  The  amount  of  SPION  internalised  by  cells  was  concentration  dependent. 
However, for concentrations above 250 µg/ml loading saturation occurred.  
•  Incubation  of  HRSMC  with  250  µg/ml  SPION  for  24  hours  resulted  in  an 
increase  in  cell  proliferation,  no  change  in  metabolic  activity,  and  a  small 
increase in release of LDH. An increase in propidium iodide staining occurred 
for all concentrations of SPION tested. 	 ﾠ
The properties and characteristics of the SPION were investigated. The nanoparticles 
used in this study were negatively charged uncoated iron oxide crystals, commercially 
available  from  Chemicell  (Germany)  and  manufactured  by  chemical  precipitation. 
SPION at a concentration of 31.25 µg/ml was mixed with culture medium or distilled 
water and incubated for 30 minutes at 37
0C and 25
0C. The results showed an increase 
in the hydrodynamic diameter of the particles for both temperatures when incubated 
with culture medium compared with distilled water. The hydrodynamic diameter of 
SPION incubated with culture medium at both temperatures dropped with time. This 
can be explained by the Brownian motion of the particles. During the first few minutes 
of  incubation  there  was  a  vigorous  movement  of  the  particles,  which  eventually 
decreased with time. The initial increase of the hydrodynamic diameter of the particles 
is likely to have resulted from their agglomeration with culture medium constituents. 
This could be explained as the corona effect, where particles, surrounded by biological 
fluids  such  as  the  culture  medium,  are  coated  by  a  corona  of  serum  proteins  and  
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biomolecules  or  they  aggregate  to  form  clusters  of  various  sizes.  The  corona  that 
surrounds the nanoparticle is the primary contact to the cells therefore the type of 
coating or the charge of the nanoparticle is important (143-145).   
To highlight the importance of surface charge, a previous study investigated iron oxide 
nanoparticles with a diameter of 8 nm, which were coated with two different types of 
coating materials with different charges. The first was coated with anionic citrate ions 
to  create  citrate  coated  particles  (Cit-γ-Fe2O3),  and  the  second  was  coated  with  a 
cationic  compound  poly(acrylic  acid)  (PAA2K).  Dynamic  light  scattering 
measurements revealed no change in the hydrodynamic diameter of the particles when 
they were mixed with phosphate buffered saline (PBS) after 2 hours of incubation. An 
increase in the hydrodynamic diameter from 20 nm to 50 nm within seconds was 
observed  when  Cit-γ-Fe2O3  were  mixed  with  Roswell  Park  Memorial  Institute 
medium (RPMI) containing 10 % fetal bovine serum (FBS), which continued to grow 
slowly  up  to  100  nm  after  2  hours  of  incubation.  Interestingly,  no  change  in  the 
hydrodynamic diameter of the PAA2K was observed when mixed with RPMI with 10% 
FBS after 2 hours of incubation. The particles remained dispersed, forming a stable 
colloid  and  did  not  form  a  corona  in  the  culture  medium  (145).  This  study  could 
explain  the  increase  in  the  hydrodynamic  diameter  observed  in  the  current  study, 
where it could be due to the culture medium constituents but also due to the negative 
surface charge of the particles used for this experiment.   
After exploring the effects of SPION with the culture medium, the effect of SPION 
when incubated with cells was investigated, specifically the loading efficiency and 
biocompatibility.  There are several possible methods to label cells with SPION. As 
described in section 3.1, cells could be labelled with a magnetically labelled antibody 
which targeted a specific protein of interest (92, 93) or with direct incubation intended  
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to load SPION inside the cells (139). For this study direct incubation of SPION with 
HRSMC was explored.  
To  investigate  the  loading  and  the  localization  of  SPION  in  HRMSC,  light 
microscopy, TEM, SQUID, and the side and forward light scatter from flow cytometry 
measurement  were  used.  HRSMC  monolayers  were  incubated  with  SPION  as 
described in section 3.2.2.1. The cells were washed thoroughly with PBS in an attempt 
to  remove  unbound  SPION.  Light  microscopy  images  of  HRSMC  loaded  with  a 
different concentration of SPION (0-1000 µg/ml) revealed that loading had occurred 
for all the concentrations of SPION; however, loading was concentration dependent. 
There was an apparent increase in the loading for 1000 µg/ml of SPION compared 
with  31.25  µg/ml  and  250  µg/ml.  SPION  attached  to  the  plasma  membrane  was 
observed for all concentrations even if the cells were washed extensively. This could 
be explained, possibly, by the membrane SPION being in the process of endocytosis 
when  this  process  was  disrupted.  Alternatively,  electrostatic  forces  between  the 
negatively  charged  particles  and  positively  charged  components  of  the  cell  plasma 
membrane could account for this. An apparent clustering of non-internalised SPION 
was observed when HRSMC were incubated with 1000 µg/ml of SPION.  
Similarly, TEM images revealed that loading had occurred for all concentrations of 
SPION investigated. Images of HRSMC incubated with different concentrations of 
SPION revealed that SPION was internalised, possibly by an endocytic process. Other 
studies have used TEM to demonstrate SPION internalization by the cells (146). In one 
study,  dimercaptosuccinic  acid  magnetic  nanoparticles  (10  nm  in  diameter)  were 
incubated with Sprague-Dawley rat aortic SMCs for 24 hours at a concentration of 0.1 
mg/ml. Images revealed that the particles were endocytosed by SMC and were located 
into the lysosomes in the cytoplasm. Additionally the formation of aggregates were  
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observed outside the cells (147).  Both findings were also observed in this study.  
The  exact  endocytic  process  was  not  investigated  in  this  study.  It  is  likely  that 
caveolae-mediated  or  caveolae-independent  endocytosis  occurs.  This  type  of 
endocytosis creates 50 nm diameter vesicles to endocytose nanoparticles, similar in 
size  to  the  magnetic  nanoparticles  used  in  this  study.  Caveolae-mediated  or 
independent endocytosis fall into a broad category of endocytosis called pinocytosis, 
together  with  clathrin-mediated  and  independent  endocytosis and  macropinocytosis 
(148).  However,  according  to  the  DLS  results  the  hydrodynamic  diameter  of  the 
particles was increased from 50 nm to 500-600 nm in culture medium and remained 
stable for 30 minutes of incubation. Therefore the particles were possibly endocytosed 
through clathrin-coated endocytosis (>150nm vesicles) or macropinocytosis (<1 µm). 
Recent reports suggest that there is not only one type of endocytosis responsible for 
SPION uptake but maybe a combination of more than one. Jing Li et al investigated 
the endocytic process of dimercaptosuccinic acid coated γ-Fe2O3 particles (10 nm in 
diameter)  into  macrophage-like  cell  line  RAW264.7.  Cells  were  incubated  with  a 
number of endocytic inhibitors such as 10 µg mL
-1 chlorpromazine (an inhibitor of 
clathrin-dependent endocytosis), 5 µg  mL
-1  of filipin III and M-β-CD that disturb the 
caveolin-dependent  endocytosis  and  2.5  mmol  L
-1  of  amiloride,  which  is  a 
macropinocytosis inhibitor. The results showed that pre-treatment with these endocytic 
inhibitors  and  subsequent  incubation  of  RAW264.7  with  DMSA  coated  γ-Fe2O3 
nanoparticles showed reduced SPION internalization for all the endocytic inhibitors 
suggesting  that  there  is  not  a  defined  endocytic  process  but  maybe  a  combination 
(149).  
SQUID magnetography was used to quantify the amount of SPION loaded in the cells. 
HRSMC were incubated with different concentration of SPION (0 - 1000 µg/ml). The  
	 ﾠ 96 
results  revealed  that  there  was  an  increase  in  SPION  internalisation  as  the 
concentration of SPION rises. These findings confirm the light microscopy and TEM 
results that SPION loading is concentration dependent. However, the SQUID results 
showed that the increase in the amount of SPION was not linear, instead plateauing, 
which  suggests  that  saturation  might  have  occurred.  This  is  supported  by  light 
microscopy images where clustering of non-internalised SPION was evident outside 
the cell.  
The  internalisation  process  was  also  investigated  using  flow  cytometry.  Forward 
scatter  indicates  the  size  of  cells  and  the  side  scatter  the  granularity.  Cells  were 
incubated with different concentrations of SPION. The results revealed that as the 
concentration of SPION increased the cells became more granular. Side scatter showed 
a significant increase for all the concentrations of SPION. This result indicated that as 
the SPION concentration was increased the cells became more granular, suggesting the 
cells had internalized more SPION. The apparent increase in side scatter corresponded 
with the SQUID results. Interestingly a decrease was observed in the forward scatter 
(cell size) for all the concentrations of SPION. This finding does not correspond with 
the light microscopy and TEM images, where no difference was observed in cell size. 
It is not certain that SPION loading affects the size of cells. A recent study suggested 
that  when  two  different  population  of  stem  cells  (human  chorial  villi  and  human 
amniotic fluid cells) were incubated with the same concentration of a dextran coated 
SPION (35 mg/ml; Endorem
®) coupled to Poly-L-Lysine for 72 hours, the side scatter 
revealed that that there was no significant difference in cell size, even if both types of 
cells had internalised the same amount of SPION (150).  
In  this  study,  uncoated  negatively  charged  SPION  were  directly  incubated  with 
HRSMC allowing the cells to take up the particles through endocytosis. The amount of  
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SPION  internalised  was  estimated  to  be  between  10–40  pg/cell  for  the  different 
concentrations of SPION. In general many studies have used transfection agents in 
order to enhance the loading efficiency (151). Transfection agents could be polymeric 
compounds such as dextran or PLL, which have an electrostatic charge that can be 
used to transfect cells without the use of viruses. Previous studies have compared the 
loading efficiency of different transfection agents. An example is a study by Miyoshi 
where rat pheochromocytoma PC12 cells were loaded with Feridex (120 to 180 nm) 
using  either  inactivated  HVJ-E  vectors  (GenomeOne,  Japan)  or  a  liposome  agent, 
Lipofectamine  2000,  in  order  to  compare  the  loading  capacity  of  2  different 
transfection agents with the same magnetic particles. HVJ-Es were used to encapsulate 
Feridex  particles.  HVJ-Es  containing  Feridex  at  volumes  of  3.2  µl  or  10  µl  were 
incubated  with  PC12  for  six  hours.  Atomic  absorption  spectrophotometry 
demonstrated that HVJ-E transfection resulted in significantly greater iron content than 
L2000 transfection. The average iron content of cells labeled using HVJ-E transfection 
was 2.97 pg/cell for 3.2 µl and 10 µl of Feridex. The iron content of cells labelled 
using L2000 transfection was 0.21 pg/cell for 3.2 µl and 10 µl of Feridex, respectively. 
The viability studies showed that Feridex-ﾭ‐loaded cells transfected with either HVJ-Es 
or  L2000  did  not  affect  the  cell  viability  compared  to  unlabelled  cells  for  all  the 
different concentration of Feridex after 6 hours of incubation when an MTS and LDH 
assay was performed (152). In another example Ferumoxides (FE) (50 µg/mL) with a 
diameter  approximately  80-150  nm  were  coated  with  a  polycationic  poly-L-lysine 
(PLL) transfection agent (The FE-to-PLL ratio was 1:0.06 or 1:0.03) and incubated 
with human cervical carcinoma (HeLa), human MSC and hematopoietic stem cells 
overnight.  The  iron  concentration  was  measured  with  nuclear  magnetic  resonance 
(NMR) relaxometry. The results showed that the iron content is cell type and density  
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dependent.  The  lowest  iron  content  was  observed  in  hematopoietic  cells  with  an 
average content of 1.53 pg and the highest iron concentration in MSC with 12.61 pg 
(both seeded with 20,000 cells/cm
2). Additionally, when different cell densities where 
compared the iron content was different. HeLa cells were cultured at different densities 
(2,000,  4000,  20,000,  40,000  and  80,000  cells/cm
2)  and  the  amount  of  SPION 
internalized was 10.58, 10.11, 9.29, 7.42 and 4.15 pg/cell. (153).  
The hypothesis that suspension cells such as hematopoietic stem cells internalize more 
SPION  has  been  seen  elsewhere  (154).  In  a  different  study  without  the  use  of 
transfection  agents,  neural  progenitor  cells  (NPC)  were  incubated  with  SPION 
(Feridex IV, Berlex, USA) at different concentrations (0-100 µg/ml) and at different 
time points (0.5, 24 and 48 hours). Electron microscopy revealed that SPION were 
endocytosed by the cells, most probably by endosomes or lysosomes. Prussian blue 
staining results showed that the higher the concentration the more labelling occurred. 
The amount of iron inside the cells was estimated 5.3 pg/cell for NPCs labelled with 
75 µg/ml for 48 hours according to Inductively Coupled Plasma Atomic Emission 
Spectroscopy  (ICP-AES)  (155).  All  these  studies  have  demonstrated  that  SPION 
internalization is time and concentration dependent, two factors that play a substantial 
role in the loading efficiency. Different types of cells and magnetic nanoparticles have 
been  investigated,  but  sufficient  loading  has  been  achieved  without  affecting  cell 
viability.  
The biocompatibility of incubating HRSMC with different concentrations of SPION 
was investigated. The toxicity of SPION-loaded HRSMC were tested with an LDH 
assay. No significant change was observed between SPION-loaded and control cells. 
However, there was a decrease in the viability when SPION-loaded cells are stained 
with  propidium  iodide  (PI).  The  decrease  in  cell  number/viability  observed  when  
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HRSMC might be explained by the particles used not being coated with a polymer. In 
the  literature,  SPION  coated  with  different  polymers  have  shown  substantial  cell 
viability. For example, previous studies have demonstrated that SPION incubation did 
in  fact  affect  the  viability  of  cells.  An  example  is  a  study  by  Kupta  et al,  where 
primary human fibroblasts were incubated with different concentration (0-2.0 mg/ml) 
of Pullalan coated magnetic nanoparticles (Pn-SPION) with a diameter between 40-50 
nm. The MTT assay results showed that loading the cells with Pn-SPION did not 
affect the cell number in comparison with uncoated SPION where the cell number was 
decreased  significantly  (156).  Similarly  when  polyvinyl  alcohol  (PVA)  magnetic 
nanoparticles with a diameter of 86 nm were incubated with primary mouse connective 
tissue cells (L929 fibroblast) at a different concentration of SPION, no change was 
observed  in  the  cell  viability  for  all  concentrations  and  time  points  investigated, 
indicating that PVA coated magnetic nanoparticles are safe in comparison to control 
cells (no SPION) (157).  In a different study, Alamar blue assay was used to study cell 
viability. Human chondrocytes were loaded with Endorem and Lipofectamine 2000 
(Invitrogen) at different concentrations. The results showed that SPION loading did 
not change the viability of cells for all the concentrations (158).  In another study the 
cell  viability  was  investigated  with  CellTracker™  Green  CMFDA  (5-
chloromethylfluorescen diacetate, Invitrogen) for 24 hours. Three different types of 
cells were compared (human bone marrow stromal cells, neonatal chondrocytes and 
adult  chondrocytes)  by  incubating  with  0.5  mM  Fe/ml  Resovist.  The  cell  viability 
images revealed no significant changes in comparison with control unlabelled cells. 
Additionally viability results revealed that SPION loading affected the morphology of 
all three types of cells compared with non-loaded cells. SPION-loaded cells appeared 
to be more stretched out compared with control non-loaded cells. (159).  Based on the  
	 ﾠ 100 
previous studies it might be assumed that coating magnetic nanoparticles is crucial to 
avoid changes in the cell viability. It is important to be mentioned that many papers 
have used an MTT assay to examine the in vitro toxicity and others the viability or the 
proliferation. This is perhaps due to the fact that the assay allows rapid evaluation of 
cell viability, cell survival, cell growth and gives good reproducibility. MTS/PMS is a 
mitochondrial  metabolic  activity  assay  where  MTS  is  bioreduced  by  cells  into  a 
formazan product that is soluble in tissue culture medium.  
The increase in cell proliferation observed when HRSMC incubated with 250 µg/ml of 
SPION was not supported by the MTS/PMS assay. This finding could be explained in 
the literature by Saha et al, where the proliferation of three different types of cells were 
compared  (human  bone  marrow  stromal  cells,  neonatal  chondrocytes  and  adult 
chondrocytes).  A  significant  change  in  the  proliferation  of  neonatal  chondrocytes 
compared  with  non-loaded  cells  occurred  after  2  days  incubation.  After  7  days  of 
incubation no significant change was observed between SPION-loaded and control 
cells  and  finally  after  14  days  of  incubation  an  increase  in  cell  proliferation  was 
observed  between  SPION-loaded  compared  with  control  cells.  No  change  was 
observed in cell proliferation for HBMSCs and adult chondrocytes (159).   
3.5 Conclusion 
The increase in cell proliferation observed when HRSMC were incubated with 250 
µg/ml of SPION could have therapeutic value in degenerated muscle. However, this 
finding needs to be investigated further. According to the SQUID results saturation 
was occurred in HRSMC loaded with SPION above 250 µg/ml. additionally loaded the 
cells with SPION did not affect the biocompatibility as demonstrated with the toxicity-
LDH  assay.  Therefore  the  SPION  concentration  250  µg/ml  produced  the  most 
consistent results without detrimental cellular effects and finally that concentration was  
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selected for the magnetic actuation experiments (chapter 4) was selected for use in the 
following chapters because of the loading characteristics and less clustering on the 
plasma membrane compared with higher concentrations investigated.  
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4.1 Introduction  
Previous studies have demonstrated it is possible to manipulate the cell phenotype 
remotely  using  magnetic  actuation.  The  aim  of  this  chapter  was  to  investigate  the 
effects  of  applying  external  magnetic  fields  to  HRSMC  loaded  with  SPION.  This 
included  exploring  the  effect  of  a  magnetic  field  on  the  cell  phenotype  and  the 
biocompatibility of applying a magnetic field to SPION-loaded HRSMC.  
The concept of applying cyclic magnetic force to the cells with a frequency of 1Hz and 
2 Hz was devised from previous experiments conducted in the department using a 
Flexcell system. The Flexcell provides a cyclic mechanical strain to cells previously 
seeded  onto  elastic  membranes.    The  cells  are  stretched  uniaxial  and  the  strain  is 
received by different mechanoreceptors and translated into a biochemical signal inside 
the  cells.  In  these  previous  studies,  HRSMC  were  subjected  to  cyclic  strain  (20% 
elongation)  at  a  frequency  of  1Hz  for  1  hour  every  day  over  a  period  of  5  days 
resulting in an increase in cell proliferation determined by a BrdU ELISA (unpublished 
data).  The magnetic actuation regime is based on the Flexcell study described earlier. 
An oscilating magnetic field delivers a cyclic strain to the cells at a frequency of 1 Hz 
and 2 Hz for a period of 7 days. However the main difference was that the cells were 
not seeded onto an elastic membrane but on a rigid bottom (6-well plate).  Therefore 
the SPION-loaded endosomes ‘’magnetosomes’’ will physically move by dragging all 
the cytoskeletal components such as actin filaments, microtubules creating a stretching 
effect similar to the Flexcell system. this cytoskeletal movement will create a change 
in the phenotype of cells.  
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4.2 Materials and Methods 
4.2.1 Materials 
4.2.1.1 Magnetic Actuator  
A prototype magnetic actuation device was designed to deliver magnetic force to cells 
loaded with SPION (Figure 4.1a+b+c). The device consisted of two components. A 
rectangular housing made from polyoxymethylene (Delrin) with external dimensions 
100 mm (L) x 45 mm (W) x 45 mm (H) allowed tissue culture vessels to be placed on 
top. The centre of the long axis of the housing block was milled to provide a channel 
into which could be inserted a cylinder holding the magnets. The magnetic cylinder 
contained    a  pair  of  magnets  asymmetrically  housed  in  a  Delrin  rod  (Figure  4.1 
c+d+e).  The  two  magnets  were  composed  of  neodymium-iron-boron  (NdFeB;N50; 
MagnetSales,  UK)  with  dimensions  6  mm  x  8  mm  x  12  mm.  The  direction  of 
magnetisation was through their thickness (Figure 4.1 d+e). The magnets were placed 
6 mm apart in a rectangular cavity in the Delrin rod, so that poles were facing the same 
direction. A soft steel plate (dimensions 3 mm x 8 mm x 30 mm) was positioned 
beneath the magnets in the Delrin rod to concentrate the magnetic field in a forward 
direction (Figure 4.1 d+e).  
The magnetic actuator was driven by an external motor (Lego Technic 8293, UK) 
battery power pack (9V) and the rotational speed controlled by an infrared controller 
unit.  
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(a)  (b) 
 
(c) 
   
(d)  (e) 
Figure 4.1. (a+b) the components of the prototype magnetic actuator for use with tissue 
culture  plates  (c)  Diagrammatic  representation  of  the  magnetic  actuator  with  all  the 
dimensions.  (d)  The  components  of  the  magnetic  cylinder    (Part  of  the  Magnetic 
Actuator) Located Inside the Delrin Housing. (e) Diagrammatic representation of the 
Dimensions of the Magnetic Cylinder  
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4.2.1.2 Localized Cell Retention in Tissue Culture Plate for Magnetic Actuation 
Experiments 
In order to seed the cells in specific areas of tissue culture plates, silicone moulds were 
fabricated (Figure 4.2). 6 ml of silicone (Sylgard 184, Corning, UK) was poured into 
wells of a six-well tissue culture plate (Nunclon
TM Delta, Denmark). Each well had a 
diameter of 17.5 mm.  A polystyrene container (7ml screw-capped Bijou; Greiner Bio-
One, UK) with a diameter of 17 mm was positioned in the centre of the well of the 
tissue culture plate and the silicone was left for 48 hours to cure. The container was 
removed leaving a silicone disc with a central hole measuring 17 mm in diameter 
where the cells would be seeded.  
 
 
Figure 4.2.Silicone mould used to retain HRSMC in a designated area in the tissue 
culture plates.  
4.2.2 Methods  
4.2.2.1 Computer Modelling of Magnetic Fields Produced by the Actuator Device 
Finite element modelling was used to model the magnetic field and magnetic force 
produced by the oscillating magnetic actuator described in this chapter. The modelling 
was performed by Mr George Frodsham (Department of Biochemical Engineering, 
University  College  London,  London  and Institute  of  Biomedical  Engineering, 
17.5mm 
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University College London).  
Finite element modelling with Opera-3D (Version 12; Vector Fields, UK) was used to 
calculate the strength of the magnetic field produced by the magnetic actuator. The 
distance from the centre of the magnetic cylinder (with assigned co-ordinates x=0, 
y=0, z=0) to the base of the tissue culture plate was 14 mm. This included the diameter 
of the magnetic cylinder (8 mm), the thickness of the Delrin housing (4 mm), and the 
distance from the surface of the magnetic actuator housing to the inside surface of the 
tissue culture plate (2 mm) (Figure 4.3).  
The force produced by the magnetic actuator on each SPION particle in the cells was 
calculated using mathematical software (MATLAB, MathWorks, Natick, MA, U.S.A), 
from which the net magnetic force per cell was calculated. For all calculations the 
direction of the force was assumed to be downward. The force applied to cells by the 
magnetic  actuator  was  calculated  for  each  SPION  with  a  density  of  1.25g/cm
3, 
diameter of 50 nm and weight of 6.545x10
-4 pg at a distance of 14 mm away from the 
centre of the magnetic cylinder. Additional calculations were also made for the force 
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Figure 4.3 Horizontal View of Magnetic Actuator with the Culture Plate Located on its 
Top. 	 ﾠ
4.2.2.2 Visualization of the Magnetic Field with Micro Iron Microparticles  
(i)  Iron microparticles (150-300 µm and a density of 3.5g/cc; Guyson Flexgrain, 
Guyson International Limited, North Yorkshire, UK) were sprinkled into a 6 well 
tissue culture plate (Nunclon
TM Delta). The magnetic actuator was placed under 
the plate for 1 minute. 
(ii)  Images were taken using a digital camera (PowerShot SX260 HS digital camera, 
Canon). 
4.2.2.3 Actuation of HRSM Loaded with SPION Using the Magnetic Actuator 
The following steps are summarized in Figure 4.4 a, b. 
(i)  2x10
4 HRSMC were seeded in a 25 cm
2 cell culture flask (Nunclon
TM Delta 
surface, Denmark) and incubated for 24 hours at 37
0C, 5% CO2. 
(ii)  The medium was removed and experimental (proliferation) medium containing 
250 µg/ml of SPION (50 nm) was added and incubated at 37
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hours. 
(iii)  After  the  incubation  period  the  medium  was  removed  and  the  cells  were 
washed 5x with 5 ml of PBS. 
(iv)  1ml of trypsin was added to each flask and incubated at 37
0C, 5% CO2 for 
1minute. 
(v)  5  ml  of  fresh  media  was  added  in  each  flask  and  the  detached  cells  were 
collected in a 30 ml container. 
(vi)  Samples  were  centrifuged  at  1000  rpm  for  5  minutes,  the  supernatant  was 
removed and the pellets were re-suspended in 1 ml of fresh medium. 
(vii)  A cell count was performed and 10,000 cells were extracted. 
(viii)  Silicone moulds described in section 4.2.1.2 were dipped in 70% alcohol to 
sterilise them and dried inside a class II safety cabinet (Walker safety cabinets 
Ltd, UK).  
(ix)  The moulds were placed inside a 6 well tissue culture plate (Nunclon
TM Delta 
treated, Denmark). 
(x)  Cells were extracted and seeded in the hole at the centre of the mould. 
(xi)  The plate was incubated at 37
0C %, 5% CO2 for 24 hours.  
(xii)  Silicone moulds were carefully removed and the medium was replaced with 
differentiation or proliferation medium and incubated for 7 days at 37
0C, 5% 
CO2.  The  medium  was  replaced  every  other  day.  A  separate  plate  was 
incubated parallel to the incubation (day 1-control). 
(xiii)  The magnetic actuator was placed under the 6 well plate and cells were exposed 
to an oscillating magnetic field for 1hour each day at 1 Hz and 2 Hz for a 
period of 7 days at 37
0C, 5% CO2. 
(xiv)  At the end of day 7 the medium was removed and kept at -80
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(a) 
 
(b) 
Figure 4.4 Magnetic Actuation of HRSMC. Incubation of SPION-Loaded HRSMC with 
Proliferation  and  Differentiation  Medium.  SPION-loaded  HRSMC  in  proliferation  or 
differentiation medium are referred to as PRO+SPION or DIFF+SPION, respectively.   
4.2.2.4  Preparation  of  Cell  Monolayers  after  Magnetic  Actuation  for 
Transmission Electron Microscopy  
Transmission  electron  microscopy  (TEM)  was  used  to  determine  the  cellular 
localisation of SPION after magnetic actuation. The method for this was described in 
section 2.2.3.1. 
(i)  Steps i- vi from section 4.2.2.3 were repeated for this experiment. 
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a 24 well plate (Nunclon
TM Delta treated, Denmark). 
(iii)  Cells were incubated for 24 hours at 37
0C 5% CO2. 
(iv)  The 24 well plate was placed on top of the magnetic actuator device for 1 hour 
under static or oscillating conditions.  
(v)  After 1 hour the supernatant was removed and 1ml of 2.5% v/v glutaraldehyde 
(Sigma, UK) in PBS was added to fix the cells inside a fume cupboard for 10 
minutes. 
(vi)  Glutaraldehyde was removed and the samples were washed 2x with 1 ml of 
PBS. 
(vii)  The  samples  were  post  fixed  with  2%  osmium  tetroxide  (OsO4)  (Ceimig 
Limited, UK) for 1hour inside a fume cupboard. 
(viii)  The samples were dehydrated in a graded series of ethanol:water solutions.  
a.  25% v/v ethanol         4 minutes 
b.  50% v/v ethanol         4 minutes  
c.  75% v/v ethanol         4 minutes 
d.  95% v/v ethanol         4 minutes 
e.  100% v/v ethanol   4 minutes (the last step was repeated 5 times). 
(ix)  The monolayers were scored with a scalpel blade creating squares of 5 mm x 5 
mm.  
(x)  Propylene oxide (Agar Scientific, UK) was added to the samples in order to 
dissolve the plastic and detach the monolayers from the bottom of the well. 
Propylene oxide acts as a transition solvent before the embedding stage.  
(xi)  When the propylene oxide started to dissolve the plastic the cell monolayers 
were  lifted  with  a  wire  loop  and  were  transferred  into  fresh  solutions  of 
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diffuse out of the monolayers.  
(xii)  Propylene  oxide  was  removed  and  the  monolayers  were  transferred  in  a 
mixture containing 1:1 v/v propylene oxide: embedding resin (Araldite CY212 
resin; Agar Scientific, UK) was added for 20 minutes. 
(xiii)  1:1 propylene oxide was removed and 1:3 propylene oxide:embedding resin 
was added for 1.5 hours. 
(xiv)  The final propylene oxide:resin was removed and 100% resin was added. 
(xv)  The cell monolayers were transferred into a silicone rubber embedding moulds. 
(xvi)  The moulds were placed into an oven at 60ºC for 24 hours. 
(xvii)  The resin blocks containing the samples were thin sectioned (70 nm) with an 
ultramicrotome (Reichertjung ultracut E, Germany) and directly collected onto 
copper grids for its examination under a JEOL JEM 1200EX TEM operating at 
80 Kv. 
4.2.2.5  Quantification  of  Cellular  Loading  with  SPION  After  Incubation  with 
Proliferation and Differentiation Medium  
A superconducting quantum interference device (SQUID) was used to measure the 
amount of iron inside the cells after a period of 7 days with proliferation medium or 
differentiation medium. The method for this was described in section 2.2.3.1. 
(i)  Steps i-vi from section 4.2.2.3 were followed from this experiment.   
(ii)  A cell count was performed and 200,000 cells were extracted and placed in a 25 
cm
2 cell culture flask (Nunclon
TM Delta surface, Denmark) and incubated for 24 
hours at 37
0C, 5% CO2. A separate flask was incubated parallel to the incubation 
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(iii)  The  medium  was  removed  and  proliferation  or  differentiation  medium  was 
replaced for 7 days. The medium was replaced every other day. 
(iv)  Steps iii-xi from section 2.2.2.1 were followed for this experiment. 
4.2.2.6 Effect of Magnetic Actuation on the Phenotype of SPION Loaded HRSMC 
4.2.2.6.1 Protein Expression of Contractile Markers of SPION-Loaded HRSMC 
Exposed to an Oscillating Magnetic Field  
Immunocytochemistry was used to investigate the expression of proteins in HRSMC 
loaded with SPION following incubation in proliferation or differentiation medium. 
The method for this was described in section 2.2.4.1.1. 
(i)  Steps i-vi from section 4.2.2.3 were followed for this experiment.   
(ii)  10,000 cells were plated in a Fluorodish and incubated at 37
0C, 5% CO2 for 24 
hours.     
(iii)  The  medium  was  replaced  with  differentiation  or  proliferation  medium  and 
incubated for 7 days at 37
0C, 5% CO2. The medium was replaced every other 
day. A separate plate was incubated parallel to the incubation (day 1-control).  
(iv)  The magnetic actuator was placed under the 6 well plate and cells were exposed 
to an oscillating magnetic field for 1hour each day at 1 Hz and 2 Hz for a 
period of 7 days at 37
0C, 5% CO2.      
(v)  The  medium  was  removed  and  the  cells  were  fixed  with  1  ml  4% 
glutaraldehyde  (Sigma-Aldrich, USA) for 10minutes. 
(vi)  The cells were washed 3x with 1ml of PBS. 
(vii)  500 µl of Triton X-100 (Sigma-Aldrich, USA) were added and the cells were 
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(viii)  After the incubation period the cells were washed 3x with 1 ml of PBS.  
(ix)  500 µl of 5% BSA (Sigma-Aldrich, USA) was added and cells were incubated 
for 30 minutes at room temperature.  
(x)  The solution was removed and 500 µl of primary antibody (1:1000 for actin, 1: 
for 1:500 myosin heavy chain, 1:1000 for calponin, 1:500 for caldesmon all in 
PBS; Sigma-Aldrich, USA) and cells were incubated over night at 4
0C.   
(xi)  The antibody was removed and cells were washed 3x with 1ml of PBS. 
(xii)  500 µl of secondary antibody (1:400) (Sigma-Aldrich, USA) was added and 
cells were incubated for 1 hour at room temperature. 
(xiii)  The solution was removed and cells were washed 3x with 1ml of PBS.  
(xiv)  The  cells  were  mounted  with  a  glass  coverslip  using  drop  of  DAPI  (Life 
Technologies, USA).  
(xv)  An upright fluorescence microscope (BX51 Olympus, GX Optical, UK) was 
used to acquire images. 
4.2.2.6.2 Gene Expression of Contractile and Proliferative Markers of HRSMC 
Loaded with SPION Exposed to an Oscillating Magnetic Field 
4.2.2.6.2.1 Real-Time Polymerase Chain Reaction  
Real time polymerase chain reaction was performed for these experiments. The general 
methods used for this were described previously in section 2.2.4.2.1. 
To complete the experiment: 
(i)  Steps i-xiii from section 4.2.2.3 were followed for this experiment.   
(ii)  Steps vi-xiv from section 2.2.4.2.1, step i from section 2.2.4.2.2, steps i-iii from 
section  2.2.4.2.3  and  steps  i-ii  from  section  2.2.4.2.4  were  followed  for  this Chapter 4: Effects of Magnetic Actuation on the Phenotype of SPION-Loaded HRSMC 
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experiment. 
4.2.2.6.3 The Aspect Ratio of SPION-Loaded HRSMC Exposed to an Oscillating 
Magnetic Field 
Aspect ratio measurements were performed for these experiments. The methods used 
for this were described previously in section 2.2.4.3. 
To complete the experiment: 
(i)  Steps i-xiii from section 4.2.2.3 were followed for this experiment. 
(ii)  The  medium  was  removed  and  the  cells  were  fixed  with  1  ml  of  2.5% 
glutaraldehyde for 10 minutes at room temperature. 
(iii)  The solution was removed and the cells were washed with 3x with 1ml of PBS.  
(iv)  The cells were imaged using a Phase Contrast Inverted Microscope (AmScope 
40X-900X Phase Contrast Inverted Microscope with 3M Camera, USA). 
(v)  The aspect ratio was calculated using an image analysis software (Image J,  
National Institute of Health, USA). 
4.2.2.6.4 Cell Proliferation of SPION-Loaded HRSMC Following Incubation with 
Proliferation or Differentiation Medium 
Four methods were used to investigate the effect of proliferation and differentiation 
medium of SPION-loaded HRSMC. 
4.2.2.6.4.1 BrdU Assay 
Cell proliferation-BrdU assay was performed for these experiments. The methods used 
for this were described previously in section 2.2.4.4.1. 
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(ii)  Before the test was started the medium was removed and 1 ml of fresh medium 
was added. 
(iii)  50 µl per well BrdU label (final volume of 500 µl) was added to all the wells 
and the plate was incubated for 2 hours at 37
0C 5% CO2. 
(iv)  Labelling medium was removed by inverting the plate and tapping off. 
(v)  500 µl of fixative and denaturing solution provided with the assay was added to 
the wells. The plate was incubated for 30 minutes at room temperature. 
(vi)  Fixative denaturing was removed from all the wells by inverting the plate and 
tapping off the solution and 500 µl per well anti-BrdU-peroxidase monoclonal 
antibody  was  added  to  each  well  and  incubated  for  90  minutes  at  room 
temperature. 
(vii)  Antibody  conjugated  solution  was  then  removed  by  inverting  the  plate  and 
tapping off the solution. The wells were rinsed 3x with PBS/washing solution. 
(viii)  1000 µl of substrate solution provided with the assay was added to each well 
and incubated for 30 minutes at room temperature. 
(ix)  100  µl  of  the  solution  was  removed  and  plated  in  a  fresh  96  well  plate 
(Nunclon
TM Delta surface, Denmark). 
(x)  25 µl of 1M H2SO4 stop solution provided with the assay was added to all the 
wells. 
(xi)  Optical  density  of  the  reaction  produced  in  the  well  was  read  with  a 
colorimetric plate reader Multiskan FC (Thermoscientific, UK) at 450 nm with 
a reference wavelength at 690 nm. 
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4.2.2.6.4.2 Measurement of Cellular DNA Content Using the CyQUANT® Assay  
The CyQUANT NF Assay was performed for these experiments. The methods used 
for this were described previously in section 2.2.4.4.2. 
(i)  Steps i-xiii from section 4.2.2.3 were followed for this experiment. 
(ii)  Before the test was started the medium was removed and 1 ml of fresh medium 
was added. 
(iii)  Remove medium and add 200 µl of CyQUANT NF dye reagent (in 1x HBSS 
buffer). 
(iv)  Incubate at 37
0C, 5% CO2   using a plate shaker at speed 70 for 1 hour.  
(v)  After the incubation period, 100 µl of the solution was transferred in a black 
plate (Nunc™ F96 MicroWell™ Plates, Denmark).  
(vi)  The  fluorescence  intensity  was  measured  using  a  fluorescence  plate  reader 
(TECAN  SpectraFluor,  USA)  at  an  excitation  wavelength  of  485nm  and  an 
emission wavelength at 530 nm. 
4.2.2.6.4.3 Direct Cell Count  
Direct cell counts were performed for these experiments. The methods used for this 
were described previously in sections 2.2.4.4.3. 
(i)  Steps i-xiii from section 4.2.2.3 were followed for this experiment. 
(ii)  After the incubation period the medium was removed and the cells were washed 
1x with 1ml of PBS. 
(iii)  1 ml of trypsin was added to each well and incubated at 37
0C, 5% CO2 for 1 
minute. 
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in a 15 ml container. 
(v)  Samples  were  centrifuged  at  1000  rpm  for  5  minutes,  the  supernatant  was 
removed and the pellets were re-suspended in 1ml of fresh media. 
(vi)  A cell count was performed as described in section 2.2.1.3. 
4.2.2.6.4.4 Cell Metabolic Activity Assay-MTS/PMS 
Cell  Metabolic  Activity  Assay-MTS/PMS  was  performed  these  experiments.  The 
methods used for this were described previously in section 2.2.4.4.4. 
(i)  Steps i-xiii from section 4.2.2.3 were followed for this experiment.  
(ii)  Before the test was started the medium was removed and 1 ml of fresh medium 
was added. 
(iii)  100  µl  /well  MTS/PMS  combined  solution  was  added  to  all  the  wells  and 
incubated for 2 hours at 37
0C, 5% CO2. 
(iv)  The regents were mixed using a plate shaker (Stuart mini orbital shaker SSM1, 
Bibby Sterilin Ltd, UK) at 70 speed at 37
0C %, 5% CO2 for 2 hours. 
(v)  After the incubation period 100ul of the supernatant was transferred to a fresh 96 
well plate (Nunclon
TM Delta surface, Denmark). 
(vi)  Absorbance of the formazan was measured at 490 nm with colorimetric reader 
Multiskan FC (Thermoscientific, UK). 
4.2.2.7 Effect of Magnetic Actuation on the Biocompatibility of SPION- Loaded 
HRSMC  
4.2.2.7.1 Reactive oxygen species	 ﾠ
Measurement of reactive oxygen species release was performed for these experiments. 
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(i)  Steps i-vii from section 4.2.2.3 were followed for this experiment.   
(ii)  10,000 cells were plated in a Fluorodish Cell Culture Dish - 35mm (World 
Precision Instruments, USA) and incubated at 37
0C, 5% CO2 for 24 hours.  
(iii)  The  medium  was  replaced  with  differentiation  or  proliferation  medium  and 
incubated for 7 days at 37
0C, 5% CO2. The medium was replaced every other 
day. A separate plate was incubated parallel to the incubation (day 1-control). 
(iv)  The magnetic actuator was placed under the 6 well plate and cells were exposed 
to an oscillating magnetic field for 1hour each day at 1Hz and 2Hz for a period 
of 7 days at 37
0C, 5% CO2.      
(v)  Before the test was started the medium was removed and cells were washed 1x 
with HBSS (Gibco, USA). 
(vi)  500 µl of 25µM carboxy-H2 DCFDA working solution (in DMSO) was added 
for the 30 minutes at 37
0C, 5% CO2. 
(vii)  The last 5 minutes of the incubation period 1 µl of (1mM) Hoechst 33342 stain 
(provided in the kit) was added. 
(viii)  After the incubation period the cells were washed 3x with HBSS (Gibco, USA). 
(ix)  The cells were mounted in a drop of HBSS (Gibco, USA).  
(x)  Images were taken using a fluorescent microscope (Leica DM2000, Germany). 
4.2.2.7.1.1 Reactive Oxygen Species-Positive Control  
A reactive oxygen species positive control was included in these experiments. The 
methods used for this were described previously in section 2.2.5.1.1. 
(i)  Steps i-vii from section 4.2.2.3 were followed for this experiment.   
(ii)  Cells were plated in a Fluorodish and incubated at 37
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(iii)  The  medium  was  replaced  with  differentiation  or  proliferation  medium  and 
incubated for 7 days at 37
0C, 5% CO2. The medium was replaced every other 
day. A separate plate was incubated parallel to the incubation (day 1-control). 
(iv)  The magnetic actuator was placed under the 6 well plate and cells were exposed 
to an oscillating magnetic field for 1 hour each day at 1 Hz and 2 Hz for a 
period of 7 days at 37
0C, 5% CO2.      
(v)  To induce reactive oxygen species, 500 µl of 100 mM TBHP (in water) were 
mixed with 1ml of culture medium and added. Cells were incubated for 90 
minutes at 37
0C, 5% CO2.  
(vi)  Before the test was started the medium was removed and cells were washed 1x 
with HBSS (Gibco, USA). 
(vii)  500 µl of 25 µM carboxy-H2 DCFDA working solution (in DMSO) was added 
for the 30 minutes at 37
0C, 5% CO2.  
(viii)  The last 5 minutes of the incubation period 1 µl of (1mM) Hoechst 33342 stain 
(provided in the kit) was added. 
(ix)  After the incubation period the cells were washed 3x with HBSS (Gibco, USA). 
(x)  The cells were mounted with a drop of HBSS (Gibco, USA). 
(xi)  Images were taken using a fluorescent microscope (Leica DM2000, Germany). 
4.2.2.7.2 Cytotoxicity Assay-LDH Assay 	 ﾠ
Cytotoxicity Assay-LDH Assay was performed in these experiments. The methods 
used for this were described previously in section 2.2.5.2. 
(i)  Steps i-xiii from section 4.2.2.3 were followed for this experiment.  
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was added. 
(iii)  Medium from SPION-loaded cells incubated with proliferation or differentiation 
medium were collected and transferred to a fresh 96 well plate (Nunclon
TM Delta 
surface, Denmark) accordingly. 
(iv)  50 µl of medium was removed and placed in a new well and 50 µl of the LDH 
solution was added to each well and the plate was incubated in the dark for 30 
minutes. 
(v)  50 µl of stop solution was added to each well and the optical density of the 
reaction  produced  in  the  well  was  read  with  a  plate  reader  Multiskan  FC 
(Thermoscientific, UK) at 490nm.   
4.2.2.7.2.1 Cytotoxicity Assay (Positive Control)	 ﾠ
Cytotoxicity  Assay-LDH  Assay  (Positive  Control)  was  performed  for  these 
experiments. The methods used for this were described previously in section 2.2.5.2.1. 
(i)  Steps i-xiii from section 4.2.2.3 were followed for this experiment.  
(ii)  10 µl of lysis solution (provided with the kit) per 100 µl was added to all the 
wells. 
(iii)  The cells were incubated for 45 minutes at 37
0C, 5% CO2. 
(iv)  The plate was centrifuged at 250 x g for 4 minutes. 
(v)  Supernatants of SPION cells incubated with proliferation or differentiation were 
collected  and  transferred  to  a  fresh  96  well  plate  (Nunclon
TM  Delta  surface, 
Denmark) accordingly. 
(vi)  50 µl of medium was removed and placed in a new well and 50 µl of the LDH 
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minutes. 
(vii)  50 µl of stop solution was added to each well and the optical density of the 
reaction  produced  in  the  well  was  read  with  a  plate  reader  Multiskan  FC 
(Thermoscientific, UK) at 490 nm. 
4.2.2.7.3 Apoptosis - Caspase 3-7 Activity 
Measurement  of  Caspase  3-7  activity  was  performed  for  these  experiments.  The 
methods used for this were described previously in sections 2.2.5.3. 
(i)  Steps i-xiii from section 4.2.2.3 were followed for this experiment.  
(ii)  The medium was removed and 200 µl of Apo-ONE
® Caspase reagent was added 
and the cells were incubated for 30 minutes at room temperature. 
(iii)  After the incubation period 100 µl were transferred in a black plate (Nunc™ F96 
MicroWell™ Plates, Denmark). 
(iv)  The  fluorescence  was  measured  using  a  fluorescence  plate  reader  (TECAN 
SpectraFluor,  USA)  at  an  excitation  wavelength  of  485  nm  and  an  emission 
wavelength at 530 nm. 
4.3 Results   
4.3.1  Modelling  of  the  Magnetic  Field  and  Forces  Acting  on  SPION-Loaded 
HRSMC  
The field plots in Figure 4.5 show the magnetic field produced at the base of the tissue 
culture plate 14 mm from the centre of the magnetic device. As the magnet rotated 
from 0 degrees (directly below the plate) to 180 degrees (farthest from the plate) the 
magnetic field became weaker. At 0 degrees the magnetic field acting on the particles 
was 82 mT and at 180 degrees the magnetic field dropped to 0 mT. The areas of the Chapter 4: Effects of Magnetic Actuation on the Phenotype of SPION-Loaded HRSMC 
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plot coloured red indicated the magnetic field had its highest value and those coloured 
blue had the lowest value. The force plot (Figure 4.6) show that as the magnet rotated 
from 0 to 180 degrees the magnetic force also became weaker. At 0 degrees the force 
acting on each particle was 0.9 pico Newton (pN) and at 180 degrees the forces was 
0.000007 pN. The calculations were made assuming each SPION was 50 nm diameter, 
had a density 1.25g/cm
3 and mass of 6.545x10
-4 pg. Therefore, if the HRSMC were 
loaded with 50 pg of magnetic material the force acting on a cell at 0 degrees was: 
50 x 0.9 pN = 45 pN 
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Figure 4.5 Magnetic Field Plots from the Magnetic Actuator. At 0 degrees the magnetic 
field  had  the  highest  value  of  82  mT.  As  the  magnet  rotated  from  0  to  180  degrees  the 
magnetic field became weaker with lowest value of 0 mT. 
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Figure 4.6 Magnetic Force Plots from the Magnetic Actuator. At 0 degrees the magnetic 
field produced the highest value of 0.9 pN. As the magnet rotated from 0 to 180 degrees the 
magnetic force became weaker with lowest value 0.000007 pN. 
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4.3.2 Visualization of the Magnetic Field with Iron Microparticles  
Figure 4.7 (a) shows where the majority of iron filings were attached when a static 
magnetic field was applied to the base of the tissue culture plate. The majority of the 
iron filings were positioned to where the magnets were located. At this position (0 
degrees) the magnetic field had its highest value as shown in Figure 4.7 (c). 
 
   
(a)  (b) 
Figure  4.7.  (a)  Distribution  of  Iron  Filings  under  a  Static  Magnetic  Field.  (b)  The 
Magnetic  Field  Plot  Shows  that  the  Field  has  its  Highest  Value  directly  above  the 
Magnets.  
4.3.3 Quantification of Cellular Loading with SPION After Incubation of  
HRSMC in Proliferation and Differentiation Medium  
SQUID magnetometry was used to quantify the amount of SPION in HRSMC after the 
incubation in differentiation or proliferation medium for 7 days. The controls (Figure 
4.8  a+b+c)  were  calculated  in  the  same  way  like  section  (3.3.2.3.1).  The  results 
showed that SPION-loaded HRSMC incubated with proliferation medium for a period 
of 24 hours had approximately 16 pg of SPION per cell. However, SPION-loaded Chapter 4: Effects of Magnetic Actuation on the Phenotype of SPION-Loaded HRSMC 
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HRSMC incubated with proliferation medium for 7 days had approximately 6 pg of 
SPION per cell, (Figure 4.9 a). The number of cells in the SPION-loaded HRSMC 
incubated  in  proliferation  medium  for  24  hours  followed  by  incubation  in 
differentiation  medium  for  7  days  did  not  increase,  whereas  the  cell  number  for 
SPION-loaded HRSMC incubated with proliferation medium for 7 days had increased 
by approximately three fold (Figure 4.9 b). 
Day 1 Proliferation Medium +SPION   Day 7 Proliferation Medium+SPION  
 
 
(a)  (b) 
Day 7 Differentiation Medium+SPION   
 
 
(c)   
Figure 4.8 The average magnetization of the magnetic material was plotted against the 
magnetic  field  of  cells  incubated  with  250  µg/ml.  (a)  the  magnetization  of  HRSMC 
incubated with 250 µg/ml in proliferation medium for 24 hours, (b) the magnetization HRSMC 
incubated with 250 µg/ml in proliferation medium for 7 days and (c) the magnetization of 
HRSMC incubated with 250 µg/ml in differentiation medium for 7 days Chapter 4: Effects of Magnetic Actuation on the Phenotype of SPION-Loaded HRSMC 
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Figure 4.9  (a) SPION Concentration per Cell after Incubation with SPION (250µg/ml) 
for 24 Hours and 7 Days with Proliferation and Differentiation Medium. (b) Cell Number 
after Incubation in Proliferation or Differentiation Medium. 
4.3.4 Cellular Localisation of SPION After Magnetic Actuation 
TEM  was  used  to  investigate  the  cellular  localization  of  SPION  after  exposure  to 
magnetic  actuation.  HRSMC  monolayers  pre-incubated  with  culture  medium 
containing 250 µg/ml of SPION for 24 hours were exposed to magnetic actuation for a 
period  of  1  hour  at  37
0C,  5%  CO2 (Figure  4.10  b).  Electron  micrographs  of  the 
actuated cells showed SPION-loaded endosomes inside the cells. The position of the 
endosomes inside the cells was similar to those of non-actuated SPION-loaded control 
cells (Figure 4.10 a).     
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(a)  (b) 
Figure  4.10  Transmission  Electron  Microscopy  Images  of  SPION-Loaded  HRSMC 
Incubated  in  Medium  Containing  250  µg/ml.  (a)  Non-actuated  control  cells  (b)  After 
actuation for 1 hour using a static magnetic field. 
4.3.5 Effect of Magnetic Actuation on the Phenotype of SPION-Loaded HRSMC  
4.3.5.1 Expression of Contractile Proteins in SPION-Loaded HRSMC Following 
Magnetic Actuation  
Immunocytochemistry  and  fluorescence  microscopy  was  used  to  investigate  the 
expression of contractile proteins actin, myosin heavy chain, caldesmon, calponin in 
SPION-loaded  HRSMC  incubated  in  proliferation  or  differentiation  medium  and 
exposed to magnetic actuation. HRSMC were incubated with 250 µg/ml of SPION in 
proliferation medium for 24 hours and then switched to differentiation or proliferation 
medium for 7 days, whilst receiving exposure to magnetic actuation. Two types of 
controls  were  used:  i)  HRSMC  without  SPION  and  no  actuation,  incubated  with 
proliferation  or  differentiation  medium  for  7  days,  and  ii)  SPION-loaded  cells 
incubated with proliferation medium for 24 hours, included as a pre-actuation control. 
After 7 days treatment the cells were stained with antibodies for the contractile protein 
markers such as actin, myosin heavy chain, caldesmon and calponin. The expression of Chapter 4: Effects of Magnetic Actuation on the Phenotype of SPION-Loaded HRSMC 
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the proteins was detected using anti-mouse IgG FITC conjugated antibody, and the 
nuclei were counterstained blue with DAPI.  
Fluorescence  microscopy  revealed  SPION-loaded  HRSMC  incubated  with 
proliferation  medium  for  24  hours  without  magnetic  actuation  had  no  detectable 
protein expression of myosin heavy chain and caldesmon compared with the control 
(cells in proliferation medium) (Figure 4.11 f, h and Figure 4.11 e, g).  
Expression of actin and calponin in SPION-loaded HRSMC was visible after 24 hours 
incubation  in  proliferation  medium  (Figure  4.11  b,  d),  and  the  intensity  and 
localization was comparable to that observed in the control (no SPION) cells, as shown 
in Figure 4.11 a, c. 
The diffuse cytoplasmic expression of actin and calponin in SPION-loaded HRSMC 
after 7 days in proliferation medium (Figure 4.12 b, f) was similar to that observed for 
control  cells  (no  SPION)  (Figure  4.12  a,  e).  No  visible  difference  existed  for  the 
expression and localization of actin and calponin in SPION-loaded cells incubated in 
proliferation medium for 7 days compared with SPION-loaded HRSMC incubated in 
proliferation medium after 24 hours. 
 SPION-loaded  HRSMC  incubated  in  proliferation  medium  for  7  days  showed  no 
visible  expression  of  myosin  heavy  chain  and  caldemon  (Figure  4.12  j,  n),  which 
matched that observed in control cells (no SPION) (Figure 4.12 i, m). 
 Incubating HRSMC with differentiation medium for 7 days appeared to result in the 
cells  shifting  from  a  proliferative  to  a  contractile  phenotype.  There  was  a  visible 
change in the localization of actin and calponin expression after 7 days incubation in 
differentiation medium for both SPION-loaded HRSMC (Figure 4.13 b and f) and Chapter 4: Effects of Magnetic Actuation on the Phenotype of SPION-Loaded HRSMC 
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control cells (no SPION) (Figure 4.13 a, e). The staining distribution was notably more 
fibrillar compared with cell incubated in proliferation medium.  
SPION-loaded HRSMC incubated in differentiation medium for 7 days showed no 
visible staining of myosin heavy chain and caldesmon (Figure 4.13 j and n) compared 
with control cells (no SPION) (Figure 4.13 i, m).  
The  expression  of  actin  and  calponin  in  SPION-loaded  HRSMC  after  7  days  of 
actuation in differentiation medium (Figure 4.13 c, g, d, h) remained similar to that 
observed in the control cells (no SPION, no actuation) (Figure 4.13 a, e).  
SPION-loaded HRSMC incubated in differentiation medium and actuated for 7 days at 
1 Hz and 2 Hz showed no visible staining of myosin heavy chain and caldesmon 
(Figure 4.13 k, o, l, p) compared with control cells (no SPION, no actuation) (Figure 
4.13 i, m).  
The expression of actin and calponin in SPION-loaded HRSMC after incubation and 7 
days of actuation in proliferation medium (Figure 4.12 c, g, d, h,) was similar to that 
observed for control cells (no SPION, no actuation) (Figure 4.12 a, e). Likewise, no 
observable  difference  existed  for  the  expression  of  actin  and  calponin  in  SPION-
loaded  cells  incubated  in  proliferation  medium  for  7  days  compared  with  SPION-
loaded HRSMC incubated in proliferation medium after 24 hours of actuation.  
SPION-loaded HRSMC incubated in proliferation medium actuated for 7 days at 1 Hz 
and 2 Hz showed no visible expression of myosin heavy chain and caldesmon (Figure 
4.12 k, o, l, p) which matched that observed in control cells (no SPION, no actuation) 
(Figure 4.12 i, m).  
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(b)  (d)  (f)  (h) 
Figure  4.11  Immunofluorescence  Microscopy  Showing  Expression  of  Contractile 
Markers  Actin,  Calponin,  Myosin  Heavy  Chain  and  Caldesmon  after  Incubation  of 
SPION-Loaded HRSMC in Proliferation Medium for 24 Hours. (a-d) Actin and calponin 
were visible in SPION-loaded HRSMC in proliferation medium after 24 hours, similar to that 
observed in control cells. (e-h) Staining for myosin heavy chain and caldesmon was not visible 
in SPION-loaded HRSMC after 24 hours of incubation in proliferation medium, nor in control 
cells. 
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(d)  (h)  (l)  (p) 
Figure  4.12  Immunofluorescence  Microscopy  Showing  Expression  of  Different 
Contractile Markers Actin, Calponin, Myosin Heavy Chain and Caldesmon in SPION-
Loaded HRSMC Incubated in Proliferation Medium for 7 Days with Magnetic Actuation 
(1 Hz or 2 Hz). (b, f) The expression of actin and calponin in SPION-loaded HRSMC after 7 
days incubation in proliferation medium was similar to that observed in control cells (a, e). (j, 
n) Staining for myosin heavy chain and caldesmon was not visible in SPION-loaded HRSMC 
after 7 days in proliferation medium, nor in control cells (i, m).  (c-h) The expression of actin 
and calponin in SPION-loaded HRSMC after 7 days of magnetic actuation in proliferation 
medium was similar to that observed in control cells (a, e). (k-p) Staining for myosin heavy 
chain  and  caldesmon  was  not  visible  in  SPION-loaded  HRSMC  after  7  days  of  magnetic 
actuation in proliferation medium, nor in control cells (i, m).  
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(d)  (h)  (l)  (p) 
Figure  4.13  Immunofluorescence  Microscopy  Showing  Expression  of  Contractile 
Markers Actin, Calponin, Myosin Heavy Chain and Caldesmon after 7 Days of Magnetic 
Actuation  (1  Hz  or  2  Hz)  of  SPION-Loaded  HRSMC  Incubated  in  Differentiation 
Medium.  (b,  f)  The  expression  of  actin  and  calponin  in  SPION-HRSMC  after  7  days  in 
differentiation medium was similar to that observed in control cells (a, e). (j, n) Staining for 
myosin heavy chain and caldesmon was not visible in SPION-loaded HRSMC after 7 days in 
differentiation medium, nor in control cells (i, m).  (c-h) The expression of actin and calponin 
in SPION-HRSMC after 7 days of magnetic actuation in differentiation medium was similar to 
that observed in control cells (a, e). (k-p) Staining for myosin heavy chain and caldesmon was 
not visible in SPION-loaded HRSMC after 7 days of magnetic actuation in differentiation 
medium, nor in control cells (i, m). 
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4.3.5.2 Gene Expression of Contractile and Proliferative Markers of HRSMC 
Loaded with SPION Exposed to an Oscillating Magnetic Field   
4.3.5.2.1 Real-Time PCR  
Real-time PCR was used to investigate the expression of different contractile (actin, 
myosin  heavy  chain,  caldesom  and  calponin)  and  proliferative  (vimentin  and 
tropomyosin)  markers  at  the  mRNA  level  in  SPION-loaded  HRSMC  incubated  in 
proliferation or differentiation medium and exposed to magnetic actuation.  
HRSMC were incubated in proliferation medium containing 250 µg/ml of SPION for 
24 hours and then switched to differentiation or proliferation medium for 7 days with 
the incorporation of magnetic actuation. Two types of controls were used: i) HRSMC 
without  SPION  and  no  actuation,  incubated  with  proliferation  or  differentiation 
medium for 7 days, and ii) SPION-loaded cells incubated with proliferation medium 
for 24 hours, included as a pre-actuation control. After 7 days magnetic actuation the 
cells  were  tested  for  different  contractile  markers  and  proliferative  markers.  For 
abbreviation, SPION-loaded HRSMC in proliferation or differentiation medium was 
referred to as PRO+SPION or DIFF+SPION, respectively.  Finally, all the values have 
been normalized according to cells in proliferation medium (PRO).  
A decrease in the mRNA expression for actin (p<0.01), myosin heavy chain (p<0.01), 
caldesmon (p<0.05), vimentin (p<0.05) and tropomyosin 4 (p<0.05) in SPION-loaded 
HRSMC incubated in proliferation medium for 24 hours without magnetic actuation 
was observed compared with control cells incubated in proliferation medium, as shown 
in Figure 4.14 (a, b, c, e, f). No significant difference in mRNA expression was found 
for calponin compared with control cells, as shown in Figure 4.14 d.  Chapter 4: Effects of Magnetic Actuation on the Phenotype of SPION-Loaded HRSMC 
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There was no change in mRNA expression for any of the contractile markers (actin, 
myosin heavy chain, caldesmon and calponin) or the proliferative markers (vimentin 
and tropomyosin 4) in SPION-loaded HRSMC incubated in proliferation medium for 7 
days compared with the control cells (no SPION) (Figure 4.15 a-f).  
HRSMC  incubated  with  differentiation  medium  for  7  days  showed  a  significant 
increase in actin (p<0.05) and calponin mRNA expression (p<0.01) (Figure 4.15 a, d). 
However,  SPION-loaded  HRSMC  incubated  in  differentiation  medium  for  7  days 
showed  a  significant  decrease  in  actin  and  calponin  mRNA  expression  (p<0.05) 
compared with control cells (no SPION), as shown in Figure 4.15 (a, d).  
No change in myosin heavy chain, caldesmon, vimentin and tropomyosin 4 mRNA 
expression  was  observed  in  SPION-loaded  HRSMC  incubated  in  differentiation 
medium for 7 days compared with control cells (no SPION), as shown in Figure 4.15 
(b, c, e, f).  
There was no change in mRNA expression for any of the contractile markers (actin, 
myosin heavy chain, caldesmon and calponin) or the proliferative markers (vimentin 
and tropomyosin 4) in SPION-loaded HRSMC in proliferation medium after magnetic 
actuation for 7 days compared with the control cells (no SPION, no actuation) (Figure 
4.15 a-f). 
 SPION-loaded HRSMC incubated in differentiation medium for 7 days with magnetic 
actuation at 1 Hz or 2 Hz showed a non-significant decrease in actin but a significant 
decrease  in  calponin  (p<0.01)  mRNA  expression  compared  with  control  cells  (no 
SPION, no actuation), as shown in Figure 4.15 (a, d). Chapter 4: Effects of Magnetic Actuation on the Phenotype of SPION-Loaded HRSMC 
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 No change in myosin heavy chain, caldesmon, vimentin and tropomyosin 4 mRNA 
expression  was  observed  in  SPION-loaded  HRSMC  incubated  in  differentiation 
medium for 7 days of actuation compared with control cells (no SPION, no actuation), 
as shown in Figure 4.15 (b, c, e, f).  Chapter 4: Effects of Magnetic Actuation on the Phenotype of SPION-Loaded HRSMC 
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4.3.5.3 Aspect Ratio of SPION-Loaded HRSMC Following Magnetic Actuation  
The aspect ratio is the ratio of the width of a cell to its length. The aspect ratio of cells 
differentiated towards a contractile phenotype is typically greater than the aspect ratio 
of cells in a proliferative state and can be used as an indicator of the phenotypic status 
of  cells  in  culture.  The  aspect  ratio  was  therefore  used  to  investigate  whether 
proliferation  or  differentiation  medium  affected  the  morphology  of  SPION-loaded 
HRSMC.    
No significant difference was observed in the aspect ratio of SPION-loaded HRSMC 
incubated for 24 hours in proliferation medium compared with control cells (Figure 
4.16 a).  
Non-loaded  HRSMC  incubated  in  differentiation  medium  for  7  days  had  a  greater 
aspect ratio compared with non-loaded cells incubated in proliferation medium (control 
cells)  (p<0.001)  (Figure  4.16  b).  SPION-loaded  cells  incubated  in  differentiation 
medium for 7 days showed a non-significant decrease in the aspect ratio compared with 
non-SPION loaded cells incubated in differentiation medium.  
SPION-loaded  cells  incubated  in  proliferation  medium  and  exposed  to  magnetic 
actuation  at  2  Hz  showed  a  significant  increase  in  the  aspect  ratio  compared  with 
control cells (no SPION, no actuation; p<0.05) (Figure 4.16 b). SPION-loaded cells 
incubated in differentiation medium and exposed to magnetic actuation at 2 Hz showed 
a non-significant decrease in the aspect ratio compared with control cells (no SPION, 
no actuation) (Figure 4.16 b). 
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(a)  (b) 
Figure 4.16 Aspect Ratio of SPION-loaded HRSMC. (a) After 24 Hours in Proliferation 
Medium. (b) In Proliferation and Differentiation Medium after Magnetic Actuation. A 
non-significant decrease was observed in SPION-loaded cells incubated with differentiation 
medium compared with control cells (no SPION).  A significant increase was observed in the 
aspect  ratio  of  SPION-loaded  HRSMC  incubated  in  proliferation  medium  and  exposed  to 
magnetic actuation at 2 Hz (p<0.05) compared with control cells (no SPION, no actuation). A 
non-significant decrease was observed in SPION-loaded cells incubated with differentiation 
medium and actuated at 2 Hz compared with control cells (no SPION, no actuation). 
4.3.5.4 Cell Proliferation of SPION-Loaded HRSMC Following Magnetic 
Actuation  
Three methods were used to investigate the effect of magnetic actuation on the 
proliferation of SPION-loaded HRSMC.  
4.3.5.4.1 BrdU ELISA Assay 
A BrdU ELISA assay was performed in order to investigate the effect of magnetic 
actuation on the proliferation of SPION-loaded HRSMC incubated in proliferation or 
differentiation medium for 7 days. No difference was observed in the optical density 
values between SPION-loaded HRSMC incubated in proliferation medium for 24 hours 
compared with control cells (no SPION), as shown in Figure 4.17 a.   
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No  difference  was  observed  in  the  optical  density  values  between  SPION-loaded 
HRSMC in either proliferation or differentiation medium compared with control cells 
(no SPION) as shown in Figure 4.17 b.  
Similarly no difference was observed in the optical density values between SPION-
loaded HRSMC in proliferation or differentiation medium after 7 days of magnetic 
actuation at 1 Hz or 2 Hz compared with control cells (no SPION, no actuation), as 
shown in figure 4.17 b.  
 
 
(a)  (b) 
Figure 4.17 Cell Proliferation of SPION-Loaded HRSMC Following Magnetic Actuation. 
(a) No difference was observed between SPION-loaded HRSMC after 24 hours compared with 
control cells (no SPION). (b) No change in the optical density values between HRSMC in 
differentiation medium after 7 days compared with HRSMC in proliferation medium (control 
cells-no SPION). (b) No difference was observed between SPION-loaded HRSMC in either 
proliferation  or  differentiation  medium  after  7  days  of  magnetic  actuation  compared  with 
control cells (no SPION, no actuation). 
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4.3.5.4.2 Measurement of Cellular DNA Content Using the CyQUANT NF Assay 
The CyQUANT NF assay was used to investigate the effect of magnetic actuation on 
the proliferation of SPION-loaded HRSMC incubated in proliferation or differentiation 
medium for 7 days. No difference in the fluorescence intensity values was observed 
between  SPION-loaded  HRSMC  incubated  in  proliferation  medium  for  24  hours 
compared with control cells (no SPION), as shown in Figure 4.18 a.  
No  difference  was  observed  in  the  fluorescence  intensity  values  between  SPION-
loaded  HRSMC  incubated  in  proliferation  or  differentiation  medium  after  7  days 
compared with control cells (no SPION), as shown in Figure 4.18 b.  
Similarly,  no  difference  was  observed  in  the  fluorescence  intensity  values  between 
SPION-loaded HRSMC incubated in proliferation or differentiation medium after 7 
days of magnetic actuation at 1 Hz or 2 Hz compared with control cells (no SPION, no 
actuation), as shown in Figure 4.18 b.  
   
(a)  (b) 
Figure 4.18 Cell Proliferation of SPION-Loaded HRSMC Following Magnetic Actuation. 
(a) No difference was observed between SPION-loaded HRSMC after 24 hours compared with 
control cells (no SPION). (b) No difference was observed between SPION-loaded HRSMC in 
either proliferation or differentiation medium after 7 days compared with control  cells (no 
SPION).  (b)  No  difference  was  observed  between  SPION-loaded  HRSMC  in  either 
proliferation  or  differentiation  medium  after  7  days  of  magnetic  actuation  compared  with 
control cells (no SPION, no actuation).  
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4.3.5.4.3 Direct Cell Counts 
Direct cell counting was performed to investigate the proliferative effect of magnetic 
actuation of SPION-loaded HRSMC after incubation in proliferation or differentiation 
medium  for  7  days.  No  difference  was  observed  between  SPION-loaded  HRSMC 
incubated  in  proliferation  medium  for  24  hours  compared  with  control  cells  (no 
SPION), as shown in Figure 4.19 a. 
No difference was observed between SPION-loaded HRSMC incubated in proliferation 
after 7 days compared with the control cells (no SPION). No difference in the number 
of  cells  between  HRSMC  in  differentiation  medium  and  control  cells  (HRSMC  in 
proliferation medium) after 7 days of incubation. No difference was observed between 
SPION-loaded HRSMC in differentiation medium after 7 days compared with control 
cells (no SPION) as shown in Figure 4.19 b. Similarly, no difference was observed 
between SPION-loaded HRSMC incubated in proliferation or differentiation medium 
after 7 days of magnetic actuation at 1 Hz or 2 Hz compared with control cells (no 
SPION, no actuation), as shown in Figure 4.19 b.  
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(a)  (b) 
Figure 4.19 The Effect of Magnetic Actuation on SPION-Loaded HRSMC Cell Counts 
Following  Magnetic  Actuation.  (a)  No  difference  was  observed  between  SPION-loaded 
HRSMC after 24 hours compared with control cells. b) No difference was observed between 
SPION-loaded  HRSMC  in  proliferation  medium  after  7  days  of  incubation  compared  with 
control  cells  (no  SPION).  No  difference  was  observed  between  SPION-loaded  HRSCM  in 
differentiation medium after 7 days of incubation compared with control cells (no SPION). (b) 
No  difference  was  observed  between  SPION-loaded  HRSMC  in  either  proliferation  or 
differentiation medium after 7 days of magnetic actuation compared with control cells (no 
SPION, no actuation). 
4.3.5.4.4 The Effect of Magnetic Actuation on the Metabolic Activity of SPION-
Loaded HRSMC 
4.3.5.4.4.1 Measurement of Metabolic Activity-MTS/PMS 
To  investigate  the  metabolic  activity  of  SPION-loaded  HRSMC  after  7  days  of 
magnetic actuation, an MTS/PMS assay was performed. No difference was observed 
between  SPION-loaded  HRSMC  incubated  in  proliferation  medium  for  24  hours 
compared with control cells (no SPION), as shown in Figure 4.20 a.  
No difference was observed between SPION-loaded HRSMC incubated in proliferation 
medium after 7 days compared with control cells (no SPION) (Figure 4.20 b). There 
was  a  decrease  in  the  metabolic  activity  of  HRSMC  incubated  in  differentiation 
medium for 7 days (p<0.05) compared with cells in proliferation medium (no SPION- 
control cells).   
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No  difference  was  observed  between  SPION-loaded  HRSMC  incubated  in 
differentiation medium after 7 days of magnetic actuation at 1 Hz or 2 Hz compared 
with control cells (no SPION, no actuation), as shown in Figure 4.20 b.  
   
(a)  (b) 
Figure 4.20 The Effect of Magnetic Actuation on the Metabolic Activity of SPION-Loaded 
HRSMC  Following  Magnetic  Actuation.  (a)  No  difference  in  metabolic  activity  was 
observed  between  SPION-loaded  HRSMC  after  24  hours  compared  with  control  cells  (no 
SPION,  no  actuation).  (b)  No  difference  was  observed  between  SPION-loaded  HRSMC 
incubated in proliferation medium after 7 days compared with control cells (no SPION). (b) A 
significant decrease in the metabolic activity of actuated SPION-loaded cells in proliferation 
medium  after  7  days  (p<0.05)  compared  with  control  cells  (no  SPION,  no  actuation).  No 
change was observed between SPION-loaded HRSMC in differentiation medium after 7 days 
of magnetic actuation compared with control cells (no SPION, no actuation). 
4.3.6 Biocompatibility of Magnetic Actuation on SPION-Loaded HRSMC   
4.3.6.1 Reactive Oxygen Species in SPION-Loaded HRSMC Following Magnetic 
Actuation  
The  release  of  reactive  oxygen  species  from  cells  incubated  with  SPION  was 
investigated by measuring the production of a fluorogenic marker, 5-(and-6)-carboxy-
2′,7′-dichlorodihydrofluorescen diacetate (carboxy-H2 DCFDA). The amount of green 
colour  product  produced  by  the  assay  is  directly  proportional  to  the  production  of 
reactive  oxygen  species  within  the  cells.  To  induce  cell  apoptosis,  tert-butyl 
hydroperoxide (TBHP) was used (Figure 4.21 c).    
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Fluorescence  microscopy  did  not  detect  the  release  of  reactive  oxygen  species  in 
SPION-loaded  HRSMC  (Figure  4.21  b)  incubated  in  proliferation  medium  for  24 
hours. This was similar to control cells (no SPION), as shown in Figure 4.20 a. 
SPION-loaded  cells  incubated  in  proliferation  (Figure  4.22  b)  or  differentiation 
medium  (Figure 4.22 f) for 7 days did not produce reactive oxygen species compared 
with control cells (no SPION), as shown in Figure 4.22 (a, e).  
Similarly,  SPION-loaded  cells  incubated  in  proliferation  (Figure  4.22  c,  d)  or 
differentiation medium  (Figure 4.22 g, h) with 7 days of magnetic actuation did not 
produce reactive oxygen species compared with control cells (no SPION, no actuation), 
as shown in Figure 4.22 (a, e).  
Proliferation  Proliferation+SPION  Positive control 
     
(a)  (b)  (c) 
Figure 4.21 Fluorescence Microscopy Images from the Reactive Oxygen Species Assay in 
SPION-Loaded HRSMC after 24 Hours. (b) No change in staining was observed in SPION-
loaded cells incubated with proliferation medium for 24 hours compared with control cells 
containing no SPION (a). (c) The positive control clearly showed detection of reactive oxygen 
species by the assay.  
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Proliferation  Proliferation+ 
SPION 
Proliferation+ 
SPION+1Hz 
Proliferation+ 
SPION+2Hz 
       
(a)  (b)  (c)  (d) 
Differentiation  Differentiation+ 
SPION 
Differentiation+ 
SPION+1Hz 
Differentiation+ 
SPION+2Hz 
       
(e)	 ﾠ (f)  (g)  (h) 
Figure 4.22 Fluorescence Microscopy Images Showing the Production of Reactive Oxygen 
Species  in  SPION-Loaded  HRSMC  Incubated  in  Proliferation  and  Differentiation 
Medium for 7 Days with Magnetic Actuation. No change was observed in SPION-loaded 
HRSMC incubated with proliferation (b) or differentiation medium (f) for 7 days compared 
with control cells (a+e) (no SPION).  No change was observed in SPION-loaded HRSMC 
incubated with proliferation (c+d) or differentiation medium (g+h) and magnetic actuation for 7 
days compared with control cells (a+e) (no SPION, no actuation). 
4.3.6.2 Cell Toxicity of SPION-Loaded HRSMC Following Magnetic Actuation   
The  cytotoxic  effect  of  SPION-loaded  HRSMC  incubated  with  proliferation  or 
differentiation medium with exposure to magnetic actuation (1 Hz or 2 Hz) for 7 days 
was investigated by measuring cellular release of LDH. No difference was observed 
between  SPION-loaded  HRSMC  incubated  in  proliferation  medium  for  24  hours 
compared with control cells (no SPION), as shown in Figure 4.23 (a).  
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A positive control (PC) was used in this study. HRSMC incubated with a lysis solution 
(provided with the kit). The lysis solution lyses the cell membrane resulting in the 
maximum production of LDH in the supernatant (100% toxic). The detailed process 
was described in sections 2.2.5.2.1 and 4.2.2.7.2.1. 
No significant difference was observed between SPION-loaded HRSMC incubated in 
proliferation medium with or without 7 days of magnetic actuation at 1 Hz and 2 Hz 
compared  with  control  cells    (no  SPION,  no  actuation).  The  positive  control  had 
increased 20% as shown in Figure 4.23 (b). No significant difference was observed 
between SPION-loaded HRSMC incubated in differentiation medium with or without 7 
days of magnetic actuation at 1 Hz and 2 Hz compared with control cells (no SPION, 
no actuation), as shown in Figure 4.23 (b). The positive control  (PC) had increased 
approximately 60% for the SPION-loaded HRSMC in proliferation medium and 20% 
for the SPION-loaded HRSMC in differentiation medium.    
   
(a)  (b) 
Figure 4.23 LDH Release in the Supernatant from SPION-Loaded HRSMC Following 
Magnetic Actuation. (a) No change was observed between SPION-loaded HRSMC after 24 
hours compared with control cells. There was an 20% increase in the release of LDH release 
(positive control) compared to control and SPION-loaded cells (b) No change was observed 
between SPION-loaded HRSMC in proliferation or differentiation medium with or without 
magnetic actuation for 7 days and control cells (no SPION). The was an apparent increase in 
the release of LDH in the supernatant in the positive control (PC) 
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4.3.6.3 Cell Apoptosis in SPION-Loaded HRSMC Following Magnetic Actuation  
The  effect  of  magnetic  actuation  apoptosis  of  SPION-loaded  HRSMC  incubated  in 
proliferation  or  differentiation  medium  for  7  days  with  magnetic  actuation  was 
investigated by measuring the release of Caspase-3/7 in the tissue culture supernatant. 
No difference was observed between SPION-loaded HRSMC incubated in proliferation 
medium for 24 hours compared with control cells (no SPION), as shown in Figure 4.24 
(a).  
No difference was observed between SPION-loaded HRSMC incubated in proliferation 
or  differentiation  medium  for  7  days  compared  with  control  cells  (no  SPION),  as 
shown  in  Figure  4.24  (b).  Similarly,  no  difference  was  observed  between  SPION-
loaded HRSMC incubated in proliferation or differentiation medium with 7 days of 
magnetic  actuation  at  1  Hz  and  2  Hz  compared  with  control  cells  (no  SPION,  no 
actuation), as shown in Figure 4.24 (b).  
 
 
(a)  (b) 
Figure  4.24  Caspase  3/7  Release  in  the  Supernatant  from  SPION-Loaded  HRSMC 
Following Magnetic Actuation. (a) No change was observed between SPION-loaded HRSMC 
after 24 hours compared with control cells (no SPION). (b) No change was observed between 
SPION-loaded HRSMC incubated in either proliferation or differentiation medium for 7 days 
compared with control cells (no SPION). (b) No change was observed between SPION-loaded 
HRSMC incubated in either proliferation or differentiation medium after 7 days of magnetic 
actuation compared with control cells (no SPION, no actuation).    
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4.4 Discussion  
4.4.1 Main Findings 
•  A magnetic actuator was devised to deliver magnetic force to HRSMC. The 
actuator was designed to deliver cyclic strain to HRSMC (continuous cycles of 
stretching-relaxation). 
•  SQUID measurements revealed that incubation of SPION-loaded HRSMC with 
differentiation medium for 7 days resulted in a similar average amount of iron 
per cell to that measured on day 1 (pre-actuation-control). However, the average 
amount of iron per cell for SPION-loaded HRSMC incubated in proliferation 
medium was reduced.  
•  TEM images of SPION-loaded HRSMC after magnetic actuation did not show 
any substantial movement of the SPION-loaded endosomes. 
•  Incubation  of  HRSMC  with  differentiation  medium  for  7  days  caused  up 
regulation  of  gene  and  re-localization  of  protein  expression  of  different 
contractile proteins actin or calponin. No significant difference was observed 
with proliferation medium.  
•  The aspect ratio of HRSMC incubated in differentiation medium for 7 days was 
increased confirming the previous findings and suggesting that HRSMC were 
differentiated. 
•  Loading HRSMC with SPION inhibited the up regulation of actin and calponin 
genes caused by incubation in differentiation medium with control cells. No 
apparent change was observed in the protein expression of the same markers.  
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•  Magnetic  actuation  did  not  change  the  inhibition  of  calponin  up  regulation 
caused  by  pre-loading  cells  with  SPION  before  incubation  in  differentiation 
medium.  
•  Incubation of SPION-loaded HRSMC in proliferation or differentiation medium 
and with magnetic actuation did not affect the proliferation of HRSMC. 
•  Incubation of SPION-loaded HRSMC in proliferation or differentiation medium 
with  magnetic  actuation  did  not  have  any  effect  on  the  biocompatibility  of 
HRSMC.  
4.4.2 Magnetic Actuation of HRSMC  
The effect of magnetic actuation on the phenotype and biocompatibility of SPION-
loaded HRSMC was investigated using an in vitro model. HRSMC were incubated 
with 250 µg/ml of SPION in proliferation and differentiation medium and exposed to 
magnetic actuation for 1 hour per day at 1 Hz and 2 Hz for 7 days as described in more 
detail in section 4.2.2.3. The magnetic actuator designed for this study contained two-
neodymium iron boron permanent magnets positioned in opposite directions with a 
steel block attached to the back in order to push the magnetic field forward as shown in 
Figure 4.1 a, b.  The magnetic actuator was designed in such a way to give a cyclic 
strain  to  the  cells  by  rotating  360
  degrees  with  the  help  of  a  motor  at  different 
frequencies  (1  Hz  and  2  Hz).  As  the  magnetic  cylinder  rotated  the  magnetic  field 
changed from a high value to a lower value it was hypothesized this would create 
continuous  cycles  of  cell  stretching  by  moving  the  SPION-loaded  endosomes  or 
‘magnetosomes’ (described in chapter 3). The physical movement of the SPION-loaded 
endosomes was proposed to stretch the cytoskeletal components such as actin filaments 
and microtubules and create a phenotypic change to the cells such as proliferation or  
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contraction. The type of cyclic mechanical stretching proposed in this study is different 
from the mechanical stretching caused by the Flexcell
® unit. In this case the cells were 
seeded onto elastic membranes where continuous cycles of cyclic strain were applied to 
the  cell.  The  external  signal  (cyclic  strain)  was  received  from  different 
mechanoreceptors such as integrins located on the plasma membrane and translated 
into  biochemical  signal  as  described  in  section  1.7.2.  This  is  summarized  in  the 
following diagram:  
 
 
(a)   
 
 
(b)   
Figure 4.25 Different Types of Delivering Cyclic Strain to the Cells. (a) The cytoskeleton of 
cells  is  stretched  in  response  to  the  movement  after  SPION-loaded  endosomes  after  being 
magnetically actuated. (b) Continuous cyclic strain on cells using a Flexcell unit.  
Having proposed a mode of action it was important to calculate the strength of the 
magnetic field produced by the actuator and also the theoretical amount of force per 
SPION inside the cells. The distance from the centre of the device to the bottom of the 
plate was 14 mm (which is approximately equivalent to the target anatomical distance 
in the anal canal as shown in Figure 1.1). The magnetic field and force plots showed 
that as the magnet rotated from 0 degrees to 180 degrees (farthest from the plate) the 
magnetic field and the magnetic force became weaker. At 0 degrees the magnetic field 
acting on the particles was 82 mT and the magnetic force 0.9 pN and at 180 degrees the  
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magnetic field dropped to 0 mT and the magnetic force was dropped to 0.1 pN as 
shown in Figure 4.5 and Figure 4.6.  
The  force  per  cell  is  influenced  by  the  position  of  the  magnet  (0  degrees  or  180 
degrees), the amount of SPION internalised by the cells and also the position of the 
SPION-loaded HRSMC related to the magnetic actuators.  
SQUID magnetometry was used to quantify the amount of SPION internalised. SPION-
loaded  HRSMC  (250  µg/ml  of  SPION)  were  incubated  with  proliferation  or 
differentiation medium for 7 days (SPION-loaded HRSMC-250 µg/ml of SPION in 
proliferation for 24 hours/pre-actuation was used as control).  The results showed that 
each  SPION-loaded  HRSMC  incubated  for  7  days  in  proliferation  medium  had  on 
average approximately 6 pg of SPION and in differentiation medium 16 pg of SPION, 
which was approximately the same amount of SPION measured in cells at day 1 pre 
actuation, as shown, in Figure 4.9 a. This is probably because SPION-loaded HRSMC 
in proliferation medium had divided and increased in number from 10,000 cells (day 1 
pre actuation control) to 60,000 cells at day 7, whereas SPION-loaded HRSCM in 
differentiation medium had not proliferated, resulting in a similar number of cells to 
that on day 1 pre-actuation control, as shown, in Figure 4.9 b.   
Based on the field plots the magnetic field had its highest value directly above of the 
magnets. To measure this directly, a visualization experiment was conducted using iron 
filings. The results showed the majority of the iron filings were positioned exactly 
above the magnet (0 degrees) where the magnetic field has its highest value as shown 
in Figure 4.7 a.  Therefore in order for the cells to receive the maximum force they had 
to be located directly above the magnetic actuator. To achieve this, silicone moulds 
were designed as described in section 4.2.1.2 with a diameter of 17.5 mm to fit a 6 well  
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culture plate. Assuming that the HRSMC were seeded directly above the magnetic 
actuator with the help of the silicone moulds where the magnetic field had it highest 
value, the force per cell could be computed. The SQUID results indicated that the 
amount of SPION in the cells decreased over time when incubated with proliferation 
medium for 7 days. Therefore, the amount of force delivered per cell by the magnetic 
actuator was also likely to decrease over time. For example, on day 1 (pre-actuation 
control)  the  cells  had  16  pg  of  SPION  per  cell.  When  the  magnetic  actuator  was 
positioned at 0 degrees the force per cell was ~14.4 pN, but after 7 days of incubation 
with proliferation medium, the cells had 6 pg of SPION per cell. Therefore at the same 
position the force per cell was reduced to ~5.4 pN (0.9 pN x 6 pg of SPION/cell = 5.4 
pN). However, when the HRSMC were cultured in differentiation medium for 7 days 
the amount of SPION inside the cells did not change. Therefore at 0 degrees the force 
per cell was ~14.4 pN which was the same as day 1. These results suggest that SPION-
loaded HRSMC incubated with proliferation medium for 7 days did not receive the 
same magnetic force through out the incubation period. This is because the cells were 
continuously proliferating and the SPION became distributed amongst the progeny as 
the  cells  divided.  On  the  other  hand  SPION-loaded  HRSCM  incubated  in 
differentiation medium for 7 days maintained the amount of SPION and the force per 
cell also remained unchanged.  
The non-uniform application of magnetic force per cell when SPION-loaded HRSMC 
were incubated with proliferation medium for 7 days could explain the results of fact 
no significant change in the phenotype of SPION-loaded HRSCM compared with cells 
incubated in differentiation medium, where a decrease in calponin mRNA expression 
was observed as will be described in more detail in section 4.4.4.    
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4.4.3 Cellular Localisation of SPION After Magnetic Actuation 
In chapter 3 it was demonstrated by TEM that SPION were endocytosed by HRSMC 
and  were  located  inside  the  endosomes  or  ‘magnetosomes’.  This  chapter  aimed  to 
investigate  whether  movement  of  SPION  (SPION-loaded  endosomes)  occurred  in 
response to magnetic actuation. A different technique was used in this chapter to that 
described  chapter  3.  SPION-loaded-HRSMC  monolayers  were  incubated  with 
proliferation medium for 24 hours and then cells were exposed to magnetic actuation 
for 1 hour at 1 Hz at 37
0C, 5% CO2.  The monolayers processed for TEM were lifted 
with propylene oxide rather than detached with trypsin and pelleted, which allowed the 
visualisation  of  the  attached  cell  morphology.  The  images  revealed  no  significant 
change in the position of the SPION-loaded endosomes compared with non-actuated 
control  cells  as  shown  in  Figure  4.10  a.  The  lack  of  movement  of  SPION-loaded 
endosomes might be explained due to the cytoskeleton being packed with organelles, 
making the movement of SPION-loaded endosomes difficult. Alternatively, and also 
the amount of SPION internalised may not have been enough to create a significant 
change in the movement of SPION-loaded endosomes. Thus, the movement of SPION-
loaded endosomes may not have been significant enough to be captured with TEM. The 
limitations of this study were investigated in more detail in Chapter 5, where scanning 
electron  microscopy  (SEM)  allowed  the  visualisation  of  the  changes  in  the  plasma 
membrane in response to an external magnetic field and also the movement of the 
SPION-loaded  endosomes  together  with  changes  on  the  plasma  membrane  were 
captured with live cell imaging.  
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4.4.4 Effect of Magnetic Actuation on the Phenotype of SPION-Loaded HRSMC  
Previous studies have used magnetic actuation to manipulate the phenotype of stem 
cells. In these studies no direct incubation of SPION with the cells were involved but a 
plasma membrane receptor of interest was magnetically tagged. An example is a study 
by Hu et al who examined the possibility of controlling the differentiation of stem cells 
by mechanically activate the PDFG receptor α and β of human bone marrow stromal 
cells (HBMSCs) with a lab based magnetic bioreactor. The objective of the study was 
to  identify  whether  magnetic  fields  applied  to  nanoparticle  bound  PDGF  receptors 
could promote smooth α-actin expression (SMA) up-regulation in HBMSC. Magnetic 
particles with a diameter of 250 nm (Micromod) were conjugated with anti-human 
PDGF-α and β antibodies (R&D Systems). The conjugated particles were incubated 
with cells and force was applied to them. The protein levels of SMA were estimated 
using immunocytochemistry. There was an increase in protein levels after 3 hours of 
continuous magnetic actuation and 24 hours further incubation of cells stimulated via 
PDGFRα compared with untreated cells. Additionally by performing real time PCR 
there was an up regulation of SMA mRNA levels after 3 hours of continuous magnetic 
actuation and 24 hours further incubation of cells stimulated via PDGFRα compared 
with untreated cells (93). Similarly Glossop et al investigated the differentiation of 
mesenchymal  stem  cells  using  magnetic  actuation.  Mechanical  forces  specifically 
uniaxial  tensile  strain  versus  magnetic  particle  forces  were  used  to  investigate  the 
expression  profile  of  mitogen-activated  protein  kinase  kinase  8  (MAP3K8)  and 
interleukin-1β  (IL-1B).  Human  bone  marrow-derived  MSCs  were  seeded  onto  a 
pronectin coated uniflex flexible-bottomed six well plate (Flexcell International) and 
exposed to a 3% cyclic uniaxial tensile strain using a FX-4000T bioreactor (Flexcell 
International). Concurrently MSCs were incubated with 250 nm SPION (Nanomag- 
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silica; Micromod) and an oscillating magnetic field was applied of 90 mT with the use 
of a magnetic force bioreactor. Mechanical forces were applied for 1 hour at 1 Hz and 
cells treated with a static magnetic field used as control. The results showed no change 
in the mRNA expression of MAP3K8 and IL-1B both for mechanical stimulation and 
magnetic actuation. One of the limitations of the study highlighted by the authors was 
the short period of the study (24 hours) when the group concluded that there was a 
possibility that cells did not respond to mechanical or magnetic actuation as they have 
previously demonstrated that MSCs cells do respond to fluid shear stress with an up 
regulation of MAP3K8 and IL-1B (107). 
In the current study, after determining the amount of force acting on HRSMC incubated 
with SPION as the magnetic actuator rotated and also the amount of SPION per cell (in 
either proliferation or differentiation medium), the effects of SPION-loaded HRSMC in 
response to magnetic actuation on the phenotype was investigated. This was conducted 
with real time PCR, where the expression of different contractile markers such as actin, 
myosin heavy chain, calponin and caldesmon and also proliferative markers such as 
vimentin and tropomyosin 4 were investigated. Immunocytochemistry and fluorescence 
microscopy, was used to examine the expression of different contractile markers such 
actin, myosin heavy chain, caldesmon and calponin were investigated. Measurement of 
the  aspect  ratio  of  SPION-loaded  HRSCM  in  response  to  an  external  field  and 
measuring the proliferation of SPION-loaded HRSMC after magnetic actuation using 
four  different  techniques  (BrdU  ELISA,  cell  CyQUANT,  direct  cell  count  and 
MTS/PMS) were also performed.  
HRSMC were incubated with 250 µg/ml of SPION in proliferation medium for 24 
hours and then switched to differentiation or proliferation medium for 7 days, whilst 
receiving exposure to magnetic actuation as described in section 4.2.2.3. Two types of  
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controls  were  used:  i)  HRSMC  without  SPION  and  no  actuation,  incubated  with 
proliferation  or  differentiation  medium  for  7  days,  and  ii)  SPION-loaded  cells 
incubated with proliferation medium for 24 hours, included as a pre-actuation control. 
HRSMC incubated in differentiation medium for 7 days, resulted in an increase in actin 
and calponin protein expression (Figure 4.13 a, e) suggesting a shift in the phenotype 
from a proliferative towards a contractile. The images revealed that the differentiated 
cells had a different more elongated shape compared with HRSMC in proliferation 
medium for 7 days as showed in Figure 4.12 a, e. Also there was an increase in the 
mRNA expression of actin and calponin when HRSMC incubated in differentiation 
medium for 7 days as shown in Figure 4.15 a, d. The changes in the morphology and 
the  phenotype  observed  with  fluorescent  microscopy  and  real  time  PCR  were 
confirmed with the aspect ratio experiment where the width of a cell was measured 
against its length. HRSMC incubated in differentiation medium for 7 days had a greater 
aspect ratio compared with HRSMC incubated in proliferation medium (control cells) 
(p<0.001) (Figure 4.16 b). The study has confirmed previous findings in the literature 
where TGF- β was used to differentiate smooth muscle cells (160). 
SPION-loaded HRSCM in differentiation medium alone (Figure 4.13 b, c) and with 
magnetic actuation (1 Hz and 2 Hz) (Figures 13 c, g, d, h) showed no change in the 
protein expression or gene expression compared with their control cells. This might be 
accounted  by  the  cells  being  insufficiently  differentiated  and  required  further 
incubation in differentiation medium before analysis. Previous studies have mentioned 
that caldesmon is considered an intermediate differentiation marker and myosin heavy 
chain is considered as a late differentiation marker in comparison actin and calponin 
which are early differentiation markers (85).   
	 ﾠ 160 
This finding partly corresponds with a previous mechanical study using a Flexcell unit 
which demonstrated that aortic smooth muscle cells when subjected to cyclic strain at a 
frequency of 30 cycles/minute and 15% elongations showed no expression of smooth 
muscle  myosin  and  calponin  but  an  increase  in  h-caldesmon  was  observed  from 
immunostaining images, suggesting that mechanical strain induced the differentiation 
of smooth muscle cells (161). Similarly in another study, airway smooth muscle cells 
subjected  to  mechanical  strain,  pre-coated  with  collagen  type  I  in  six-well  plates 
(Flexcell®, McKeesport, PA) were subjected to 10% membranes deformation for 2 
seconds followed by 2 seconds of relaxation for 12 days. Myosin light chain kinase 
content was increased as shown by Western blotting (162). 
The  expression  of  the  proliferative  markers  vimentin  and  tropomyosin  4  were  not 
affected by either proliferation or differentiation medium, nor with magnetic actuation 
as shown in Figures 4.14. For these markers an increase in the mRNA expression was 
expected when HRSMC were incubated in proliferation medium. Further investigation 
is necessary to confirm these findings.  
SPION-loaded HRSMC incubated in differentiation medium (Figure 4.13 b, f) for 7 
days and with the addition of magnetic actuation (Figure 4.13 c, g, d, h) showed an 
increase  in  actin  and  calponin  expression  compared  to  SPION-loaded  HRSCM  in 
proliferation medium (Figure 4.12 b, f) for 7 days and with the addition of magnetic 
actuation  (Figure  4.12  c,  g,  d,  h)  but  no  apparent  differences  were  observed  when 
compared with control HRSMC in differentiation medium for 7 days without SPION as 
shown in Figure 4.13 a, e. Additionally, a significant decrease in the mRNA expression 
of  actin  and  calponin  of  SPION-loaded  HRSMC  in  differentiation  medium  was 
observed compared with proliferation control cells as shown in Figure 4.12 a, d.  A 
significant  decrease  in  mRNA  expression  of  calponin  SPION-loaded  HRSMC  in  
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differentiation medium with magnetic actuation at 1 Hz was observed compared with 
proliferation control cells as shown in Figure 4.12. These results correspond with the 
aspect  ratio  findings  where  SPION-loaded  HRSCM  in  differentiation  medium  and 
exposed to magnetic actuation at 2 Hz showed a decrease in the aspect ratio compared 
with control cells (no SPION, no actuation) (Figure 4.16 b). Finally, SPION-loaded 
cells incubated in proliferation medium and exposed to magnetic actuation at 2 Hz 
showed  a  significant  increase  in  the  aspect  ratio  compared  with  control  cells  (no 
SPION, no actuation; p<0.05) (Figure 4.16 b).  
The decrease in the aspect ratio (Figure 4.16 b) and the mRNA expression observed in 
actin  (Figure  4.15  a)  for  SPION-loaded  HRSMC  in  differentiation  medium  and 
calponin  (Figure  4.15  d)  for  SPION  loaded  in  differentiation  medium  and  with 
magnetic  actuation  suggested  that  maybe  SPION  are  inhibiting  the  differentiation 
process  of  HRSMC  and  shifting  them  towards  a  more  proliferative  phenotype. 
Therefore the effect of magnetic actuation on proliferation on SPION-HRSMC was 
investigated  with  four  different  techniques  (BrdU  ELISA,  CyQUANT  cell 
proliferation, direct cell counts and MTS/PMS assay) as shown in Figures 4.17, 4.18, 
4.19, 4.20.  
The  results  showed  no  change  in  the  proliferation  of  SPION-loaded  HRSMC  in 
differentiation  medium  after  7  days  of  magnetic  actuation  with  none  of  the  four 
different cell proliferation assays.  
The decrease in the mRNA expression of actin and calponin of SPION-loaded HRSMC 
observed could be caused by SPION interference of the SMAD genes in the TGF-β 
signalling pathway. A previous study suggested that when HeLa cells were loaded with 
2 mg ml
-1 magnetite (Fe3O4) nanocrystals (MNC) 26 nm in diameter for 12 hours there  
	 ﾠ 162 
was a 4 fold down regulation of the mRNA of ID1, ID2 and SMAD6 compared to ID3 
and SMAD7 as shown with real time PCR (163).  
The  oscillating  magnetic  field  used  in  this  study  did  not  induce  a  change  in  cell 
proliferation when cells were incubated with proliferation or differentiation medium.  
However, different studies have demonstrated an increase in cell proliferation using 
static  magnetic  field  (SMF).  In  a  previous  study  where  a  SMF  was  used,  human 
keratinocytes (HaCaT) were incubated with 15 mg/ml of SPION and exposed to SMF 
of  0.5  mT  and  30  mT  (cells  were  4  mm  above  the  magnet  surface)  for  24  hours. 
Control samples with no SPION and with/without SMF were investigated. The results 
showed an increase in cell proliferation (10-15%) in the SMF samples loaded with 
SPION  suggesting  that  SMF  affect  the  proliferation  of  SPION-loaded  cells.  The 
combination  of  SPION-loading  and  SMF  increased  the  cell  proliferation  60-fold  in 
both 0.5 mT and 30 mT (164). However, the previous finding contradicts with another 
study, where mouse liver cell line (NCTC 1469) was incubated with 0.5 mM of SPION 
ferucarbotran (SHU 555A, Resovist) and the cells were exposed to a SMF of 0.4 T 
using  permanent  neodymium  magnets.  A  cell  viability/proliferation  assay  was  used 
which measured the intracellular ATP concentration. The results showed a reduction of 
cell  viability/cell  proliferation  after  concomitant  treatment  with  SPION  and  SMF 
exposure  (75%)  after  1  hour  of  exposure.  The  reduction  in  the  viability/cell 
proliferation was proportional to the time of treatment and SPION concentration and 
duration of SMF exposure (142).    
Other studies using a Flexcell unit have demonstrated a change in cell proliferation 
when  the  cells  were  subjected  to  cyclic  strain.  Aortic  smooth  muscle  cells  from 
embryonic rats (A10 cell line) were seeded on type I collagen pre-coated membranes 
and subjected to 5% elongation with the Bioflex membrane and 24% elongation with  
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the  Flexercell  membrane  for  1  second  followed  by  a  1  second  relaxation  of  the 
membrane at 0.5 Hz frequency for 48 hours. The results showed that cell proliferation 
was  reduced,  with  both  techniques  suggesting  that  cyclic  strain  affected  the 
proliferation of cells and was independent of the cellular matrix (165). This finding 
contradicts the findings of another study where bovine airway smooth muscle cells 
were  seeded  onto  pre-coated  surface  of  laminin  or  type  I  collagen  Flexcell  plates 
(Flexcell, McKeesport, PA, USA) and subjected to a 4% cyclical deformation (this 
stretch amplitude is similar to that encountered by smooth muscle cells during quiet 
tidal breathing in a healthy individual). An increase in cell proliferation was observed 
in cells grown on a collagen surface under static conditions compared with cells grown 
on a laminin surface with the addition of 4% cyclic deformation. This study suggested 
that  type  I  collagen  encouraged  the  proliferation  of  cells  regardless  of  mechanical 
activation (89).	 ﾠAdditionally, vascular smooth muscle cells (VSM) were stretched with 
two different devices that delivered stretch along one axis (uniaxial) or along all axes 
(equiaxial). The Flexercell Strain Unit (FX-3000, Flexcell) and Bioflex were used to 
expose  VSMC  to  an  equiaxial  or  uniaxial  cyclic  stretch  of  10%  magnitude  and  a 
frequency of 1 Hz. The VSMC were quiescent for 48 hours in serum-free media (FCS 
replaced  by  0.1%  BSA)  before  exposure  to  the  experimental  treatments.  The  cell 
proliferation  was  investigated  with  direct  cell  counts.  The  results  showed  that  a 
physiological level of cyclic stretch inhibits vascular SMC proliferation (166) 
Based on the previous findings, it is evident that SMF or mechanical activation can 
affect the proliferation of cells. In this study the oscillating magnetic field used did not 
affect  the  proliferation  of  cells  or  their  differentiation.  Further  investigation  is 
necessary  in  order  to  understand  what  was  responsible  for  this.  Stronger  magnetic 
fields or perhaps SMF could be investigated in a future study. Additionally, the amount  
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of magnetic material per cell could be increased by incubating the cells with higher 
concentration of SPION or using a larger diameter of SPION (above 200 nm). One 
disadvantage is that SPION-loaded HRSMC in proliferation medium did not maintain 
the same amount of SPION per cell throughout the 7 days incubation period and that 
affected the force acting on the cells as well. One way to overcome this limitation is to 
would be to deliver a sufficient amount of magnetic material in the area of interest that 
is going to be biocompatible but not biodegradable and will not be distributed with cell 
division. In this study, HRSMC were seeded on a rigid surface that does not provide a 
good  simulation  of  the  mechanical  properties  of  tissue  in vivo.  Based  on  previous 
studies seeding cells on elastic membranes with the Flexcell unit that affected the cell 
proliferation and differentiation. Future studies could use HRSMC seeded on elastic 
membranes before subjecting them to the same oscillating magnetic field used in this 
study.  
4.4.5 Biocompatibility of Magnetic Actuation on SPION-Loaded HRSMC   
After  investigating  the  effects  of  magnetic  actuation  on  the  phenotype  of  SPION-
loaded HRSMC the biocompatibility of magnetic actuation on SPION-loaded HRSMC 
was investigated.  
Fluorescence  microscopy  did  not  detect  the  release  of  reactive  oxygen  species  in 
SPION-loaded HRSMC incubated in proliferation or differentiation medium after 7 
days of incubation and with magnetic actuation as shown in Figure 4.22 b, c, d, f, g, h 
compared with control cells (Figure 4.22 a, e).  
The toxic effect of SPION and magnetic actuation was investigated with an LDH assay. 
No difference was observed between SPION-loaded HRSMC incubated in proliferation 
medium for 24 hours compared with control cells (no SPION), as shown in Figure 4.23  
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(a).  Also  No  significant  difference  was  observed  between  SPION-loaded  HRSMC 
incubated in proliferation medium with or without 7 days of magnetic actuation at 1 Hz 
and 2 Hz compared with control cells  (no SPION, no actuation). The positive control 
had increased 20% as shown in Figure 4.23 (b). No significant difference was observed 
between SPION-loaded HRSMC incubated in differentiation medium with or without 7 
days of magnetic actuation at 1 Hz and 2 Hz compared with control cells (no SPION, 
no actuation), as shown in Figure 4.23 (b). The positive control  (PC) had increased 
approximately 60% for the SPION-loaded HRSMC in proliferation medium and 20% 
for the SPION-loaded HRSMC in differentiation medium.    
Apoptosis of HRSMC was investigated using a Caspase 3-7 assay. No difference was 
observed  in  the  fluorescence  intensity  values  between  SPION-loaded  HRSMC  in 
proliferation  or  differentiation  medium  after  7  days  and  with  magnetic  actuation 
compared with control cells (no SPION, no actuation), as shown in Figure 4.24 b. 
Incubation of SPION-loaded HRSMC in differentiation medium alone did not affect 
the apoptosis of cells. Previously it has been described that SPION loading interfered 
with  SMAD  genes  responsible  in  the  TGF-β  signalling  pathway.  The  effect  of 
apoptosis was investigated by quantifying the expression of CASP9 (a gene responsible 
for apoptosis) on HeLa cells loaded with 2 mg ml
-1 magnetite (Fe3O4) nanocrystals 
(MNC) 26 nm in diameter for 12 hours. The results showed a down regulation of 
CASP9 activity suggesting that SPION-loading caused cell apoptosis (163).	 ﾠ
Results from the current study suggest that the oscillating magnetic field used did not 
affect  the  viability  of  SPION-loaded  HRSMC.  This  differs  to  other  studies 
investigating the effect of SMF on the biocompatibility of different types of cells. In a 
previous study where SMF was used, human keratinocytes (HaCaT) were incubated 
with 15 mg/ml of SPION and exposed to SMF of 0.5 mT and 30 mT (cells were 4 mm  
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above the magnet surface) for 24 hours. The ROS were investigated in response to 
SMF with a ROS-fluorescent probe dichlorofluorescin diacetate. The results showed an 
increase in the production of ROS compared with control cells by approximately 15–
20%. ROS production was measured 24 h after the introduction of combinations of 
SPION and SMF. Additionally, the apoptosis was investigated by looking at the gene 
expression of the profile of different genes such as CASP10 and TNFSF10 that are 
responsible for the apoptosis of cells. The results revealed no change for the no SPION 
no SMF treated cells but SPION-loaded HaCaT with SMF showed a 2 fold and 3 fold 
increase in the mRNA expression of these genes suggesting that SPION-loading and 
SMF caused apoptosis to the cells (164).   
Similar findings were observed in another study where the cytotoxicity, apoptosis and 
ROS were investigated in response to a SMF. Mouse liver cell line cells (NCTC 1469) 
were incubated with 0.5 mM of SPION ferucarbotran (SHU 555A, Resovist) and were 
exposed to a SMF of 0.4 T using permanent neodymium magnets. The apoptosis was 
measured based on the Caspase 3-7 release using a Caspase-3/7 Glo assay and the 
necrosis/cytotoxicity  by  measuring  the  activity  of  LDH  released  from  membrane 
damaged cells using the CytoTox-ONE Homogeneous Membrane Integrity assay and 
the ROS was evaluated by spectrofluorometry and fluorescence microscopy using the 
ROS-detectable  cell-permeable  reagent  5-(and-6)-carboxy-20,  70-
dichlorodihydrofluorescin  diacetate  (carboxy-H2  DCFDA).  The  results  showed  an 
increase in apoptotic activity relative to the concentration of SPION whereas necrotic 
activity was only marginally changed by SMF exposure. An increase in the formation 
of reactive oxygen species was observed (142).  
Other studies using a Flexcell unit have demonstrated a change in the biocompatibility 
when  the  cells  were  subjected  to  cyclic  strain.  Aortic  smooth  muscle  cells  from  
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embryonic  rats  (A10  cell  line)  were  stretched  and  cell  damage/cytotoxicity  and 
apoptosis measured. No significant change in cell damage or necrosis was observed 
and also the apoptosis rate was similar between stretched cells and control cells (165). 
In the previous study the apoptosis or toxicity was not affected but in another study, 
vascular smooth muscle cells were exposed to an equiaxial or uniaxial cyclic stretch of 
10% magnitude and a frequency of 1 Hz resulting in a change in caspase-3 activity 
with stretch vs static controls (166). 	 ﾠ
4.4.6 Conclusion  
A magnetic actuator was devised in an attempt to deliver force to HRSMC in a cyclic 
manner. SQUID measurements revealed that SPION-loaded HRSMC in proliferation 
medium after 7 days of incubation had approximately 3 times less SPION compared 
with control cells. SPION-loaded HRSMC in differentiation medium maintained the 
amount  of  SPION  throughout  the  incubation  period.  An  increase  in  the  mRNA 
expression and protein localization of HRSMC in differentiation medium was observed 
suggesting that cells had shifted towards a differentiated phenotype. The aspect ratio 
findings confirmed the previous results.  
SPION-loaded HRSMC alone and with magnetic actuation in differentiation medium 
showed  a  decrease  in  the  mRNA  expression  for  actin  and  calponin  expression 
suggesting that the cells were maintained towards a proliferative phenotype. However, 
this finding was not confirmed with cell proliferation assays. Magnetic actuation of 
SPION-loaded HRSMC did not affect the biocompatibility of cells.  
The magnetic actuation results from the study need further investigation because they 
might not have been optimal for achieving magnetic actuation of cells. For example, 
the strength of the magnets used, their orientation, and the frequency of the oscillating  
	 ﾠ 168 
magnets are all parameters that need further investigation. Based on the current results, 
the amount of SPION was reduced after 7 days, therefore the force per cell was not 
constant. This issue could be overcome by using a different type of magnetic material 
to achieve long-term actuation, such as different SPION that are not lost from the cells.    
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5.1 Introduction  
There are several ways to induce mechanical stretching in cells. One way to achieve 
this is with a FlexCell system, where the cells are seeded onto an elastic membrane and 
stretched using an applied vacuum (161). Magnetic actuation has been achieved by 
tagging magnetically specific mechanoreceptors of interest on the plasma membrane 
and  then  applying  magnetic  force  to  them,  resulting  in  a  biochemical  effect  by 
stretching  the  specific  receptor  (167-170).  In  Chapter  4  a  novel  technique  was 
described for delivering strain to cells previously loaded with SPION using a magnetic 
actuator. It was hypothesized that the cells loaded with SPION inside the endosomes 
would be actuated towards an externally applied magnetic field, causing a stretching 
effect  to  the  cytoskeleton  of  cells.  However,  TEM  analysis  suggested  that  SPION 
internalized by HRSMC located inside the endosomes did not undergo any observable 
movement to the externally applied magnetic field. In this chapter, deformation of the 
plasma membrane of SPION-loaded HRSMC by an externally applied magnetic field 
was investigated using scanning electron microscopy (SEM) and live-cell imaging.   
5.2 Materials and Methods  
5.2.1 Materials 
5.2.1.1 Magnets   
Permanent magnets were used to investigate the effect of delivering a magnetic field to 
cells loaded with SPION. Four circular neodymium-iron-boron magnets (NdFeB; N42; 
MagnetSales, UK) with dimensions 16 mm x 5 mm (Figure 5.1 a) and magnetized 
through  their  thickness  were  stacked  with  opposing  poles  facing  each  other  and 
mounted on top of a rectangular plastic box with dimensions 60 mm x 30 mm. The Chapter 5: Membrane Deformation of SPION-Loaded HRSMC 
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distance between the top of the magnets to the bottom of the plate was 5 mm (Figure 
5.1 b). 
 
 
(a)  (b) 
Figure 5.1 Dimensions of the Magnets and the Rectangular Mounting Box Used to Apply 
the External Magnetic Field to Cells. 
5.2.1.2 SPION  
Two types of SPION were investigated in these experiments: 
•  SPION  (fluidMAG-UC/A  anionic  charged  SPION;  50  nm  particles  with  a 
magnetite core suspended in water with a stock concentration of 25 mg/ml and 
particle density of ~1.3x10
16 particles/g; Chemicell GmbH, Berlin, Germany). 
•  SPION  (fluidMAG-UC/A  anionic  charged  SPION;  200  nm  particles  with  a 
magnetite core suspended in water with a stock concentration of 25 mg/ml and 
particle density of ~ 2.2 x 10
14 particles/g; Chemicell GmbH, Berlin, Germany). 
5.2.1.3 Confocal Microscope 
A Leica SP2 AOBS laser scanning confocal microscope (Leica Microsystems Ltd, UK) 
was used to image membrane deformation in response to the external magnetic field. Chapter 5: Membrane Deformation of SPION-Loaded HRSMC 
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The condenser beneath the stage of the microscope was removed to create space for the 
magnets to be introduced manually, as shown in Figure 5.2. 
 
Figure  5.2  Leica SP2 AOBS Laser Scanning Confocal Microscope.  The  condenser  was 
removed so the magnets could be manually inserted under the microscope as indicated by the 
arrow.  
5.2.2 Methods  
5.2.2.1 Computer Modelling of Magnetic Fields Produced by the Magnets 
Finite element modelling was used to model the magnetic field and magnetic force 
produced by the oscillating magnetic actuator described in this chapter. The modelling 
was  performed  by  Mr  George  Frodsham  (Department  of  Biochemical  Engineering, 
University  College  London,  London  and Institute  of  Biomedical  Engineering, 
University College London).  
Finite element modelling with Opera-3D (Version 12; Vector Fields, UK) was used to 
calculate the strength of the magnetic field produced by the magnets. The distance from Chapter 5: Membrane Deformation of SPION-Loaded HRSMC 
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the centre of the magnets (with assigned co-ordinates x=0, y=0, z=0) to the base of the 
tissue culture plate was 5 mm. (Figure 5.1 b).  
The force produced by the magnets on each SPION particle in the cells was calculated 
using  mathematical  software  (MATLAB,  MathWorks,  Natick,  MA,  U.S.A),  from 
which the net magnetic force per cell was calculated. For all calculations, the direction 
of the force was assumed to be downward.  
The force acting on each particle was between 1.8 - 2.0 pN 0.9 pico Newton (pN). The 
calculations were made assuming each SPION was 200 nm diameter, had a density 
1.25 g/cm
3 and mass of 6.545x10
-4 pg. Therefore, if the HRSMC were loaded with 100 
pico grams of magnetic material the force acting on a cell was: 
1.8 x 10
-10N (180-200 pN) 
5.2.2.2 Live Cell Imaging of SPION-Loaded HRSMC Exposed to a Magnetic Field 
Live cell imaging was used to investigate membrane deformation of SPION-loaded 
HRSMC in response to the externally applied magnetic field. 
 (i)  2x10
4 HRSMC were seeded in a 25 cm
2 cell culture flask (Nunclon
TM Delta 
surface, Denmark) and incubated for 24 hours at 37
0C, 5% CO2. 
(ii)  The medium was removed and experimental (proliferation) medium containing 
250 µg/ml of SPION (50 nm or 200 nm) was added and incubated at 37
0C, 5% 
CO2 for 24 hours. 
(iii)  After  the  incubation  period,  the  medium  was  removed  and  the  cells  were 
washed 5x with 5 ml of PBS. 
(iv)  1 ml of trypsin-EDTA was added to each flask and incubated at 37
0C, 5% CO2 
for 1 minute. Chapter 5: Membrane Deformation of SPION-Loaded HRSMC 
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(v)  5  ml  of  fresh  media  was  added  in  each  flask  and  the  detached  cells  were 
collected in a 30 ml container. 
(vi)  Samples  were  centrifuged  at  1000  rpm  for  5  minutes,  the  supernatant  was 
removed and the pellets were re-suspended in 1ml of fresh media. 
(vii)  A cell count was performed and 100,000 cells were extracted and transferred 
into a 35 mm FluoroDish cell culture dish (World precision Instruments, USA) 
and incubated at 37
0C, 5% CO2 for 24 hours.   
(viii)  The medium was removed and the cells were incubated with 1 µl of CellMask™ 
Deep  Red  Plasma  membrane  Stain  (1:2000  in  culture  medium)  (Life 
Technologies, USA) for 1 hour at 37
0C, 5% CO2 in order to visualise the plasma 
membrane of the cells.  
(ix)  The solution was removed and the cells were washed 3x with 1 ml of PBS. 
(x)  The  cells  were  placed  in  an  upright  confocal  microscope  Leica  SP2  AOBS 
Laser Scanning Confocal (Leica Microsystems Ltd, UK) where the condenser 
was  removed  previously  to  create  space  for  the  stack  of  magnets  to  be 
introduced manually. 
(xi)  Phase  contrast  microscopy  was  used  to  capture  the  movement  of  SPION 
particles inside the cells and the fluorescently labelled plasma membrane was 
imaged at 649 nm excitation and 666 nm emission. 
(xii)  185 individual images overall were acquired (1 image every 1.62 seconds) over 
a  period  of  300  seconds.  At  t=30  seconds,  the  magnets  were  manually 
introduced beneath the microscope stage at distance of 40 mm below the base of 
the  cell  culture  dish.  The  magnets  were  steadily  raised  over  a  period  of  20 
seconds until they were at a distance of 5 mm below the base of the cell culture 
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underneath the cell culture dish then lowered initially to 40 mm below the base 
of the cell culture dish for 20 seconds before being finally removed. Images 
were acquired for a further 40 seconds after the magnet was removed.  
5.2.2.3 Quantification of Membrane Deformation and SPION Movement  
Image J (Image Processing and Analysis in Java, National Institute of Health, USA) 
was used to quantify changes to the position of the membrane and SPION movement in 
response  to  the  applied  external  magnetic  field.  For  HRSMC  loaded  with  200  nm 
SPION,  the  movement  of  the  magnetic  particles  and  the  plasma  membrane  was 
recorded in a 5-minute movie clip, which resulted in 185 images (1 image every 1.62 
seconds).  For  HRSMC  loaded  with  50  nm  SPION,  the  movement  of  the  magnetic 
particles  and  the  plasma  membrane  was  recorded  in  a  5-minute  movie  clip,  which 
resulted in 89 images (1 image every 3.37 seconds). 
For the analysis, the movement of the plasma membrane and SPION were analysed 
separately. Each of the acquired images in the movie clip was converted to black and 
white. This led to the appearance of clusters of SPION particles within each image, 
which were used to quantify bulk movement. Each cluster in the frame was assigned a 
number that was kept the same for each image. The central point of each numbered 
cluster was assigned an x and y location coordinate within the image.  
To calculate the overall distance moved by the cluster of SPION particles and the 
plasma  membrane  in  each  image  after  magnetic  actuation  relative  to  their  starting 
location (x, y coordinate), a set reference point at the base (B) of the cell in the image 
(Bx, By) was subtracted from each cluster (C) coordinate (Cx, Cy). It was observed 
from the video clips that there was also movement of the SPION and plasma membrane 
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membrane clusters relative to the cell base was calculated for X and Y axes separately, 
as  summarized in Figure 5.3. Limitations with the software used meant it was not 
possible to follow individual clusters of SPION during the movie clip. Therefore, the 
average movement of all the clusters relative to a set reference point per image was 
calculated for all images acquired in the movie clips. The average movement of SPION 
clusters  per  image  was  then  plotted  against  time  and  changes  caused  by  magnetic 
actuation compared with SPION-loaded cells exposed to no magnetic actuation.  
Analysis of SPION Movement 
 
 
 
 
(a)  (b)  (c) 
 
Analysis of Plasma Membrane Movement 
 
   
 
(c)  (d)  (e) 
Figure  5.3  Analysis  of  SPION  and  Plasma  Membrane  Movement.  (a  and  c)  A  single 
HRSMC with the plasma membrane stained red using the Cell Mask dye. The white specks in 
the cell are caused by refractance of the SPION particles. Movement of the plasma membrane 
and SPION clusters were analyzed separately. (b, d) Each image underwent thresholding to Chapter 5: Membrane Deformation of SPION-Loaded HRSMC 
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create a black and white image with the cluster of particles and plasma membrane outlined. 
Each cluster was numbered and the x, y coordinate of the center of the cluster recorded. (c and 
e)  The  distance  moved  by  the  plasma  membrane  or  cluster  from  a  set  base  position  was 
calculated for each image.  
5.2.2.4 Scanning Electron Microscopy of SPION-Loaded HRSMC after Magnetic 
Actuation  
Scanning electron microscopy (SEM) was used to investigate morphological changes to 
the membrane of SPION-loaded HRSMC in response to an external magnetic field.  
(i)  Steps i- vi from section 5.2.2.2 were followed for this experiment.  
(ii)  A cell count was performed and 50,000 cells were extracted and transferred in a 
24 well plate (Nunclon
TM Delta treated, Denmark). 
(iii)  Cells were incubated for 24 hours at 37
0C 5% CO2. 
(iv)  After the incubation period the stack of 4 magnets was placed under the plate 
for 1 hour.  
(v)  After 1 hour of static exposure the supernatant was removed and 1 ml of 2% 
paraformaldehyde  +  2.5%  gluteraldehyde  in  0.1M  cacodylate buffer,  pH  7.2 
was added to fix the cells inside a fume cupboard for 10 minutes. 
(vi)  The fixative was removed and the samples were washed 2x with 1 ml of PBS. 
(vii)  The  samples  were  post  fixed  with  2%  osmium  tetroxide  (OsO4)  (Ceimig 
Limited, UK) for 1 hour inside a fume cupboard. 
(viii)  The samples were dehydrated in a progressive series in water/ethanol mixtures:  
a.  25% v/v ethanol        4 minutes 
b.  50% v/v ethanol        4 minutes 
c.  75% v/v ethanol        4 minutes 
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e.  100% v/v ethanol      4 minutes (the last step was repeated 5 
times). 
(ix)  The samples are carefully mounted on an aluminium stub using silver paint and   
then introduced into the chamber of the sputter coater and coated with a very 
thin film of gold\palladium for its examination under a JSM-7500F Scanning 
Electron Microscope (JEOL, USA). 
5.2.2.5 Quantification of Cellular Loading with SPION   
5.2.2.5.1 Superconducting Quantum Interference Device (SQUID) 
SQUID  magnetometry  was  used  to  measure  the  amount  of  SPION  in  each  cell  as 
described in 4.2.2. 
(i)  Steps i- vi from section 5.2.2.2 were followed for this experiment. 
(ii)  Steps vii-xi from section 2.2.2.1 were followed for this experiment. 
5.2.2.6 Cell Viability Assays 
5.2.2.6.1 Cytotoxicity Assay - LDH Assay 
(i)  2 x 10
4 HRSMC were seeded in a 25 cm
2 cell culture flask (Nunclon
TM Delta 
surface, Denmark) and incubated for 24 hours at 37
0C, 5% CO2. 
(ii)  The medium was removed and experimental (proliferation) medium containing 
250 µg/ml of SPION (50 nm or 200 nm) was added and incubated at 37
0C, 5% 
CO2 for 24 hours. 
(iii)  After the incubation period the medium was removed and the cells were washed 
5x with 5 ml of PBS. 
(iv)  1 ml of trypsin was added to each flask and incubated at 37
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minute. 
(v)  5  ml  of  fresh  media  was  added  in  each  flask  and  the  detached  cells  were 
collected in a 30ml container. 
(vi)  Samples  were  centrifuged  at  1000  rpm  for  5  minutes,  the  supernatant  was 
removed and the pellets were re-suspended in 1 ml of fresh media.  
(vii)  A cell count was performed and 10,000 cells were extracted and seeded in a 24 
well plate (Thermo Scientific, Nunc, Fisher Scientific, UK).  
(viii)  The plate was incubated at 37
0C %, 5% CO2 for 24 hours.  
(ix)  The stack of magnets described in section 6.2.1.1 were placed under the plate 
exerting a static field to the cells at 37
0C, 5% CO2  for 1 hour. 
(x)  Supernatants of cells incubated with SPION (50 nm or 200 nm) for 24 hours 
were collected and transferred to a fresh 96 well plate (Thermo Scientific, Nunc, 
Fisher Scientific, UK) accordingly. 
(xi)  50 µl of medium was removed and placed in a new well and 50 µl of the LDH 
assay reagents was added to each well and the plate was incubated in the dark at 
room temperature for 30 minutes. 
(xii)  50 µl of stop solution was added to each well and the optical density of the 
reaction  produced  in  the  well  was  read  with  a  plate  reader  Multiskan  FC 
(Thermoscientific, UK) at 490 nm. 
5.2.2.6.2 Cytotoxicity Assay (Positive Control) 
(i)  Steps i-ix from section 5.2.2.6.1 were followed for this experiment. 
(ii)  10 µl of cell lysis solution (provided with the assay) per 100 µl was added to all 
the wells. 
(iii)  The cells were incubated for 45 minutes at 37
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(iv)  The plate was centrifuged at 250 x g for 4 minutes. 
(v)  Supernatants of cells incubated with SPION (50nm or 200nm) for 24 hours were 
collected  and  transferred  to  a  fresh  96  well  plate  (Thermo  Scientific,  Nunc, 
Fisher Scientific, UK) accordingly. 
(vi)  50 µl of medium was removed and placed in a new well and 50 µl of the LDH 
solution was added to each well and the plate was incubated in the dark for 30 
minutes. 
(vii)  50 µl of stop solution was added to each well and the optical density of the 
reaction  product  in  the  well  was  read  with  a  plate  reader  Multiskan  FC 
(Thermoscientific, UK) at 490 nm. 
5.3. Results  
5.3.1 Modelling of the Magnetic Field and Forces on SPION Loaded HRSMC 
The field plots in Figure 5.4 show the magnetic field produced at the base of the tissue 
culture plate 5 mm from the centre of the device. At the edges of the magnet the 
magnetic field became weaker. In the centre of the magnet (red region) the magnetic 
field acting on the particles was 180 mT and at the edges the magnetic field dropped to 
110 mT. The areas of the plot coloured red indicated the magnetic field had its highest 
value and those coloured blue had the lowest value.  
The  force  plot  shown  in  Figure  5.5  indicates  that  at  the  edges  of  the  magnet  the 
magnetic  force  also  became  weaker.  In  the  centre  of  the  magnet  (red  region)  the 
magnetic force acting on the particles was 1.9 pN and at the edges the magnetic force 
dropped to 0.4 pN.  Chapter 5: Membrane Deformation of SPION-Loaded HRSMC 
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Figure  5.4  Magnetic  Field  Plots  from  the  Magnets  Used  to  Investigate  HRSMC 
Deformation. In the centre of the magnet the magnetic field had its highest value of 180 mT. 
At the edges of the magnet the magnetic field had each weakest value of 110 mT. 
 
 
Figure  5.5  Magnetic  Force  Plots  from  the  Magnets  Used  to  Investigate  HRSMC 
Deformation. In the centre of the magnet the magnetic force had its highest value of 1.9 pN. At 
the edges of the magnet the magnetic force had each weakest value of 0.4 pN. 
5.3.2 Quantification of Cellular Loading with SPION  
SQUID  magnetometry  was  used  to  quantify  the  amount  of  SPION  in  HRSMC  in 
proliferation medium. HRSMC loaded with 200 nm SPION, incubated in proliferation 
medium for a period of 24 hours contained approximately 100 pg of SPION. Previous 
SQUID measurements (Chapter 4) showed that HRSMC loaded with 50 nm SPION in  
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5.3.3 Membrane Disruption to SPION-Loaded HRSMC Following Exposure to 
Magnets  
5.3.3.1 Measurement of Lactate Dehydrogenase    
Membrane damage to SPION-loaded HRSMC exposed to the magnets was investigated 
by measuring cellular release of LDH. HRSMC were incubated with SPION (50 nm or 
200  nm)  as  described  in  section  5.2.2.2.  A  positive  control  (PC)  was  obtained  by 
incubating HRSMC in lysis solution (provided with the kit). The lysis solution lyses the 
cell membrane resulting in the maximum production of LDH in the supernatant (100% 
toxic).  The  detailed  process  was  described  in  sections  2.2.5.2.1  and  5.2.2.6.2.  No 
significant change was observed between SPION-loaded HRSMC (200 nm) and control 
cells (no magnet) in Figure 5.6 a. Similar results were observed between SPION-loaded 
HRSMC (50 nm) and control cells (no magnet). The optical density of the positive 
control (PC) had approximately 30% increased for both experiments (200 nm and 50 
nm) Figure 5.6 a+b. 
Particle size 200nm  Particle size 50nm 
   
(a)  (b) 
Figure  5.6  LDH  Release  in  the  Supernatant  from  SPION-Loaded  HRSMC  Following 
Magnetic  Actuation.  (a)  No  significant  change  was  observed  between  the  SPION-loaded 
HRSMC (200 nm) after exposure to a magnetic field compared with control cells (no magnet). 
(b) No significant change was observed between the SPION-loaded HRSMC (50 nm) after 
exposure to a magnetic field compared with control cells (no magnet). The was an apparent Chapter 5: Membrane Deformation of SPION-Loaded HRSMC 
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increase  in  the  release  of  LDH  in  the  supernatant  in  the  positive  control  (PC)  for  both 
experiments (a+b) 
5.3.4  Morphological  Changes  to  SPION-Loaded  HRSMC  in  Response  to  an 
Externally Applied Magnetic Field 
SEM was used to investigate deformation of SPION-loaded HRSMC membranes after 
exposure to the permanent magnets for 1 hour.  HRSMC were incubated with SPION 
(50 nm in diameter) as described in section 5.2.2.2. Electron micrographs show the 
membranes  of  the  SPION-loaded  cells  not  exposed  to  the  magnets  had  a  similar 
appearance  to  non-loaded  control  cells.  The  membranes  of  SPION-loaded  cells 
exposed to the magnets had many protrusions rising from the membrane surface.   
   
(a)  (b) 
   
(c)  (d) 
Figure 5.7 Scanning Electron Microscopy of SPION-Loaded HRSMC after Exposure to a 
Magnetic  Fields  for  1  Hour.  (a)  Control  cells.  (b)  SPION-loaded  cells  without  magnet Chapter 5: Membrane Deformation of SPION-Loaded HRSMC 
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exposure. (c) SPION-loaded cells exposed to a magnet for 1 hour. (d) The protrusions observed 
on membrane of SPION-loaded cells exposed to a magnet were not uniformly distributed.  
5.3.5 Quantification of Membrane Deformation and SPION Movement 
Deformation  of  the  cell  membrane  of  SPION-loaded  HRSMC  and  the  clusters  of 
internalized SPION following exposure to an externally applied magnetic field were 
investigated for both types of SPION (50 nm and 200 nm). HRSMC monolayers were 
incubated  with  250  µg/ml  of  SPION  (50  nm  and  200  nm)  as  described  in  section 
5.2.2.2.  
Analysis  of  the  acquired  images  rendered  into  movie  clips  revealed  significant 
movement of the clusters of 200 nm SPION in the Y axis after the magnetic field was 
applied compared with control cells (no magnetic field; p<0.001; Figure 5.8 a and 5.9 
a). The movement that occurred with the clusters of 50 nm SPION in the Y axis after 
the  magnetic  field  was  applied  compared  with  control  cells  was  smaller  but  also 
significant (Figure 5.8 c and 5.9 c; p<0.001).  
There was significant movement of the plasma membrane in the Y axis for cells loaded 
with 200 nm SPION after the magnetic field was applied compared with control cells 
(no magnetic field; p<0.001; Figure 5.8 b and 5.9 b). Similarly, there was significant 
movement of the plasma membrane in the Y axis for cells loaded with 50 nm SPION 
after the magnetic field was applied compared with control cells (no magnetic field; 
p<0.001; Figure 5.8 d and Figure 5.9 d).  
Analysis  of  the  acquired  images  rendered  into  movie  clips  revealed  significant 
movement of the clusters of 200 nm SPION in the X axis after the magnetic field was 
applied compared with control cells (no magnetic field; p<0.00; Figure 5.10 a and 5.11 
a). The movement that occurred with the clusters of 50 nm SPION in the X axis after Chapter 5: Membrane Deformation of SPION-Loaded HRSMC 
	 ﾠ 185 
the  magnetic  field  was  applied  compared  with  control  cells  was  smaller  but  also 
significant (Figure 5.10 c and 5.11 c; p<0.001).  
There was significant movement of the plasma membrane in the X axis for cells loaded 
with 200 nm SPION after the magnetic field was applied compared with control cells 
(no  magnetic  field;  p<0.001;  Figure  5.10  b  and  5.11  b).  There  was  no  significant 
movement of the plasma membrane in the X axis for cells loaded with 50 nm SPION 
after the magnetic field was applied compared with control (Figure 5.10 d and Figure 
5.11 d).  
   Analysis of Movement in the Y Axis 
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Figure 5.8 SPION (50 nm and 200 nm) and Plasma Membrane Movement in the Y-axis. t1 
=  30  seconds-the  time  point  at  which  magnets  were  manually  introduced  beneath  the 
microscope stage at a distance of 40 mm below the base of the cell culture dish. t2 = The 
magnets were steadily raised over a period of 20 seconds  until they were at a distance of 5 mm Chapter 5: Membrane Deformation of SPION-Loaded HRSMC 
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below the base of the cell culture dish. t3 = The magnets were held in a steady position for a 
total of 230 seconds underneath the cell culture dish. t4 = The magnets were lowered initially to 
40mm below the base of the cell culture dish for 20 seconds before being finally removed. 
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Figure 5.9 Statistical Analysis of SPION (50 nm and 200 nm) and Plasma Membrane 
Migration on the Y-Axis.  
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Analysis of Movement in the X Axis 
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Figure 5.10 SPION (50 nm and 200 nm) and Plasma Membrane Migration on the X-Axis. 
t1 = 30 seconds, the magnets were manually introduced beneath the microscope stage at a 
distance of 40 mm below the base of the cell culture dish. t2 = The magnets were steadily 
raised over a period of 20 seconds  until they were at a distance of 5 mm below the base of the 
cell culture dish. t3 = The magnets were held in a steady position for a total of 230 seconds 
underneath the cell culture dish. t4= The magnets were lowered initially to 40 mm below the 
base of the cell culture dish for 20 seconds before being finally removed. 
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Figure 5.11 Statistical Analysis of SPION (50 nm and 200 nm) and Plasma Membrane 
Migration on the X-Axis.  
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5.4 Discussion  
5.4.1 Main findings:  
•  HRSMC incubated with 200 nm SPION had approximately 100 pg of SPION 
internalized whereas HRSMC incubated with 50 nm SPION had approximately 
16 pg after 24 hours of incubation.           
•  SEM images of HRSMC incubated with 50 nm SPION showed evidence of 
membrane deformation in response to an externally applied magnetic field. 
•  Live  cell  imaging  analysis  revealed  that  SPION  movement  and  plasma 
membrane  deformation  were  more  prominent  on  the  Y-axis  (movement 
upwards) for 50 nm and 200 nm particles confirming the SEM results. 
•  Movement  was  observed  the  X-axis  (movement  sideways)  by  the  plasma 
membrane for 200 nm particles. This suggests that the plasma membrane not 
only moved upwards but also sideways. 
5.4.2 Magnetic Actuation of SPION-loaded HRSM and Membrane Deformation 
In chapter 4, TEM was used to determine movement of the SPION-loaded endosomes. 
No movement was observed compared to non-actuated control cells. To explore this 
further, this chapter used SEM and live cell imaging.  
Some important differences existed between the experiment in this chapter and those 
described in Chapter 4. HRSMC were incubated with 200 nm particles, resulting in a 
higher  concentration  of  iron  per  cell.  The  amount  of  SPION  per  cell  was  100  pg 
compared  with  16  pg  of  SPION  when  HRSMC  incubated  with  50  nm  diameter 
particles. The magnets used in this chapter also had a stronger magnetic field. Four 
neodymium-iron-boron (NdFeB) permanent disc magnets with dimensions 16 mm x 5 
mm  (Figure  5.1  b)  were  stacked  together  in  order  to  increase  the  strength  of  the Chapter 5: Membrane Deformation of SPION-Loaded HRSMC 
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magnetic field. Additionally the distance between the tissue culture plate was 5 mm 
compared  to  14  mm  with  the  magnetic  actuator  used  in  Chapter  4.  Therefore  the 
magnetic force applied per cell was significantly increased.  
SEM was used to investigate the deformation of the cell membrane of SPION-loaded 
HRSMC  (50  nm  in  diameter)  and  the  clusters  of  internalized  SPION  following 
exposure  to  an  externally  applied  magnetic  field.  The  results  showed  that  the 
membranes of SPION-loaded cells exposed to the magnets had many protrusions rising 
from the membrane surface for HRSCM incubated with 50 nm suggesting that SPION 
had pushed the plasma membrane resulting in a deformation.  
Live  cell  imaging  was  used  to  observe  changes  in  SPION  movement  or  plasma 
membrane deformation. From the movie clips captured it was observed that SPION and 
the plasma membrane not only move in the Y-axis but also on the X-axis.  
For the plasma membrane deformation there was a significant movement for both 50 
nm and 200 nm in the Y-axis. Interestingly there was no change in the membrane 
movement on the X-axis for 50 nm but for 200 nm there was movement.  This result 
showed that the deformation of the plasma membrane occurred in a negative quadrant 
and  possibly  the  SPION-loaded  endosomes  pushed  the  plasma  membrane  in  the 
opposite direction.  Overall, for the 200 nm SPION movement occurred only in the Y-
axis but plasma membrane movement occurred in both the Y-axis and X-axis. These 
findings suggest that the SPION not only pushed the membrane upward but also shifted 
it sideways, possibly causing a stretching effect. For 50 nm SPION, movement was 
observed on the X-axis suggesting that the SPION clusters moved sideways and not 
upwards,  which  is  the  opposite  from  what  was  observed  with  200  nm  SPION. 
Significant movement in the plasma membrane in the Y-axis was observed, suggesting Chapter 5: Membrane Deformation of SPION-Loaded HRSMC 
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that  even  if  the  SPION  move  sideways  and  not  upwards  like  the  200  nm,  this 
movement  was  sufficient  to  cause  a  membrane  deformation.  The  live  cell  imaging 
results  confirmed  the  SEM  findings,  where  the  membranes  of  SPION-loaded  cells 
exposed to the magnets had many protrusions appearing to rise from the membrane 
surface.  
The SPION movement and the membrane deformation did not affect the viability of 
HRSMC.  LDH  data  suggested  that  no  membrane  damage  occurred  in  the  SPION-
loaded cells exposed to magnets for either both 50 nm and 200 nm of SPION.  
A previous study described the deformation of SPION-loaded endosomes. Hela cells 
were incubated with 10 nM of cobalt ferrite nanoparticles (CoFe2O4) with a diameter of 
10 nm. The particles were coated with negatively charged citrate ligands to ensure 
colloidal stability in aqueous suspension through electrostatic repulsions. Hela cells 
were incubated for 1 hour at 37
0C and the cell magnetophoresis assay revealed that the 
number of magnetic particles per cell was 1.1x10
7 nanoparticles per cell. To observe 
endosome deformation TEM was used. The cells were exposed to a uniform magnetic 
field of 660 mT for 15 seconds. The results showed the magnetic endosomes were 
elongated and aligned in the direction of the magnetic field (171). 
 In another study similar findings were observed for SPION-loaded endosomes that 
were attracted to each other via dipole-dipole magnetic interactions and formed chains 
inside the cytoplasm along with the direction of the magnetic field, but this did not 
affect the architecture of actin filaments and microtubules (172). Magnetic tweezers 
have been used for manipulating small magnetic beads inside the cell cytoplasm in 
order to gain insight into the structural and mechanical properties of the cytoskeleton 
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viscoelasticity of the cell interior. Granulocytes were incubated with magnetic beads 
(0.35 mm 1.05 mm) for 30 minutes. Each granulocyte phagocytosed a single bead 
which was moved between the 3 different poles of the magnetic tweezers in a cyclic 
manner. The granulocytes incubated with 1.05-mm beads experienced forces of 120 pN 
and granulocytes incubated with 0.35-mm beads experienced forces of 12 pN. Live 
cell-imaging experiments showed that beads could be manipulated through the interior 
of a cell. Magnetic beads with a diameter of 0.35 mm showed reduced elasticity and a 
10-fold  reduction  in  viscosity  (3  Pa)  compared  with  the  1.05  mm.  The  measured 
viscosity was 3 times greater than the viscosity of water. This was thought to have 
resulted because of the breaking of the cross-links within the cytoplasmic region (175).  
In  this  study  Image  J  analysis  was  used  to  analyse  the  SPION  movement  and 
membrane deformation. A limitation of using this technique was that SPION or plasma 
membrane had to be measured separately, which made the combined assessment more 
difficult. There are previous studies that have tried to manipulate cells with magnetic 
actuation (167) and mechanical studies using the Flexcell unit (170). These are likely to 
have created a cytoskeletal change but the studies did not describe how mechanical 
stimuli were transmitted into biochemical signals and if it was possible to visualize or 
quantify this.  
To  quantify  intracellular  changes  in  response  to  an  external  magnetic  field, 
fluorescence energy transfer technology (FRET) imaging has been used. FRET is a 
popular imaging technique in order to label specific intracellular components (176, 
177).    Many  studies  have  investigated  mechanical  or  magnetic  stimulation  of  cells 
using FRET and a Src reporter that allows the imaging and quantification of spatio-
temporal changes upon activation of Src in living cells. It is known that Src regulate 
integrin-cytoskeleton  interactions  following  mechanical  stimuli.  When  integrins  are Chapter 5: Membrane Deformation of SPION-Loaded HRSMC 
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activated with a mechanical or magnetic signal, Src is associated with integrin via the 
SH3 domain and cause dissolution of actin stress fibres and the release of mechanical 
tensile stress. 
Based on the FRET technology and the limitations encountered with the use of Image J 
in this chapter, a different approach to study the movement of could be used to study 
the  effect  of  SPION  movement  and  membrane  deformation  could  be  used. 
Microtubules are connected with endosomes with Rab5 protein (178, 179). A FRET 
green  fluorescent  protein  (GFP)-Rab  5  could  be  developed  for  the  visualisation  of 
endosome and microtubule movement in response to an external magnetic field. 
5.4.3 Conclusion  
The  findings  from  this  chapter  suggest  that  magnetic  actuation  of  SPION-loaded 
HRSMC causes the plasma membrane to move upwards and sideways. This is likely to 
cause deformation of the cytoskeleton. Future studies will involve the use of FRET 
imaging and magnetic tweezers in order to explore the cytoskeletal changes in response 
to an external magnetic field.  
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6.1 Conclusion  
Faecal  incontinence  is  a  debilitating  condition  that  affects  a  big  percentage  of  the 
population (6-9). Is defined as an alteration of the faecal passage where the patient 
experiences involuntary loss of flatus, liquid or solid faecal contents(1, 2).  People who 
suffer from faecal incontinence have a consequence in their quality of life by avoiding 
activities such as shopping, go to the cinema, dinning with friends or family are some 
examples. Furthermore they hesitate to disclose their conditions to friends or to a health 
professional, which scales up the severity of their problem.   
There  are  a  number  of  treatment  options  for  people  who  suffer  from  faecal 
incontinence. Depends on the severity of their situation, treatments can be classified as 
non-invasive  such  as  biofeedback,  minimally  invasive  such  as  bulking  agents  and 
finally invasive procedures such as surgery, sacral nerve stimulation and artificial anal 
sphincter.   
Biofeedback as conservative treatment is a reliable treatment, which could improve the 
quality of life but only in the short term. In addition to people who suffer from severe 
faecal incontinence are not benefiting from this treatment (55) (56) (44). 
In  patients  with  faecal  incontinence  in  whom  conservative  treatment  fails  different 
options  are  incorporated  such  as  bulking  agent.  Bulking  agents  have  been  used  to 
narrow the anal canal and consequently to help retain stool (4, 48). The use of these 
agents  is  considered  a  minimally  invasive  treatment  for  incontinence  (46).  Several 
injectable materials have been tried such as carbon-based, silicone particles, collagen 
agents, autologous fat, none have been shown to provide long-term efficacy. If the 
condition of the patient has not been improved at this stage, further invasive procedures 
will be incorporated. (48).  References 
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When conservative or minimally invasive procedures fails then invasive procedures 
need to be incorporated such as dynamic graciloplasty, an artificial anal sphincter, and 
sacral  nerve  stimulation.  Sacral  nerve  stimulation  greatly  improves  continence  and 
quality of life does not have long-term functional improvement. (61) (62) (65).  Similar 
result shave been observed with dynamic gracioplasty (71) (72). Patients subjected to 
ASS implantation showed Early infection and rectal erosion, together with difficulty in 
evacuating and mechanical failure (67) (68). If none of the previous treatments have 
been  successful,  aggressive  surgery  such  as  colostomy  needs  to  be  incorporated. 
Colostomy does not restore sphincter function but permits bowel evacuation and allows 
the patient to return to a normal life (6) (73) (74). 
New  regenerative  medicine  therapies  are  still  at  very  early  stage.  They  involve 
regenerating  the  sphincter  tissue  with  the  injection  of  stem  cells(76)  (77)  or  the 
complete replacement of a 3D bioengineered sphincter (78). Regenerative medicine 
approaches  hold  a  great  promise,  however  the  studies  conducted  require  further 
investigation. More research is necessary to be conducted in order to be safe for clinical 
applications. 
The current magnetic stimulation therapies involve a Magnetic Anal Sphincter (MAS), 
it is a promising new technique, however, the results are not very conclusive and the 
number  of  patients  is  very  low.  Also  there  is  no  study  investigating  the  long-term 
effects (79) (80). 
Therefore, there is still a need for developing new technologies or interventions to 
improve faecal incontinence. This will help incontinent people to reach a normal level 
of faecal continence. Ideally new interventions should use minimal or non-invasive and 
cost effective methods that people can easily access.  References 
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Previously human cardiac stem cells have been regulated mechanically with a Flexcell 
system. Mechanical strain was applied with 60 cycles per minute and 120% elongation 
(stretching conditions that mimic the heart rate and 20% fractional shortening). Non-
stretched cells were used as controls. The release of different growth factors after 12 
hours of stretching was investigated to determine how mechanical strain affected the 
release of different growth factors. Results showed there was a 1.9-fold and 29.5-fold 
increase in the concentration of VEGF and bFGF in the stretched group compared with 
the  non-stretched  group  (90).  Similarly  bovine  airway  smooth  muscle  cells  (ASM) 
were enhanced their proliferation proliferation after mechanical strain applied to the 
cells (89).   
Also  different  studies  have  controlled  remotely  with  magnetic  fields  and  magnetic 
particles  the  phenotype  of  cells  by  tagging  specific  receptors  responsible  for  the 
differentiation of cells. Hu et al examined the possibility of controlling differentiation 
by mechanically activating the PDFG receptor α and β of HBMSCs. The results have 
shown an increase in α-actin (SMA) gene and protein expression (106). 
Therefore combining the cyclic mechanical strain with the magnetic force. The overall 
aim of the work described in this thesis was to investigate magnetic actuation of the 
SPION-loaded  HRSMC.  In  this  study  HRSMC  were  used  as  a  model  of  sphincter 
smooth  muscle  cells.  The  phenotypic  continuum  of  smooth  muscle  cells  has  been 
controlled mechanically with Flexcell units as shown in previous studies. However, in 
this study HRSMC were incubated with SPION and seeded in culture plates with a 
rigid bottom. The different mode of action allowed the oscillating magnetic field to 
stretch  the  plasma  membrane  of  HRSMC  creating  a  stretching  effect  similar  to  a 
Flexcell unit.  References 
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The  nanoparticles  used  in  this  study  were  negatively  charged  uncoated  iron  oxide 
crystals, manufactured by chemical precipitation. In chapter 3, the effects of SPION on 
HRSMC were explored. The particles retain the hydrodynamic diameter in water but in 
culture  medium  they  form  big  clusters  due  to  the  corona  effect  where  particles, 
surrounded  by  biological  fluids  such  as  the  culture  medium  and  form  clusters  of 
various  sizes.  Also  SPION  were  endocytosed  by  HRSMC  and  located  inside  the 
endosomes  as  showed  by  TEM  and  also  concentrations  above  250  µg/ml  loading 
saturation occurred according to SQUID measurements. The exact endocytic process 
was  not  investigated  in  this  study.  It  is  likely  that  caveolae-mediated  or  caveolae-
independent  endocytosis  occurs.  This  type  of  endocytosis  creates  50  nm  diameter 
vesicles to endocytose nanoparticles, similar in size to the magnetic nanoparticles used 
in this study. Caveolae-mediated or independent endocytosis fall into a broad category 
of  endocytosis  called  pinocytosis,  together  with  clathrin-mediated  and  independent 
endocytosis and macropinocytosis (148) 
In  Chapter  4  a  magnetic  actuator  devise  was  devised  to  deliver  magnetic  force  to 
HRSMC. As the magnetic cylinder rotated the magnetic field changed from a high 
value to a lower value it was hypothesized this would create continuous cycles of cell 
stretching by moving the SPION-loaded endosomes or ‘magnetosomes’. The physical 
movement of the SPION-loaded endosomes was proposed to stretch the cytoskeletal 
components such as actin filaments and microtubules and create a phenotypic change to 
the cells such as proliferation or contraction. The type of cyclic mechanical stretching 
proposed  in  this  study  is  different  from  the  mechanical  stretching  caused  by  the 
Flexcell
®  unit.  In  this  case  the  cells  were  seeded  onto  elastic  membranes  where 
continuous cycles of cyclic strain were applied to the cell. The concentration of 250 
µg/ml of SPION was chosen as the optimum concentration for magnetic actuation. References 
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HRSMC were subjected to magnetic actuation for 1 hour per day at 1 Hz and 2 Hz for 
7 days. SQUID measurement have shown that SPION-loaded HRSMC in proliferation 
medium had 6 pg of SPION and in differentiation medium 16 pg of SPION. This is 
because SPION-loaded HRSMC have proliferated and increased the number of cells 
compared to SPION-loaded HRSMC in differentiation medium.  The force per cell is 
influenced by the position of the magnet  (0 degrees or 180 degrees) and the amount of 
SPION  internalised  by  the  cells.  The  SQUID  results  showed  that  SPION-loaded 
HRSMC in proliferation medium for 7 days had a reduced number of SPION therefore 
the force per cell is likely to have been decreased over time. For example, SPION-
loaded HRSCM in proliferation medium; from 14.4 pN (pre-actuation) to 5.4 pN after 
7  days  of  actuation.  On  the  other  hand  SPION-loaded  HRSMC  in  differentiation 
preserved the same force (14.4 pN) for 7 days.  
The  effect  of  magnetic  actuation  of  SPION-loaded  HRSMC  on  the  phenotype  and 
biocompatibility was investigated. The expression of the proliferative markers vimentin 
and tropomyosin 4 were not affected by either proliferation or differentiation medium, 
nor with magnetic actuation. For these markers an increase in the mRNA expression 
was  expected  when  HRSMC  were  incubated  in  proliferation  medium.  Further 
investigation is necessary to confirm these findings.  
SPION-loaded HRSMC in differentiation medium alone or with magnetic actuation did 
not show any increase in caldesmon or myosin heavy chain expression. This is because 
caldesmon  and  myosin  heavy  chain  are  intermediate  or  late  differentiation  markers 
(85). Therefore a longer incubation period (more than 7 days) perhaps was required.  
Previous mechanical study using the Flexcell system has found similar findings. The 
results showed that airway smooth muscle cells subjected to mechanical strain for 12 
days express myosin heavy chain protein as shown by western blot. (162) References 
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SPION-loaded  HRSMC  in  differentiation  medium  and  with  magnetic  actuation 
inhibited the expression of actin and calponin genes but no apparent differences were 
observed  in  the  protein  level.  This  finding  may  suggest  that  cells  were  maintained 
towards a proliferative phenotype. However this finding was not confirmed with cell 
proliferation assays.  
The  oscillating  magnetic  field  used  in  this  study  did  not  induce  a  change  in  cell 
proliferation when cells were incubated with proliferation or differentiation medium. 
However, different studies have demonstrated an increase in cell proliferation using 
static magnetic field (SMF) (164). Also mechanical studies using a Flexcell system 
have demonstrated that cyclic strain could enhance cell proliferation(89). Or reduce cell 
proliferation (165, 166) 
Based on the current findings, it is evident that the oscillating magnetic field produced 
by the magnetic actuator did affect the proliferation of cells or their differentiation. 
Incubation of SPION-loaded HRSMC in proliferation or differentiation medium with 
magnetic actuation did not have any effect on the biocompatibility of HRSMC.  
The  main  disadvantage  in  this  study  is  the  SPION-loaded  HRSMC  in  proliferation 
medium did not maintain the same amount of SPION per cell throughout the 7 days 
incubation period and that affected the force acting on the cells as well. That could 
explain also the fact that magnetic actuation did not cause any change in the phenotype 
of HRSMC. One way to overcome this limitation is to would be to deliver a sufficient 
amount of magnetic material in the area of interest that is going to be biocompatible but 
not biodegradable and will not be distributed with cell division. In this study, HRSMC 
were  seeded  on  a  rigid  surface  that  does  not  provide  a  good  simulation  of  the 
mechanical properties of tissue in vivo. Based on previous studies seeding cells on 
elastic  membranes  with  the  Flexcell  unit  that  affected  the  cell  proliferation  and References 
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differentiation. Future studies could use HRSMC seeded on elastic membranes before 
subjecting them to the same oscillating magnetic field used in this study. 
The effects of magnetic actuation on the biocompatibility of SPION-loaded HRSMC  
was investigated. No change was observed with LDH-toxicity assay or Caspase 3-7 
apoptosis assay and reactive oxygen species.  
Different studies have demonstrated that incubation of magnetite (Fe3O4) nanocrystals 
(MNC) 26 nm with HeLa cells induce cell apotptosis (163). In a different study the 
effect of static magnetic fields (0.5mT) on human keratinocytes (HaCaT) incubated 
with 15 mg/ml of SPION showed an increase in ROS production compared to control 
cells. (164).  Also, mouse liver cell line cells (NCTC 1469) were incubated with 0.5 
mM of SPION ferucarbotran (SHU 555A, Resovist) and were exposed to a SMF of 0.4 
T. The results showed an increase in apoptotic activity relative to the concentration of 
SPION whereas necrotic activity was only marginally changed by SMF exposure. An 
increase in the formation of reactive oxygen species was observed (142). 
From the previous findings can be concluded that the oscillating field is safe compared 
to a static magnetic field. Also the conditions used in this study such as the frequency 
are optimum for the magnetic actuation of cells. 
In Chapter 5 the movement of the SPION-loaded ‘’magnetosomes’’ was investigated 
with scanning electron microscopy and live cell imaging. Different type of SPION (200 
nm) and also stronger magnetic field was used therefore the amount of SPION per cells 
had significantly increased (100 pg of SPION). Therefore the magnetic force applied 
per cell was significantly increased compared to the magnetic actuator set-up in 
Chapter 4. This becuase no signifcant movement of the SPION-loaded magnetosomes 
was observed with the magnetic actuator therefore the change was necessary.  References 
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SEM images of SPION-loaded HRSMC showed evidence of membrane deformation in 
response to an externally applied magnetic field. Live cell imaging analysis revealed 
that SPION movement and plasma membrane deformation were more prominent on the 
Y-axis (movement upwards) confirming the SEM results. Movement was observed the 
X-axis  (movement  sideways)  by  the  plasma  membrane  for  200  nm  particles.  This 
suggests that the plasma membrane not only moved upwards but also sideways. The 
findings from this chapter suggest that magnetic actuation of SPION-loaded HRSMC 
causes the plasma membrane to move upwards and sideways. This is likely to cause 
deformation of the cytoskeleton. 
In a previous study the deformation of SPION-loaded endosomes were described. HeLa 
cells were incubated with 10 nM of cobalt ferrite nanoparticles (CoFe2O4) and exposed 
to  of  660  mT  magnetic  field.  The  results  showed  the  magnetic  endosomes  were 
elongated and aligned in the direction of the magnetic field (171). 
The limitation of this study was the use of Image J analysis to analyse the SPION 
movement and membrane deformation. A limitation of using this technique was that 
SPION or plasma membrane had to be measured separately, which made the combined 
assessment more difficult.  
Fluorescence energy transfer technology (FRET) has been used previously in order to 
quantify spatio-temporal changes in the cytoskeleton with the use of reporters, which 
label specific intracellular receptors. Many mechanical or magnetic stimulation studies 
have  incorporated  FRET  and  a  Src  reporter  which  regulates  the  integrin  activation 
followed by a mechanical stimuli (176, 177). Based on the FRET technology and the 
limitations encountered with the use of Image J in this chapter, a different approach to 
study the movement of could be used to study the effect of SPION movement and 
membrane deformation could be used. Microtubules are connected with endosomes References 
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with Rab5 protein (178, 179). A FRET green fluorescent protein (GFP)-Rab 5 could be 
developed for the visualisation of endosome and microtubule movement in response to 
an external magnetic field. 
6.2 Future work 
The magnetic actuation results from this study need further investigation because they 
might not have been optimal for achieving magnetic actuation of cells. For example, 
the strength of the magnets used, their orientation, and the frequency of the oscillating 
magnets together with the fact that the cells were seeded on a rigid bottom culture 
plates are all parameters that need further investigation. Based on the current results, 
the amount of internalized SPION was reduced after 7 days incubation; therefore the 
force  per  cell  was  not  constant  over  the  period  of  actuation.  This  issue  could  be 
overcome  by  using  a  different  type  of  magnetic  material  to  achieve  long-term 
actuation, such as different SPION that are not ejected from the cells.   
Stronger magnetic fields and/or static magnetic fields could be incorporated for a future 
study.  Also  the  amount  of  magnetic  material  endocytosed  by  the  cells  could  be 
increased  with  larger  diameter  particles  such  as  200  nm  instead  of  50  nm.  As 
demonstrated in chapter 5, SPION-loaded HRSCM with 200 nm had a greater effect 
and the deformation of the plasma membrane was more pronounced.  
It was observed that it was possible to achieve magnetic actuation of the cell membrane 
with  stronger  magnetic  fields.  Also  future  studies  could  involve  the  use  of  FRET 
imaging and magnetic twizzers in order to explore the cytoskeletal changes in response 
to an external magnetic field.  
Long-term cell studies (more than 7 days) will be necessary, as some of the markers 
such as myosin heavy chain or caldesmon require prolong incubation periods.  References 
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Animal studies were not conducted in this study. These will eventually be necessary to 
investigate the in vivo effects of magnetic actuation.  
Although  in  this  study  magnetic  actuation  of  SPION-Loaded  HRSMC  did  not 
demonstrate  any  significant  change  in  the  phenotype,  the  inhibition  of  actin  and 
calponin gene expression in SPION-loaded HRSMC without magnetic actuation is an 
interesting  finding  that  could  be  used  as  part  of  a  novel  therapeutic  approach  for 
controlling  muscle  regeneration  in  conditions  such  as  incontinence.  The  magnetic 
regulation of the smooth muscle phenotypic continuum is a very promising concept. 
The work presented within this thesis provides useful insights into novel approaches for 
muscle conditioning that could be utilized for human application. 
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